A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
Analogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation.
A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.
The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
Disorders related or resulting from use of amphetamines.
A genetically heterogeneous, multifaceted disorder characterized by short stature, webbed neck, ptosis, skeletal malformations, hypertelorism, hormonal imbalance, CRYPTORCHIDISM, multiple cardiac abnormalities (most commonly including PULMONARY VALVE STENOSIS), and some degree of INTELLECTUAL DISABILITY. The phenotype bears similarities to that of TURNER SYNDROME that occurs only in females and has its basis in a 45, X karyotype abnormality. Noonan syndrome occurs in both males and females with a normal karyotype (46,XX and 46,XY). Mutations in a several genes (PTPN11, KRAS, SOS1, NF1 and RAF1) have been associated the the NS phenotype. Mutations in PTPN11 are the most common. LEOPARD SYNDROME, a disorder that has clinical features overlapping those of Noonan Syndrome, is also due to mutations in PTPN11. In addition, there is overlap with the syndrome called neurofibromatosis-Noonan syndrome due to mutations in NF1.
Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.
A central nervous system stimulant and sympathomimetic with actions and uses similar to DEXTROAMPHETAMINE. The smokable form is a drug of abuse and is referred to as crank, crystal, crystal meth, ice, and speed.
An autosomal dominant disorder with an acronym of its seven features (LENTIGO; ELECTROCARDIOGRAM abnormalities; ocular HYPERTELORISM; PULMONARY STENOSIS; abnormal genitalia; retardation of growth; and DEAFNESS or SENSORINEURAL HEARING LOSS). This syndrome is caused by mutations of PTPN11 gene encoding the non-receptor PROTEIN TYROSINE PHOSPHATASE, type 11, and is an allelic to NOONAN SYNDROME. Features of LEOPARD syndrome overlap with those of NEUROFIBROMATOSIS 1 which is caused by mutations in the NEUROFIBROMATOSIS 1 GENES.
Anxiety disorders manifested by the development of characteristic symptoms following a psychologically traumatic event that is outside the normal range of usual human experience. Symptoms include re-experiencing the traumatic event, increased arousal, and numbing of responsiveness to or reduced involvement with the external world. Traumatic stress disorders can be further classified by the time of onset and the duration of these symptoms.
Movements or behaviors associated with sleep, sleep stages, or partial arousals from sleep that may impair sleep maintenance. Parasomnias are generally divided into four groups: arousal disorders, sleep-wake transition disorders, parasomnias of REM sleep, and nonspecific parasomnias. (From Thorpy, Sleep Disorders Medicine, 1994, p191)
A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence.
Sexual stimulation or gratification of the self.
A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
Removal of ENVIRONMENTAL POLLUTANTS or contaminants for the general protection of the environment. This is accomplished by various chemical, biological, and bulk movement methods, in conjunction with ENVIRONMENTAL MONITORING.
Detection of drugs that have been abused, overused, or misused, including legal and illegal drugs. Urine screening is the usual method of detection.
Categorical classification of MENTAL DISORDERS based on criteria sets with defining features. It is produced by the American Psychiatric Association. (DSM-IV, page xxii)
A class of traumatic stress disorders that is characterized by the significant dissociative states seen immediately after overwhelming trauma. By definition it cannot last longer than 1 month, if it persists, a diagnosis of post-traumatic stress disorder (STRESS DISORDERS, POST-TRAUMATIC) is more appropriate.
A characteristic symptom complex.
An anxiety disorder characterized by recurrent, persistent obsessions or compulsions. Obsessions are the intrusive ideas, thoughts, or images that are experienced as senseless or repugnant. Compulsions are repetitive and seemingly purposeful behavior which the individual generally recognizes as senseless and from which the individual does not derive pleasure although it may provide a release from tension.
The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM.
Persistent and disabling ANXIETY.
Those disorders that have a disturbance in mood as their predominant feature.
An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
Societies whose membership is limited to nurses.
An autosomal dominant disorder of CONNECTIVE TISSUE with abnormal features in the heart, the eye, and the skeleton. Cardiovascular manifestations include MITRAL VALVE PROLAPSE, dilation of the AORTA, and aortic dissection. Other features include lens displacement (ectopia lentis), disproportioned long limbs and enlarged DURA MATER (dural ectasia). Marfan syndrome is associated with mutations in the gene encoding fibrillin, a major element of extracellular microfibrils of connective tissue.
A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. (DSM-V)
One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action.
A group of inherited ectodermal dysplasias whose most prominent clinical feature is hypertrophic nail dystrophy resulting in PACHYONYCHIA. Several specific subtypes of pachyonychia congenita have been associated with mutations in genes that encode KERATINS.
A synuclein that is a major component of LEWY BODIES that plays a role in neurodegeneration and neuroprotection.
A syndrome characterized by CHRONIC KIDNEY FAILURE and GONADAL DYSGENESIS in phenotypic females with karyotype of 46,XY or female individual with a normal 46,XX karyotype. It is caused by donor splice-site mutations of Wilms tumor suppressor gene (GENES, WILMS TUMOR) on chromosome 11.
'Abnormalities, Multiple' is a broad term referring to the presence of two or more structural or functional anomalies in an individual, which may be genetic or environmental in origin, and can affect various systems and organs of the body.
Relatively invariant mode of behavior elicited or determined by a particular situation; may be verbal, postural, or expressive.
A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V)
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
The physical activity of a human or an animal as a behavioral phenomenon.
Disorders related to substance abuse.
A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS (supranuclear ophthalmoplegia); DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7)
Collection of pleomorphic cells in the caudal part of the anterior horn of the LATERAL VENTRICLE, in the region of the OLFACTORY TUBERCLE, lying between the head of the CAUDATE NUCLEUS and the ANTERIOR PERFORATED SUBSTANCE. It is part of the so-called VENTRAL STRIATUM, a composite structure considered part of the BASAL GANGLIA.
A heterogeneous group of hereditary and acquired disorders in which the KIDNEY contains one or more CYSTS unilaterally or bilaterally (KIDNEY, CYSTIC).
Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.
The observable response an animal makes to any situation.
The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment.
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.
Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness.
A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
Study of mental processes and behavior of schizophrenics.
A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
A microanalytical technique combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds.
April 25th -26th, 1986 nuclear power accident that occurred at Chernobyl in the former USSR (Ukraine) located 80 miles north of Kiev.
Drugs obtained and often manufactured illegally for the subjective effects they are said to produce. They are often distributed in urban areas, but are also available in suburban and rural areas, and tend to be grossly impure and may cause unexpected toxicity.
Diseases that affect the structure or function of the cerebellum. Cardinal manifestations of cerebellar dysfunction include dysmetria, GAIT ATAXIA, and MUSCLE HYPOTONIA.
Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake.
A group of hereditary disorders involving tissues and structures derived from the embryonic ectoderm. They are characterized by the presence of abnormalities at birth and involvement of both the epidermis and skin appendages. They are generally nonprogressive and diffuse. Various forms exist, including anhidrotic and hidrotic dysplasias, FOCAL DERMAL HYPOPLASIA, and aplasia cutis congenita.
Marked depression appearing in the involution period and characterized by hallucinations, delusions, paranoia, and agitation.
Drugs designed and synthesized, often for illegal street use, by modification of existing drug structures (e.g., amphetamines). Of special interest are MPTP (a reverse ester of meperidine), MDA (3,4-methylenedioxyamphetamine), and MDMA (3,4-methylenedioxymethamphetamine). Many drugs act on the aminergic system, the physiologically active biogenic amines.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
Agents that are used to suppress appetite.
An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake.
Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of dopaminergic neurons. They remove DOPAMINE from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS and are the target of DOPAMINE UPTAKE INHIBITORS.
Disturbances in mental processes related to learning, thinking, reasoning, and judgment.
A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company.
An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.
A family of homologous proteins of low MOLECULAR WEIGHT that are predominately expressed in the BRAIN and that have been implicated in a variety of human diseases. They were originally isolated from CHOLINERGIC FIBERS of TORPEDO.
Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE.
The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.
The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival.
Intracytoplasmic, eosinophilic, round to elongated inclusions found in vacuoles of injured or fragmented neurons. The presence of Lewy bodies is the histological marker of the degenerative changes in LEWY BODY DISEASE and PARKINSON DISEASE but they may be seen in other neurological conditions. They are typically found in the substantia nigra and locus coeruleus but they are also seen in the basal forebrain, hypothalamic nuclei, and neocortex.
A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable.
Elements of limited time intervals, contributing to particular results or situations.
A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
A class of traumatic stress disorders with symptoms that last more than one month. There are various forms of post-traumatic stress disorder, depending on the time of onset and the duration of these stress symptoms. In the acute form, the duration of the symptoms is between 1 to 3 months. In the chronic form, symptoms last more than 3 months. With delayed onset, symptoms develop more than 6 months after the traumatic event.
A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4)
The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition.
An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable.
Severe distortions in the development of many basic psychological functions that are not normal for any stage in development. These distortions are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements.
Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise.
A latent susceptibility to disease at the genetic level, which may be activated under certain conditions.
'Nerve tissue proteins' are specialized proteins found within the nervous system's biological tissue, including neurofilaments, neuronal cytoskeletal proteins, and neural cell adhesion molecules, which facilitate structural support, intracellular communication, and synaptic connectivity essential for proper neurological function.
The relationship between the dose of an administered drug and the response of the organism to the drug.
Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.
Microtubule-associated proteins that are mainly expressed in neurons. Tau proteins constitute several isoforms and play an important role in the assembly of tubulin monomers into microtubules and in maintaining the cytoskeleton and axonal transport. Aggregation of specific sets of tau proteins in filamentous inclusions is the common feature of intraneuronal and glial fibrillar lesions (NEUROFIBRILLARY TANGLES; NEUROPIL THREADS) in numerous neurodegenerative disorders (ALZHEIMER DISEASE; TAUOPATHIES).
Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury.
Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin.
An immunoenzyme test for the presence of drugs and other substances in urine and blood. The test uses enzyme linked antibodies that react only with the particular drug for which the sample is being tested.
The application of medical knowledge to questions of law.
The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.
Assessment of psychological variables by the application of mathematical procedures.
Drugs that bind to and activate dopamine receptors.
The age, developmental stage, or period of life at which a disease or the initial symptoms or manifestations of a disease appear in an individual.
The phylogenetically newer part of the CORPUS STRIATUM consisting of the CAUDATE NUCLEUS and PUTAMEN. It is often called simply the striatum.
Chlorinated analog of AMPHETAMINE. Potent neurotoxin that causes release and eventually depletion of serotonin in the CNS. It is used as a research tool.
A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D2-class receptor genes contain INTRONS, and the receptors inhibit ADENYLYL CYCLASES.
The terms, expressions, designations, or symbols used in a particular science, discipline, or specialized subject area.
A mutation in which a codon is mutated to one directing the incorporation of a different amino acid. This substitution may result in an inactive or unstable product. (From A Dictionary of Genetics, King & Stansfield, 5th ed)
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME.
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance.
A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents).
A repetitive and persistent pattern of behavior in which the basic rights of others or major age-appropriate societal norms or rules are violated. These behaviors include aggressive conduct that causes or threatens physical harm to other people or animals, nonaggressive conduct that causes property loss or damage, deceitfulness or theft, and serious violations of rules. The onset is before age 18. (From DSM-IV, 1994)
A technique for measuring extracellular concentrations of substances in tissues, usually in vivo, by means of a small probe equipped with a semipermeable membrane. Substances may also be introduced into the extracellular space through the membrane.
A group of compounds that are methyl derivatives of the amino acid TYROSINE.
Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue.
Biochemical identification of mutational changes in a nucleotide sequence.
A sympathomimetic drug used primarily as an appetite depressant. Its actions and mechanisms are similar to DEXTROAMPHETAMINE.
Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques.
Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.
An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.
Excessive movement of muscles of the body as a whole, which may be associated with organic or psychological disorders.
Disorders characterized by recurrent TICS that may interfere with speech and other activities. Tics are sudden, rapid, nonrhythmic, stereotyped motor movements or vocalizations which may be exacerbated by stress and are generally attenuated during absorbing activities. Tic disorders are distinguished from conditions which feature other types of abnormal movements that may accompany another another condition. (From DSM-IV, 1994)
Compounds with a five-membered heterocyclic ring with two nitrogens and a keto OXYGEN. Some are inhibitors of TNF-ALPHA production.
An infant during the first month after birth.
A phenethylamine found in EPHEDRA SINICA. PSEUDOEPHEDRINE is an isomer. It is an alpha- and beta-adrenergic agonist that may also enhance release of norepinephrine. It has been used for asthma, heart failure, rhinitis, and urinary incontinence, and for its central nervous system stimulatory effects in the treatment of narcolepsy and depression. It has become less extensively used with the advent of more selective agonists.
Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time.
Learning situations in which the sequence responses of the subject are instrumental in producing reinforcement. When the correct response occurs, which involves the selection from among a repertoire of responses, the subject is immediately reinforced.
A centrally active drug that apparently both blocks serotonin uptake and provokes transport-mediated serotonin release.
Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN.
Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
Elongated gray mass of the neostriatum located adjacent to the lateral ventricle of the brain.
A sympathomimetic agent with properties similar to DEXTROAMPHETAMINE. It is used in the treatment of obesity. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1222)
A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.
A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator.
The term "United States" in a medical context often refers to the country where a patient or study participant resides, and is not a medical term per se, but relevant for epidemiological studies, healthcare policies, and understanding differences in disease prevalence, treatment patterns, and health outcomes across various geographic locations.
The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS.
A personality disorder marked by a pattern of instability of interpersonal relationships, self-image, and affects, and marked impulsivity beginning by early adulthood and present in a variety of contexts. (DSM-IV)
Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes.
Drugs used for their effects on serotonergic systems. Among these are drugs that affect serotonin receptors, the life cycle of serotonin, and the survival of serotonergic neurons.
Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them.
Inbred C57BL mice are a strain of laboratory mice that have been produced by many generations of brother-sister matings, resulting in a high degree of genetic uniformity and homozygosity, making them widely used for biomedical research, including studies on genetics, immunology, cancer, and neuroscience.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
An object or a situation that can serve to reinforce a response, to satisfy a motive, or to afford pleasure.
A complex involuntary response to an unexpected strong stimulus usually auditory in nature.
Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by a another medical condition, by the direct effects of a substance, or by another mental disorder. The symptoms must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)
The action of a drug that may affect the activity, metabolism, or toxicity of another drug.
A region in the MESENCEPHALON which is dorsomedial to the SUBSTANTIA NIGRA and ventral to the RED NUCLEUS. The mesocortical and mesolimbic dopaminergic systems originate here, including an important projection to the NUCLEUS ACCUMBENS. Overactivity of the cells in this area has been suspected to contribute to the positive symptoms of SCHIZOPHRENIA.
Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation.
An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Conditions characterized by disturbances of usual sleep patterns or behaviors. Sleep disorders may be divided into three major categories: DYSSOMNIAS (i.e. disorders characterized by insomnia or hypersomnia), PARASOMNIAS (abnormal sleep behaviors), and sleep disorders secondary to medical or psychiatric disorders. (From Thorpy, Sleep Disorders Medicine, 1994, p187)
A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use.
A group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. (From Merck Index, 11th ed)
A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
A condition characterized by recurrent episodes of daytime somnolence and lapses in consciousness (microsomnias) that may be associated with automatic behaviors and AMNESIA. CATAPLEXY; SLEEP PARALYSIS, and hypnagogic HALLUCINATIONS frequently accompany narcolepsy. The pathophysiology of this disorder includes sleep-onset rapid eye movement (REM) sleep, which normally follows stage III or IV sleep. (From Neurology 1998 Feb;50(2 Suppl 1):S2-S7)
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
Disorders related or resulting from use of cocaine.
The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway.
Studies in which variables relating to an individual or group of individuals are assessed over a period of time.
Cell surface proteins that bind biogenic amines with high affinity and regulate intracellular signals which influence the behavior of cells. Biogenic amine is a chemically imprecise term which, by convention, includes the catecholamines epinephrine, norepinephrine, and dopamine, the indoleamine serotonin, the imidazolamine histamine, and compounds closely related to each of these.
An outbred strain of rats developed in 1915 by crossing several Wistar Institute white females with a wild gray male. Inbred strains have been derived from this original outbred strain, including Long-Evans cinnamon rats (RATS, INBRED LEC) and Otsuka-Long-Evans-Tokushima Fatty rats (RATS, INBRED OLETF), which are models for Wilson's disease and non-insulin dependent diabetes mellitus, respectively.
An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.
A substituted benzamide that has antipsychotic properties. It is a dopamine D2 receptor (see RECEPTORS, DOPAMINE D2) antagonist.
Administration of a drug or chemical by the individual under the direction of a physician. It includes administration clinically or experimentally, by human or animal.
Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters.
The tendency to explore or investigate a novel environment. It is considered a motivation not clearly distinguishable from curiosity.
A sympathomimetic that acts mainly by causing release of NOREPINEPHRINE but also has direct agonist activity at some adrenergic receptors. It is most commonly used as a nasal vasoconstrictor and an appetite depressant.
A filament-like structure consisting of a shaft which projects to the surface of the SKIN from a root which is softer than the shaft and lodges in the cavity of a HAIR FOLLICLE. It is found on most surfaces of the body.
A class of chemicals derived from barbituric acid or thiobarbituric acid. Many of these are GABA MODULATORS used as HYPNOTICS AND SEDATIVES, as ANESTHETICS, or as ANTICONVULSANTS.
Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.
The rostral part of the frontal lobe, bounded by the inferior precentral fissure in humans, which receives projection fibers from the MEDIODORSAL NUCLEUS OF THE THALAMUS. The prefrontal cortex receives afferent fibers from numerous structures of the DIENCEPHALON; MESENCEPHALON; and LIMBIC SYSTEM as well as cortical afferents of visual, auditory, and somatic origin.
Histochemical localization of immunoreactive substances using labeled antibodies as reagents.
Disorders characterized by proliferation of lymphoid tissue, general or unspecified.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells.
Movement or the ability to move from one place or another. It can refer to humans, vertebrate or invertebrate animals, and microorganisms.
An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use.
Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment.
A monoamine oxidase inhibitor with antihypertensive properties.
An organophosphorus cholinesterase inhibitor that is used as an insecticide and an acaricide.
Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall.
A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D1-class receptor genes lack INTRONS, and the receptors stimulate ADENYLYL CYCLASES.
A general term referring to the learning of some particular response.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
An act performed without delay, reflection, voluntary direction or obvious control in response to a stimulus.
Learning that takes place when a conditioned stimulus is paired with an unconditioned stimulus.
A selective, irreversible inhibitor of Type B monoamine oxidase. It is used in newly diagnosed patients with Parkinson's disease. It may slow progression of the clinical disease and delay the requirement for levodopa therapy. It also may be given with levodopa upon onset of disability. (From AMA Drug Evaluations Annual, 1994, p385) The compound without isomeric designation is Deprenyl.
The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.
A dopamine D2/D3 receptor agonist.
Fluoroimmunoassay where detection of the hapten-antibody reaction is based on measurement of the increased polarization of fluorescence-labeled hapten when it is combined with antibody. The assay is very useful for the measurement of small haptenic antigens such as drugs at low concentrations.
The ratio of the density of a material to the density of some standard material, such as water or air, at a specified temperature.
Disorders related to or resulting from abuse or mis-use of alcohol.
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters.
A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414)
An indirect sympathomimetic. Tyramine does not directly activate adrenergic receptors, but it can serve as a substrate for adrenergic uptake systems and monoamine oxidase so it prolongs the actions of adrenergic transmitters. It also provokes transmitter release from adrenergic terminals. Tyramine may be a neurotransmitter in some invertebrate nervous systems.
Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.
Propylamines are organic compounds consisting of an amino group (-NH2) attached to a propyl group (CH3CH2CH2-), which can act as central nervous system stimulants, local anesthetics, or vasopressors, depending on their specific chemical structure.
An exaggerated feeling of physical and emotional well-being not consonant with apparent stimuli or events; usually of psychologic origin, but also seen in organic brain disease and toxic states.
The largest and most lateral of the BASAL GANGLIA lying between the lateral medullary lamina of the GLOBUS PALLIDUS and the EXTERNAL CAPSULE. It is part of the neostriatum and forms part of the LENTIFORM NUCLEUS along with the GLOBUS PALLIDUS.
A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance.
Agents that are used to treat bipolar disorders or mania associated with other affective disorders.
Acquired or developmental conditions marked by an impaired ability to comprehend or generate spoken forms of language.
Neurotic reactions to unusual, severe, or overwhelming military stress.
A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors.
The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)
Biogenic amines having only one amine moiety. Included in this group are all natural monoamines formed by the enzymatic decarboxylation of natural amino acids.
A hallucinogen formerly used as a veterinary anesthetic, and briefly as a general anesthetic for humans. Phencyclidine is similar to KETAMINE in structure and in many of its effects. Like ketamine, it can produce a dissociative state. It exerts its pharmacological action through inhibition of NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE). As a drug of abuse, it is known as PCP and Angel Dust.

Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. (1/547)

We used a novel computerized decision-making task to compare the decision-making behavior of chronic amphetamine abusers, chronic opiate abusers, and patients with focal lesions of orbital prefrontal cortex (PFC) or dorsolateral/medial PFC. We also assessed the effects of reducing central 5-hydroxytryptamine (5-HT) activity using a tryptophan-depleting amino acid drink in normal volunteers. Chronic amphetamine abusers showed suboptimal decisions (correlated with years of abuse), and deliberated for significantly longer before making their choices. The opiate abusers exhibited only the second of these behavioral changes. Importantly, both sub-optimal choices and increased deliberation times were evident in the patients with damage to orbitofrontal PFC but not other sectors of PFC. Qualitatively, the performance of the subjects with lowered plasma tryptophan was similar to that associated with amphetamine abuse, consistent with recent reports of depleted 5-HT in the orbital regions of PFC of methamphetamine abusers. Overall, these data suggest that chronic amphetamine abusers show similar decision-making deficits to those seen after focal damage to orbitofrontal PFC. These deficits may reflect altered neuromodulation of the orbitofrontal PFC and interconnected limbic-striatal systems by both the ascending 5-HT and mesocortical dopamine (DA) projections.  (+info)

Methamphetamine abuse and emergency department utilization. (2/547)

Methamphetamine (MAP) abuse continues to increase worldwide, based on morbidity, mortality, drug treatment, and epidemiologic studies and surveys. MAP abuse has become a significant health care, environmental, and law enforcement problem. Acute intoxication often results in agitation, violence, and death. Chronic use may lead to infection, heart failure, malnutrition, and permanent psychiatric illness. MAP users frequently use the emergency department (ED) for their medical care. Over a 6-month period we studied the demographics, type, and frequency of medical and traumatic problems in 461 MAP patients presenting to our ED, which serves an area noted for high levels of MAP production and consumption. Comparison was made to the general ED population to assess use patterns. MAP patients were most commonly Caucasian males who lacked health insurance. Compared to other ED patients during this time, MAP patients used ambulance transport more and were more likely to be admitted to the hospital. There was a significant association between trauma and MAP use in this patient population. Our data suggest MAP users utilize prehospital and hospital resources at levels higher than the average ED population. Based on current trends, we can expect more ED visits by MAP users in the future.  (+info)

Methamphetamine and the expanding complications of amphetamines. (3/547)

During the past 10 years, the use of methamphetamine has increased rapidly in the West and throughout the United States. Because of this increase, our attention has focused on methamphetamine's toxicity. Methamphetamine and related compounds generate many of the same toxic effects as cocaine. Because of methamphetamine's widespread use, clinicians should be familiar with its medical effects and toxicity and with treatment options for acute and long-term effects of methamphetamine abuse.  (+info)

Amphetamine withdrawal alters bistable states and cellular coupling in rat prefrontal cortex and nucleus accumbens neurons recorded in vivo. (4/547)

Repeated amphetamine administration is known to produce changes in corticoaccumbens function that persist beyond termination of drug administration. We have found previously that long-term alteration in dopamine systems leads to changes in gap junction communication, expressed as dye coupling, between striatal neurons. In this study, the cellular bases of amphetamine-induced changes were examined using in vivo intracellular recordings and dye injection in ventral prefrontal-accumbens system neurons of control and amphetamine-treated rats. Rats that had been withdrawn from repeated amphetamine displayed a significant increase in the incidence of dye coupling in the prefrontal cortex and nucleus accumbens, which persisted for up to 28 d after withdrawal. The increased coupling was limited to projection neurons in both prefrontal cortical and accumbens brain regions, as identified by their axonal trajectory or the absence of interneuron-selective immunocytochemical markers. These changes occurred with no substantial loss of tyrosine hydroxylase-immunoreactive terminals in these cortical and accumbens regions, ruling out dopamine degeneration as a precipitating factor. Previous studies showed that nitric oxide plays a role in the regulation of coupling; however, amphetamine-withdrawn rats had fewer numbers of neurons and processes that stained for nitric oxide synthase immunoreactivity. In amphetamine-treated rats, a higher proportion of cortical cells fired in bursts, and a larger proportion of accumbens and prefrontal cortical neurons exhibited bistable membrane oscillations. By increasing corticoaccumbens transmission, amphetamine withdrawal may lead to neuronal synchronization via gap junctions. Furthermore, this adaptation to amphetamine treatment persists long after the drug is withdrawn.  (+info)

Effects of isradipine, a dihydropyridine-class calcium channel antagonist, on D-methamphetamine-induced cognitive and physiological changes in humans. (5/547)

D-methamphetamine is abused for its euphoric effects and stimulatory action on cognitive function. Its abuse can, however, be associated with massive hypertension resulting in strokes, ruptured aneurysms, or myocardial infarction. We examined the utility of isradipine, a dihydropyridine-class calcium channel antagonist, in treating d-methamphetamine induced hypertension and evaluated its effects on cognitive function, both of which are mediated by dopaminergic mechanisms. D-methamphetamine dose-dependently increased all vital signs (systolic, diastolic, and mean arterial pressure, and pulse rate) parameters. Isradipine significantly reduced d-methamphetamine-induced increases in diastolic and mean arterial pressure; however, this potentially beneficial therapeutic effect was offset by a significant reflex rise in pulse rate. D-methamphetamine also improved attention, accuracy of reasoning ability, and performance on computerized cognitive function tasks. D-methamphetamine's cognitive improving effects were not altered significantly by isradipine. Isradipine increased the false responding rate but was without significant effect on any other attentional task, or on reasoning ability, or performance. Isradipine does not appear to enhance cognitive function in healthy humans.  (+info)

Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram. (6/547)

3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") is a recreational drug that has been shown to release serotonin (5-HT) and dopamine (DA) in animals. The effect of MDMA on 5-HT release can be blocked by 5-HT uptake inhibitors such as citalopram, suggesting that MDMA interacts with the 5-HT uptake site. It is unknown whether this mechanism is also responsible for the psychological effects of MDMA in humans. We investigated the effect of citalopram pretreatment (40 mg iv) on the psychological effects of MDMA (1.5 mg/kg po) in a double-blind placebo-controlled psychometric study in 16 healthy human volunteers. MDMA produced an emotional state with heightened mood, increased self-confidence and extroversion, moderate derealization, and an intensification of sensory perception. Most of these effects were markedly reduced by citalopram. This finding suggests that the psychological effects of MDMA are mediated via action at the 5-HT uptake site to increase 5-HT release through the carrier, as expected from animal studies.  (+info)

Carbamazepine suppresses methamphetamine-induced Fos expression in a regionally specific manner in the rat brain. Possible neural substrates responsible for antimanic effects of mood stabilizers. (7/547)

Carbamazepine (CBZ) has been widely used for treatment of manic states. Because amphetamine produces effects in humans similar to those of idiopathic mania, acute methamphetamine administration could serve as a model of this condition. To elucidate the neurobiological substrates responsible for the antimanic effects of carbamazepine, this study investigated the effects of chronic carbamazepine administration on regional Fos protein expression induced by a single dose of methamphetamine (2mg/kg). Chronic treatment with CBZ (0.25% in food for 7 days, followed by 0.5% for 7 days; final mean serum carbamazepine concentration: 4.09 +/- 0.34 microg/ml) significantly attenuated the number of Fos-like immunoreactivity-positive nuclei induced by methamphetamine administration in the core of the nucleus accumbens and the caudate/putamen. The results indicate these brain regions are involved in the antimanic effects of carbamazepine.  (+info)

Substance abuse and the kidney. (8/547)

Substance abuse has been increasing steadily in the UK and some other countries. Recent evidence suggests more than 40% of young people have tried illicit drugs at some time. There are numerous medical consequences to recreational drug use, and a physician should always consider substance abuse in any unexplained illness. The renal complications of drug abuse are also becoming more frequent, and may encompass a spectrum of glomerular, interstitial and vascular diseases. Although some substances are directly nephrotoxic, a number of other mechanisms are also involved. These effects are often chronic and irreversible, but occasionally acute with possible recovery. The rapid growth of illicit drug use is clearly a major public health problem. We review the commonly used substances of abuse and their associations with renal disease.  (+info)

Amphetamine is a central nervous system stimulant drug that works by increasing the levels of certain neurotransmitters (chemical messengers) in the brain, such as dopamine and norepinephrine. It is used medically to treat conditions such as attention deficit hyperactivity disorder (ADHD), narcolepsy, and obesity, due to its appetite-suppressing effects.

Amphetamines can be prescribed in various forms, including tablets, capsules, or liquids, and are available under several brand names, such as Adderall, Dexedrine, and Vyvanse. They are also known by their street names, such as speed, uppers, or wake-ups, and can be abused for their euphoric effects and ability to increase alertness, energy, and concentration.

Long-term use of amphetamines can lead to dependence, tolerance, and addiction, as well as serious health consequences, such as cardiovascular problems, mental health disorders, and malnutrition. It is essential to use amphetamines only under the supervision of a healthcare provider and follow their instructions carefully.

Amphetamines are a type of central nervous system stimulant drug that increases alertness, wakefulness, and energy levels. They work by increasing the activity of certain neurotransmitters (chemical messengers) in the brain, such as dopamine and norepinephrine. Amphetamines can be prescribed for medical conditions such as attention deficit hyperactivity disorder (ADHD) and narcolepsy, but they are also commonly abused for their ability to produce euphoria, increase confidence, and improve performance in tasks that require sustained attention.

Some common examples of amphetamines include:

* Adderall: a combination of amphetamine and dextroamphetamine, used to treat ADHD and narcolepsy
* Dexedrine: a brand name for dextroamphetamine, used to treat ADHD and narcolepsy
* Vyvanse: a long-acting formulation of lisdexamfetamine, a prodrug that is converted to dextroamphetamine in the body, used to treat ADHD

Amphetamines can be taken orally, snorted, smoked, or injected. Long-term use or abuse of amphetamines can lead to a number of negative health consequences, including addiction, cardiovascular problems, malnutrition, mental health disorders, and memory loss.

Central nervous system (CNS) stimulants are a class of drugs that increase alertness, attention, energy, and/or mood by directly acting on the brain. They can be prescribed to treat medical conditions such as narcolepsy, attention deficit hyperactivity disorder (ADHD), and depression that has not responded to other treatments.

Examples of CNS stimulants include amphetamine (Adderall), methylphenidate (Ritalin, Concerta), and modafinil (Provigil). These medications work by increasing the levels of certain neurotransmitters, such as dopamine and norepinephrine, in the brain.

In addition to their therapeutic uses, CNS stimulants are also sometimes misused for non-medical reasons, such as to enhance cognitive performance or to get high. However, it's important to note that misusing these drugs can lead to serious health consequences, including addiction, cardiovascular problems, and mental health issues.

Dextroamphetamine is a central nervous system stimulant that is used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It works by increasing the levels of certain neurotransmitters, such as dopamine and norepinephrine, in the brain. Dextroamphetamine is available as a prescription medication and is sold under various brand names, including Adderall and Dexedrine. It is important to use this medication only as directed by a healthcare professional, as it can have potentially serious side effects if used improperly.

Amphetamine-related disorders are a category of mental disorders related to the use of amphetamines or similar stimulant drugs. According to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), there are several specific amphetamine-related disorders:

1. Amphetamine Use Disorder: This disorder is characterized by a problematic pattern of amphetamine use leading to clinically significant impairment or distress. The symptoms include increased tolerance, withdrawal, unsuccessful attempts to cut down or quit using, and continued use despite negative consequences.
2. Amphetamine Intoxication: This disorder occurs when an individual uses amphetamines and experiences symptoms such as agitation, aggression, hallucinations, delusions, tachycardia, hypertension, and elevated body temperature.
3. Amphetamine Withdrawal: This disorder is characterized by a cluster of symptoms that occur after cessation or reduction in amphetamine use, including dysphoric mood, fatigue, increased appetite, sleep disturbances, vivid dreams, and slowing of psychomotor activity.
4. Other Specified Amphetamine-Related Disorder: This category is used when an individual experiences significant problems related to amphetamine use that do not meet the full criteria for any of the other disorders in this category.
5. Unspecified Amphetamine-Related Disorder: This category is used when an individual experiences significant problems related to amphetamine use, but the specific diagnosis cannot be determined due to insufficient information or because the clinician chooses not to specify the reason.

It's important to note that amphetamines are a class of drugs that include prescription stimulants such as Adderall and Ritalin, as well as illicit substances like methamphetamine. Amphetamine-related disorders can have serious consequences for an individual's physical and mental health, relationships, and overall quality of life.

Noonan Syndrome is a genetic disorder that affects various parts of the body and is characterized by distinctive facial features, short stature, heart defects, and developmental delays. It is caused by mutations in genes responsible for regulating cell growth and division. The syndrome is often identified at birth or in early childhood due to its physical manifestations, which may include widely spaced eyes, low-set ears, a short neck, a broad or webbed neck, chest deformities, and pulmonary valve stenosis. Noonan Syndrome affects both sexes and all races equally, with an estimated prevalence of 1 in 1,000 to 1 in 2,500 live births.

A mental disorder is a syndrome characterized by clinically significant disturbance in an individual's cognition, emotion regulation, or behavior. It's associated with distress and/or impaired functioning in social, occupational, or other important areas of life, often leading to a decrease in quality of life. These disorders are typically persistent and can be severe and disabling. They may be related to factors such as genetics, early childhood experiences, or trauma. Examples include depression, anxiety disorders, bipolar disorder, schizophrenia, and personality disorders. It's important to note that a diagnosis should be made by a qualified mental health professional.

Methamphetamine is a powerful, highly addictive central nervous system stimulant that affects brain chemistry, leading to mental and physical dependence. Its chemical formula is N-methylamphetamine, and it is structurally similar to amphetamine but has additional methyl group, which makes it more potent and longer-lasting.

Methamphetamine exists in various forms, including crystalline powder (commonly called "meth" or "crystal meth") and a rocklike form called "glass." It can be taken orally, snorted, smoked, or injected after being dissolved in water or alcohol.

Methamphetamine use leads to increased levels of dopamine, a neurotransmitter responsible for reward, motivation, and reinforcement, resulting in euphoria, alertness, and energy. Prolonged use can cause severe psychological and physiological harm, including addiction, psychosis, cardiovascular issues, dental problems (meth mouth), and cognitive impairments.

LEOPARD syndrome is a rare genetic disorder that is characterized by multiple lentigines (freckle-like spots), electrocardiographic abnormalities, ocular hypertelorism (wide-set eyes), pulmonic stenosis (narrowing of the pulmonary valve opening), abnormal genitalia, retardation of growth, and deafness. It is caused by mutations in the PTPN11 gene, which provides instructions for making a protein called SHP-2. This protein plays important roles in signaling pathways that control various cellular functions, such as cell growth and division. The signs and symptoms of LEOPARD syndrome can vary widely among affected individuals, even among members of the same family. Treatment is typically focused on managing the specific features of the condition in each individual.

Traumatic stress disorders are a category of mental health conditions that occur after exposure to a traumatic event or series of events. The Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) recognizes several types of traumatic stress disorders, including:

1. Post-Traumatic Stress Disorder (PTSD): This disorder occurs after a person experiences or witnesses a traumatic event, such as combat, sexual assault, or a natural disaster. Symptoms include avoidance of reminders of the trauma, intrusive thoughts about the event, negative changes in mood and cognition, alterations in arousal and reactivity, and disturbances in sleep and concentration.
2. Acute Stress Disorder (ASD): This disorder is similar to PTSD but has a shorter duration. It occurs after exposure to a traumatic event and lasts for less than a month. Symptoms include dissociation, intrusive thoughts about the event, and avoidance of reminders of the trauma.
3. Adjustment Disorders: These disorders occur in response to a stressor or change in life circumstances, such as the loss of a job or the death of a loved one. Symptoms include anxiety, depression, and disturbances in conduct.
4. Reactive Attachment Disorder (RAD) and Disinhibited Social Engagement Disorder (DSED): These disorders occur in children who have experienced neglect or abuse and have difficulty forming attachments to caregivers.

It's important to note that traumatic stress disorders can have significant impacts on a person's daily functioning, relationships, and overall well-being. If you or someone you know is experiencing symptoms of a traumatic stress disorder, it's essential to seek professional help from a mental health provider.

Parasomnias are a category of sleep disorders that involve unwanted physical events or experiences that occur while falling asleep, sleeping, or waking up. These behaviors can include abnormal movements, talk, emotions, perceptions, or dreams. Parasomnias can be caused by various factors such as stress, alcohol, certain medications, or underlying medical conditions. Some examples of parasomnias are sleepwalking, night terrors, sleep talking, and REM sleep behavior disorder. These disorders can disrupt sleep and cause distress to the individual and their bed partner.

Bipolar disorder, also known as manic-depressive illness, is a mental health condition that causes extreme mood swings that include emotional highs (mania or hypomania) and lows (depression). When you become depressed, you may feel sad or hopeless and lose interest or pleasure in most activities. When your mood shifts to mania or hypomania (a less severe form of mania), you may feel euphoric, full of energy, or unusually irritable. These mood swings can significantly affect your job, school, relationships, and overall quality of life.

Bipolar disorder is typically characterized by the presence of one or more manic or hypomanic episodes, often accompanied by depressive episodes. The episodes may be separated by periods of normal mood, but in some cases, a person may experience rapid cycling between mania and depression.

There are several types of bipolar disorder, including:

* Bipolar I Disorder: This type is characterized by the occurrence of at least one manic episode, which may be preceded or followed by hypomanic or major depressive episodes.
* Bipolar II Disorder: This type involves the presence of at least one major depressive episode and at least one hypomanic episode, but no manic episodes.
* Cyclothymic Disorder: This type is characterized by numerous periods of hypomania and depression that are not severe enough to meet the criteria for a full manic or depressive episode.
* Other Specified and Unspecified Bipolar and Related Disorders: These categories include bipolar disorders that do not fit the criteria for any of the other types.

The exact cause of bipolar disorder is unknown, but it appears to be related to a combination of genetic, environmental, and neurochemical factors. Treatment typically involves a combination of medication, psychotherapy, and lifestyle changes to help manage symptoms and prevent relapses.

Masturbation is the self-stimulation of the genitals to achieve sexual pleasure or orgasm. It's a normal and healthy sexual behavior that is commonly practiced by people of all ages, gender identities, and sexual orientations. Masturbation is generally considered safe and has few, if any, negative physical side effects.

It's important to note that masturbation is a personal choice, and individuals should feel comfortable and unpressured in their decision to engage in this behavior or not. Some people may choose not to masturbate due to personal, cultural, or religious beliefs, while others may find it to be a valuable way to explore their bodies, learn about their sexual responses, and relieve sexual tension.

If you have any concerns or questions about masturbation, it's always a good idea to speak with a healthcare provider who can provide you with accurate information and address any concerns you may have.

Schizophrenia is a severe mental disorder characterized by disturbances in thought, perception, emotion, and behavior. It often includes hallucinations (usually hearing voices), delusions, paranoia, and disorganized speech and behavior. The onset of symptoms typically occurs in late adolescence or early adulthood. Schizophrenia is a complex, chronic condition that requires ongoing treatment and management. It significantly impairs social and occupational functioning, and it's often associated with reduced life expectancy due to comorbid medical conditions. The exact causes of schizophrenia are not fully understood, but research suggests that genetic, environmental, and neurodevelopmental factors play a role in its development.

Psychotic disorders are a group of severe mental health conditions characterized by distorted perceptions, thoughts, and emotions that lead to an inability to recognize reality. The two most common symptoms of psychotic disorders are hallucinations and delusions. Hallucinations are when a person sees, hears, or feels things that aren't there, while delusions are fixed, false beliefs that are not based on reality.

Other symptoms may include disorganized speech, disorganized behavior, catatonic behavior, and negative symptoms such as apathy and lack of emotional expression. Schizophrenia is the most well-known psychotic disorder, but other types include schizoaffective disorder, delusional disorder, brief psychotic disorder, shared psychotic disorder, and substance-induced psychotic disorder.

Psychotic disorders can be caused by a variety of factors, including genetics, brain chemistry imbalances, trauma, and substance abuse. Treatment typically involves a combination of medication, therapy, and support services to help manage symptoms and improve quality of life.

Environmental remediation is the process of treating, removing, or containing contamination from environmental media such as soil, groundwater, sediment, or surface water for the purpose of reducing the impact on human health and the environment. The goal of environmental remediation is to return the contaminated area to its original state, or to a state that is safe for use and poses no significant risk to human health or the environment. This process often involves various techniques such as excavation, soil washing, bioremediation, chemical treatment, and thermal treatment. The specific method used depends on the type and extent of contamination, as well as site-specific conditions.

Substance abuse detection refers to the process of identifying the use or misuse of psychoactive substances, such as alcohol, illicit drugs, or prescription medications, in an individual. This can be done through various methods, including:

1. Physical examination: A healthcare professional may look for signs of substance abuse, such as track marks, enlarged pupils, or unusual behavior.
2. Laboratory tests: Urine, blood, hair, or saliva samples can be analyzed to detect the presence of drugs or their metabolites. These tests can provide information about recent use (hours to days) or longer-term use (up to several months).
3. Self-report measures: Individuals may be asked to complete questionnaires or interviews about their substance use patterns and behaviors.
4. Observational assessments: In some cases, such as in a treatment setting, healthcare professionals may observe an individual's behavior over time to identify patterns of substance abuse.

Substance abuse detection is often used in clinical, workplace, or legal settings to assess individuals for potential substance use disorders, monitor treatment progress, or ensure compliance with laws or regulations.

The Diagnostic and Statistical Manual of Mental Disorders (DSM) is a publication of the American Psychiatric Association (APA) that provides diagnostic criteria for mental disorders. It is widely used by mental health professionals in the United States and around the world to diagnose and classify mental health conditions.

The DSM includes detailed descriptions of symptoms, clinical examples, and specific criteria for each disorder, which are intended to facilitate accurate diagnosis and improve communication among mental health professionals. The manual is regularly updated to reflect current research and clinical practice, with the most recent edition being the DSM-5, published in 2013.

It's important to note that while the DSM is a valuable tool for mental health professionals, it is not without controversy. Some critics argue that the manual medicalizes normal human experiences and that its categories may be too broad or overlapping. Nonetheless, it remains an essential resource for clinicians, researchers, and policymakers in the field of mental health.

Traumatic acute stress disorder is a short-term mental health condition that occurs in response to a traumatic or stressful event. According to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), it is characterized by the development of various symptoms, such as intrusive memories of the traumatic event, avoidance of reminders of the event, negative mood and cognitions, marked autonomic arousal, and sleep disturbances. These symptoms usually occur within one month after the traumatic event and last for no more than three months.

Acute stress disorder is different from post-traumatic stress disorder (PTSD) in that it has a shorter duration and does not involve some of the more severe symptoms associated with PTSD, such as avoidance behaviors, negative alterations in cognitions and mood, and persistent symptoms of increased arousal. Additionally, acute stress disorder may be more likely to resolve on its own without treatment, while PTSD typically requires professional intervention.

It's important to note that experiencing a traumatic event can have long-lasting effects on mental health, and it is essential to seek help from a qualified mental health professional if symptoms persist or interfere with daily functioning.

A syndrome, in medical terms, is a set of symptoms that collectively indicate or characterize a disease, disorder, or underlying pathological process. It's essentially a collection of signs and/or symptoms that frequently occur together and can suggest a particular cause or condition, even though the exact physiological mechanisms might not be fully understood.

For example, Down syndrome is characterized by specific physical features, cognitive delays, and other developmental issues resulting from an extra copy of chromosome 21. Similarly, metabolic syndromes like diabetes mellitus type 2 involve a group of risk factors such as obesity, high blood pressure, high blood sugar, and abnormal cholesterol or triglyceride levels that collectively increase the risk of heart disease, stroke, and diabetes.

It's important to note that a syndrome is not a specific diagnosis; rather, it's a pattern of symptoms that can help guide further diagnostic evaluation and management.

Obsessive-Compulsive Disorder (OCD) is a mental health disorder characterized by the presence of obsessions and compulsions. Obsessions are recurrent and persistent thoughts, urges, or images that are intrusive, unwanted, and often distressing. Compulsions are repetitive behaviors or mental acts that an individual feels driven to perform in response to an obsession or according to rigid rules, and which are aimed at preventing or reducing anxiety or distress, or preventing some dreaded event or situation. These obsessions and/or compulsions cause significant distress, take up a lot of time (an hour or more a day), and interfere with the individual's daily life, including social activities, relationships, and work or school performance. OCD is considered a type of anxiety disorder and can also co-occur with other mental health conditions.

The brain is the central organ of the nervous system, responsible for receiving and processing sensory information, regulating vital functions, and controlling behavior, movement, and cognition. It is divided into several distinct regions, each with specific functions:

1. Cerebrum: The largest part of the brain, responsible for higher cognitive functions such as thinking, learning, memory, language, and perception. It is divided into two hemispheres, each controlling the opposite side of the body.
2. Cerebellum: Located at the back of the brain, it is responsible for coordinating muscle movements, maintaining balance, and fine-tuning motor skills.
3. Brainstem: Connects the cerebrum and cerebellum to the spinal cord, controlling vital functions such as breathing, heart rate, and blood pressure. It also serves as a relay center for sensory information and motor commands between the brain and the rest of the body.
4. Diencephalon: A region that includes the thalamus (a major sensory relay station) and hypothalamus (regulates hormones, temperature, hunger, thirst, and sleep).
5. Limbic system: A group of structures involved in emotional processing, memory formation, and motivation, including the hippocampus, amygdala, and cingulate gyrus.

The brain is composed of billions of interconnected neurons that communicate through electrical and chemical signals. It is protected by the skull and surrounded by three layers of membranes called meninges, as well as cerebrospinal fluid that provides cushioning and nutrients.

Anxiety disorders are a category of mental health disorders characterized by feelings of excessive and persistent worry, fear, or anxiety that interfere with daily activities. They include several different types of disorders, such as:

1. Generalized Anxiety Disorder (GAD): This is characterized by chronic and exaggerated worry and tension, even when there is little or nothing to provoke it.
2. Panic Disorder: This is characterized by recurring unexpected panic attacks and fear of experiencing more panic attacks.
3. Social Anxiety Disorder (SAD): Also known as social phobia, this is characterized by excessive fear, anxiety, or avoidance of social situations due to feelings of embarrassment, self-consciousness, and concern about being judged or viewed negatively by others.
4. Phobias: These are intense, irrational fears of certain objects, places, or situations. When a person with a phobia encounters the object or situation they fear, they may experience panic attacks or other severe anxiety responses.
5. Agoraphobia: This is a fear of being in places where it may be difficult to escape or get help if one has a panic attack or other embarrassing or incapacitating symptoms.
6. Separation Anxiety Disorder (SAD): This is characterized by excessive anxiety about separation from home or from people to whom the individual has a strong emotional attachment (such as a parent, sibling, or partner).
7. Selective Mutism: This is a disorder where a child becomes mute in certain situations, such as at school, but can speak normally at home or with close family members.

These disorders are treatable with a combination of medication and psychotherapy (cognitive-behavioral therapy, exposure therapy). It's important to seek professional help if you suspect that you or someone you know may have an anxiety disorder.

Mood disorders are a category of mental health disorders characterized by significant and persistent changes in mood, affect, and emotional state. These disorders can cause disturbances in normal functioning and significantly impair an individual's ability to carry out their daily activities. The two primary types of mood disorders are depressive disorders (such as major depressive disorder or persistent depressive disorder) and bipolar disorders (which include bipolar I disorder, bipolar II disorder, and cyclothymic disorder).

Depressive disorders involve prolonged periods of low mood, sadness, hopelessness, and a lack of interest in activities. Individuals with these disorders may also experience changes in sleep patterns, appetite, energy levels, concentration, and self-esteem. In severe cases, they might have thoughts of death or suicide.

Bipolar disorders involve alternating episodes of mania (or hypomania) and depression. During a manic episode, individuals may feel extremely elated, energetic, or irritable, with racing thoughts, rapid speech, and impulsive behavior. They might engage in risky activities, have decreased sleep needs, and display poor judgment. In contrast, depressive episodes involve the same symptoms as depressive disorders.

Mood disorders can be caused by a combination of genetic, biological, environmental, and psychological factors. Proper diagnosis and treatment, which may include psychotherapy, medication, or a combination of both, are essential for managing these conditions and improving quality of life.

N-Methyl-3,4-methylenedioxyamphetamine (also known as MDA) is a synthetic psychoactive drug that belongs to the class of amphetamines. It acts as a central nervous system stimulant and hallucinogen. Chemically, it is a derivative of amphetamine with an additional methylenedioxy ring attached to the 3,4 positions on the aromatic ring. MDA is known for its empathogenic effects, meaning that it can produce feelings of empathy, emotional openness, and euphoria in users. It has been used recreationally as a party drug and at raves, but it also has potential therapeutic uses. However, MDA can have serious side effects, including increased heart rate and blood pressure, hyperthermia, dehydration, and in some cases, serotonin syndrome. As with other psychoactive drugs, MDA should only be used under medical supervision and with a clear understanding of its potential risks and benefits.

A nursing society is a professional organization composed of registered nurses and other healthcare professionals who share a common mission, vision, and goals to advance the nursing profession and improve patient care. These societies provide a platform for members to collaborate, network, and exchange knowledge and ideas related to their practice, research, education, and policy-making. They offer various opportunities for professional development, including conferences, seminars, workshops, publications, and awards. Nursing societies also advocate for the rights and interests of nurses and patients at local, national, and international levels. Examples of nursing societies include the American Nurses Association (ANA), the International Council of Nurses (ICN), and the Society of Pediatric Nurses (SPN).

Marfan syndrome is a genetic disorder that affects the body's connective tissue. Connective tissue helps to strengthen and support various structures in the body, including the skin, ligaments, blood vessels, and heart. In Marfan syndrome, the body produces an abnormal amount of a protein called fibrillin-1, which is a key component of connective tissue. This leads to problems with the formation and function of connective tissue throughout the body.

The most serious complications of Marfan syndrome typically involve the heart and blood vessels. The aorta, which is the large artery that carries blood away from the heart, can become weakened and stretched, leading to an increased risk of aortic dissection or rupture. Other common features of Marfan syndrome include long, thin fingers and toes; tall stature; a curved spine; and eye problems such as nearsightedness and lens dislocation.

Marfan syndrome is usually inherited in an autosomal dominant pattern, which means that a child has a 50% chance of inheriting the gene mutation from a parent who has the condition. However, about 25% of cases are the result of a new mutation and occur in people with no family history of the disorder. There is no cure for Marfan syndrome, but treatment can help to manage the symptoms and reduce the risk of complications.

Autistic Disorder, also known as Autism or Classic Autism, is a neurodevelopmental disorder that affects communication and behavior. It is characterized by:

1. Persistent deficits in social communication and social interaction across multiple contexts, including:
* Deficits in social-emotional reciprocity;
* Deficits in nonverbal communicative behaviors used for social interaction;
* Deficits in developing, maintaining, and understanding relationships.
2. Restricted, repetitive patterns of behavior, interests, or activities, as manifested by at least two of the following:
* Stereotyped or repetitive motor movements, use of objects, or speech;
* Insistence on sameness, inflexible adherence to routines, or ritualized patterns of verbal or nonverbal behavior;
* Highly restricted, fixated interests that are abnormal in intensity or focus;
* Hyper- or hyporeactivity to sensory input or unusual interest in sensory aspects of the environment.
3. Symptoms must be present in the early developmental period (but may not become fully manifest until social demands exceed limited capacities) and limit or impair everyday functioning.
4. Symptoms do not occur exclusively during the course of a schizophrenia spectrum disorder or other psychotic disorders.

Autistic Disorder is part of the autism spectrum disorders (ASDs), which also include Asperger's Syndrome and Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS). The current diagnostic term for this category of conditions, according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), is Autism Spectrum Disorder.

Dopamine is a type of neurotransmitter, which is a chemical messenger that transmits signals in the brain and nervous system. It plays several important roles in the body, including:

* Regulation of movement and coordination
* Modulation of mood and motivation
* Control of the reward and pleasure centers of the brain
* Regulation of muscle tone
* Involvement in memory and attention

Dopamine is produced in several areas of the brain, including the substantia nigra and the ventral tegmental area. It is released by neurons (nerve cells) and binds to specific receptors on other neurons, where it can either excite or inhibit their activity.

Abnormalities in dopamine signaling have been implicated in several neurological and psychiatric conditions, including Parkinson's disease, schizophrenia, and addiction.

Pachyonychia Congenita (PC) is a rare genetic disorder characterized by thickened and abnormally shaped nails, painful blisters on the skin, and thickened palms and soles. The condition is caused by mutations in genes responsible for producing keratin proteins, which are essential components of our skin, hair, and nails.

There are two main types of PC: Type 1 (Jadassohn-Lewandowsky syndrome) and Type 2 (Jackson-Lawler syndrome). Both types have similar symptoms but may vary in severity. The symptoms typically appear at birth or within the first few years of life.

The medical definition of Pachyonychia Congenita includes:

1. Nails: Thickening and overcurvature of the nails, often with a yellow-white discoloration.
2. Skin: Formation of blisters and calluses on pressure points such as hands, feet, knees, and elbows. These blisters can be painful and may lead to secondary infections.
3. Palms and soles: Hyperkeratosis (thickening) of the skin on the palms and soles, causing discomfort or pain while walking or performing manual tasks.
4. Mucous membranes: In some cases, the condition can also affect the mucous membranes, leading to oral lesions and thickened vocal cords.
5. Genetics: PC is an autosomal dominant disorder, meaning that only one copy of the mutated gene inherited from either parent is sufficient to cause the disease. However, some cases may result from spontaneous mutations in the affected individual.

Alpha-synuclein is a protein that is primarily found in neurons (nerve cells) in the brain. It is encoded by the SNCA gene and is abundantly expressed in presynaptic terminals, where it is believed to play a role in the regulation of neurotransmitter release.

In certain neurological disorders, including Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy, alpha-synuclein can form aggregates known as Lewy bodies and Lewy neurites. These aggregates are a pathological hallmark of these diseases and are believed to contribute to the death of nerve cells, leading to the symptoms associated with these disorders.

The precise function of alpha-synuclein is not fully understood, but it is thought to be involved in various cellular processes such as maintaining the structure of the presynaptic terminal, regulating synaptic vesicle trafficking and neurotransmitter release, and protecting neurons from stress.

I'm sorry for any confusion, but "Frasier Syndrome" is not a recognized medical condition or syndrome in the standard medical literature. It seems like it might be a term that is specific to a certain context or fictional work. In popular culture, "Frasier" is a television show about a character named Frasier Crane, and it's possible that "Frasier Syndrome" could refer to something within the realm of that fiction. However, without more specific information about where you encountered this term, I cannot provide an accurate definition.

'Abnormalities, Multiple' is a broad term that refers to the presence of two or more structural or functional anomalies in an individual. These abnormalities can be present at birth (congenital) or can develop later in life (acquired). They can affect various organs and systems of the body and can vary greatly in severity and impact on a person's health and well-being.

Multiple abnormalities can occur due to genetic factors, environmental influences, or a combination of both. Chromosomal abnormalities, gene mutations, exposure to teratogens (substances that cause birth defects), and maternal infections during pregnancy are some of the common causes of multiple congenital abnormalities.

Examples of multiple congenital abnormalities include Down syndrome, Turner syndrome, and VATER/VACTERL association. Acquired multiple abnormalities can result from conditions such as trauma, infection, degenerative diseases, or cancer.

The medical evaluation and management of individuals with multiple abnormalities depend on the specific abnormalities present and their impact on the individual's health and functioning. A multidisciplinary team of healthcare professionals is often involved in the care of these individuals to address their complex needs.

Stereotyped behavior, in the context of medicine and psychology, refers to repetitive, rigid, and invariant patterns of behavior or movements that are purposeless and often non-functional. These behaviors are not goal-directed or spontaneous and typically do not change in response to environmental changes or social interactions.

Stereotypies can include a wide range of motor behaviors such as hand flapping, rocking, head banging, body spinning, self-biting, or complex sequences of movements. They are often seen in individuals with developmental disabilities, intellectual disabilities, autism spectrum disorder, and some mental health conditions.

Stereotyped behaviors can also be a result of substance abuse, neurological disorders, or brain injuries. In some cases, these behaviors may serve as a self-soothing mechanism or a way to cope with stress, anxiety, or boredom. However, they can also interfere with daily functioning and social interactions, and in severe cases, may cause physical harm to the individual.

Attention Deficit Hyperactivity Disorder (ADHD) with hyperactivity is a neurodevelopmental disorder that affects both children and adults. The condition is characterized by symptoms including:

1. Difficulty paying attention or staying focused on a single task
2. Impulsivity, or acting without thinking
3. Hyperactivity, or excessive fidgeting, restlessness, or talking

In order to be diagnosed with ADHD with hyperactivity, an individual must exhibit these symptoms to a degree that is developmentally inappropriate and interferes with their daily functioning. Additionally, the symptoms must have been present for at least six months and be present in multiple settings (e.g., at home, school, work).

It's important to note that ADHD can manifest differently in different people, and some individuals may experience predominantly inattentive or impulsive symptoms rather than hyperactive ones. However, when the hyperactive component is prominent, it is referred to as ADHD with hyperactivity.

Effective treatments for ADHD with hyperactivity include a combination of medication (such as stimulants) and behavioral therapy. With appropriate treatment, individuals with ADHD can learn to manage their symptoms and lead successful, fulfilling lives.

A mutation is a permanent change in the DNA sequence of an organism's genome. Mutations can occur spontaneously or be caused by environmental factors such as exposure to radiation, chemicals, or viruses. They may have various effects on the organism, ranging from benign to harmful, depending on where they occur and whether they alter the function of essential proteins. In some cases, mutations can increase an individual's susceptibility to certain diseases or disorders, while in others, they may confer a survival advantage. Mutations are the driving force behind evolution, as they introduce new genetic variability into populations, which can then be acted upon by natural selection.

3,4-Methylenedioxyamphetamine (MDA) is a psychoactive drug that belongs to the amphetamine class. It is also known as "ecstasy" or "molly." MDA acts as a stimulant, hallucinogen, and entactogen, which means it can produce feelings of increased energy, emotional warmth, and empathy.

MDA is illegal in many countries, including the United States, due to its potential for abuse and the risk of serious adverse effects. Some of the negative consequences associated with MDA use include nausea, vomiting, muscle tension, teeth grinding, increased heart rate and blood pressure, and hyperthermia (elevated body temperature). In high doses or when used in combination with other substances, MDA can cause seizures, coma, and even death.

It is important to note that the use of illegal drugs like MDA carries significant legal and health risks. If you are concerned about your own or someone else's drug use, it is recommended that you seek help from a qualified healthcare professional.

"Motor activity" is a general term used in the field of medicine and neuroscience to refer to any kind of physical movement or action that is generated by the body's motor system. The motor system includes the brain, spinal cord, nerves, and muscles that work together to produce movements such as walking, talking, reaching for an object, or even subtle actions like moving your eyes.

Motor activity can be voluntary, meaning it is initiated intentionally by the individual, or involuntary, meaning it is triggered automatically by the nervous system without conscious control. Examples of voluntary motor activity include deliberately lifting your arm or kicking a ball, while examples of involuntary motor activity include heartbeat, digestion, and reflex actions like jerking your hand away from a hot stove.

Abnormalities in motor activity can be a sign of neurological or muscular disorders, such as Parkinson's disease, cerebral palsy, or multiple sclerosis. Assessment of motor activity is often used in the diagnosis and treatment of these conditions.

Substance-related disorders, as defined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), refer to a group of conditions caused by the use of substances such as alcohol, drugs, or medicines. These disorders are characterized by a problematic pattern of using a substance that leads to clinically significant impairment or distress. They can be divided into two main categories: substance use disorders and substance-induced disorders. Substance use disorders involve a pattern of compulsive use despite negative consequences, while substance-induced disorders include conditions such as intoxication, withdrawal, and substance/medication-induced mental disorders. The specific diagnosis depends on the type of substance involved, the patterns of use, and the presence or absence of physiological dependence.

Progressive Supranuclear Palsy (PSP) is a rare neurological disorder characterized by the progressive degeneration of brain cells that regulate movement, thoughts, behavior, and eye movements. The term "supranuclear" refers to the location of the damage in the brain, specifically above the level of the "nuclei" which are clusters of nerve cells that control voluntary movements.

The most common early symptom of PSP is a loss of balance and difficulty coordinating eye movements, particularly vertical gaze. Other symptoms may include stiffness or rigidity of muscles, slowness of movement, difficulty swallowing, changes in speech and writing, and cognitive decline leading to dementia.

PSP typically affects people over the age of 60, and its progression can vary from person to person. Currently, there is no cure for PSP, and treatment is focused on managing symptoms and maintaining quality of life.

The nucleus accumbens is a part of the brain that is located in the ventral striatum, which is a key region of the reward circuitry. It is made up of two subregions: the shell and the core. The nucleus accumbens receives inputs from various sources, including the prefrontal cortex, amygdala, and hippocampus, and sends outputs to the ventral pallidum and other areas.

The nucleus accumbens is involved in reward processing, motivation, reinforcement learning, and addiction. It plays a crucial role in the release of the neurotransmitter dopamine, which is associated with pleasure and reinforcement. Dysfunction in the nucleus accumbens has been implicated in various neurological and psychiatric conditions, including substance use disorders, depression, and obsessive-compulsive disorder.

Cystic kidney diseases are a group of genetic disorders that cause fluid-filled sacs called cysts to form in the kidneys. These cysts can vary in size and can grow over time, which can lead to damage in the kidneys and affect their function. There are two main types of cystic kidney diseases: autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD).

ADPKD is the most common type and is characterized by the presence of numerous cysts in both kidneys. It is usually diagnosed in adulthood, but it can also occur in children. The cysts can cause high blood pressure, kidney stones, urinary tract infections, and eventually kidney failure.

ARPKD is a rare, inherited disorder that affects both the kidneys and liver. It is characterized by the presence of numerous cysts in the kidneys and abnormalities in the bile ducts of the liver. ARPKD is usually diagnosed in infancy or early childhood and can cause serious complications such as respiratory distress, kidney failure, and liver fibrosis.

Other types of cystic kidney diseases include nephronophthisis, medullary cystic kidney disease, and glomerulocystic kidney disease. These conditions are also inherited and can cause kidney damage and kidney failure.

Treatment for cystic kidney diseases typically involves managing symptoms such as high blood pressure, pain, and infections. In some cases, surgery may be necessary to remove large cysts or to treat complications such as kidney stones. For individuals with advanced kidney disease, dialysis or a kidney transplant may be necessary.

Dopamine agents are medications that act on dopamine receptors in the brain. Dopamine is a neurotransmitter, a chemical messenger that transmits signals in the brain and other areas of the body. It plays important roles in many functions, including movement, motivation, emotion, and cognition.

Dopamine agents can be classified into several categories based on their mechanism of action:

1. Dopamine agonists: These medications bind to dopamine receptors and mimic the effects of dopamine. They are used to treat conditions such as Parkinson's disease, restless legs syndrome, and certain types of dopamine-responsive dystonia. Examples include pramipexole, ropinirole, and rotigotine.
2. Dopamine precursors: These medications provide the building blocks for the body to produce dopamine. Levodopa is a commonly used dopamine precursor that is converted to dopamine in the brain. It is often used in combination with carbidopa, which helps to prevent levodopa from being broken down before it reaches the brain.
3. Dopamine antagonists: These medications block the action of dopamine at its receptors. They are used to treat conditions such as schizophrenia and certain types of nausea and vomiting. Examples include haloperidol, risperidone, and metoclopramide.
4. Dopamine reuptake inhibitors: These medications increase the amount of dopamine available in the synapse (the space between two neurons) by preventing its reuptake into the presynaptic neuron. They are used to treat conditions such as attention deficit hyperactivity disorder (ADHD) and depression. Examples include bupropion and nomifensine.
5. Dopamine release inhibitors: These medications prevent the release of dopamine from presynaptic neurons. They are used to treat conditions such as Tourette's syndrome and certain types of chronic pain. Examples include tetrabenazine and deutetrabenazine.

It is important to note that dopamine agents can have significant side effects, including addiction, movement disorders, and psychiatric symptoms. Therefore, they should be used under the close supervision of a healthcare provider.

'Animal behavior' refers to the actions or responses of animals to various stimuli, including their interactions with the environment and other individuals. It is the study of the actions of animals, whether they are instinctual, learned, or a combination of both. Animal behavior includes communication, mating, foraging, predator avoidance, and social organization, among other things. The scientific study of animal behavior is called ethology. This field seeks to understand the evolutionary basis for behaviors as well as their physiological and psychological mechanisms.

A phenotype is the physical or biochemical expression of an organism's genes, or the observable traits and characteristics resulting from the interaction of its genetic constitution (genotype) with environmental factors. These characteristics can include appearance, development, behavior, and resistance to disease, among others. Phenotypes can vary widely, even among individuals with identical genotypes, due to differences in environmental influences, gene expression, and genetic interactions.

Antipsychotic agents are a class of medications used to manage and treat psychosis, which includes symptoms such as delusions, hallucinations, paranoia, disordered thought processes, and agitated behavior. These drugs work by blocking the action of dopamine, a neurotransmitter in the brain that is believed to play a role in the development of psychotic symptoms. Antipsychotics can be broadly divided into two categories: first-generation antipsychotics (also known as typical antipsychotics) and second-generation antipsychotics (also known as atypical antipsychotics).

First-generation antipsychotics, such as chlorpromazine, haloperidol, and fluphenazine, were developed in the 1950s and have been widely used for several decades. They are generally effective in reducing positive symptoms of psychosis (such as hallucinations and delusions) but can cause significant side effects, including extrapyramidal symptoms (EPS), such as rigidity, tremors, and involuntary movements, as well as weight gain, sedation, and orthostatic hypotension.

Second-generation antipsychotics, such as clozapine, risperidone, olanzapine, quetiapine, and aripiprazole, were developed more recently and are considered to have a more favorable side effect profile than first-generation antipsychotics. They are generally effective in reducing both positive and negative symptoms of psychosis (such as apathy, anhedonia, and social withdrawal) and cause fewer EPS. However, they can still cause significant weight gain, metabolic disturbances, and sedation.

Antipsychotic agents are used to treat various psychiatric disorders, including schizophrenia, bipolar disorder, major depressive disorder with psychotic features, delusional disorder, and other conditions that involve psychosis or agitation. They can be administered orally, intramuscularly, or via long-acting injectable formulations. The choice of antipsychotic agent depends on the individual patient's needs, preferences, and response to treatment, as well as the potential for side effects. Regular monitoring of patients taking antipsychotics is essential to ensure their safety and effectiveness.

Psychiatric Status Rating Scales are standardized assessment tools used by mental health professionals to evaluate and rate the severity of a person's psychiatric symptoms and functioning. These scales provide a systematic and structured approach to measuring various aspects of an individual's mental health, such as mood, anxiety, psychosis, behavior, and cognitive abilities.

The purpose of using Psychiatric Status Rating Scales is to:

1. Assess the severity and improvement of psychiatric symptoms over time.
2. Aid in diagnostic decision-making and treatment planning.
3. Monitor treatment response and adjust interventions accordingly.
4. Facilitate communication among mental health professionals about a patient's status.
5. Provide an objective basis for research and epidemiological studies.

Examples of Psychiatric Status Rating Scales include:

1. Clinical Global Impression (CGI): A brief, subjective rating scale that measures overall illness severity, treatment response, and improvement.
2. Positive and Negative Syndrome Scale (PANSS): A comprehensive scale used to assess the symptoms of psychosis, including positive, negative, and general psychopathology domains.
3. Hamilton Rating Scale for Depression (HRSD) or Montgomery-Åsberg Depression Rating Scale (MADRS): Scales used to evaluate the severity of depressive symptoms.
4. Young Mania Rating Scale (YMRS): A scale used to assess the severity of manic or hypomanic symptoms.
5. Brief Psychiatric Rating Scale (BPRS) or Symptom Checklist-90 Revised (SCL-90-R): Scales that measure a broad range of psychiatric symptoms and psychopathology.
6. Global Assessment of Functioning (GAF): A scale used to rate an individual's overall psychological, social, and occupational functioning on a hypothetical continuum of mental health-illness.

It is important to note that Psychiatric Status Rating Scales should be administered by trained mental health professionals to ensure accurate and reliable results.

Alzheimer's disease is a progressive disorder that causes brain cells to waste away (degenerate) and die. It's the most common cause of dementia — a continuous decline in thinking, behavioral and social skills that disrupts a person's ability to function independently.

The early signs of the disease include forgetting recent events or conversations. As the disease progresses, a person with Alzheimer's disease will develop severe memory impairment and lose the ability to carry out everyday tasks.

Currently, there's no cure for Alzheimer's disease. However, treatments can temporarily slow the worsening of dementia symptoms and improve quality of life.

I must clarify that there is no such thing as "Schizophrenic Psychology." The term schizophrenia is used to describe a specific and serious mental disorder that affects how a person thinks, feels, and behaves. It's important not to use the term casually or inaccurately, as it can perpetuate stigma and misunderstanding about the condition.

Schizophrenia is characterized by symptoms such as hallucinations (hearing or seeing things that aren't there), delusions (false beliefs that are not based on reality), disorganized speech, and grossly disorganized or catatonic behavior. These symptoms can impair a person's ability to function in daily life, maintain relationships, and experience emotions appropriately.

If you have any questions related to mental health conditions or psychology, I would be happy to provide accurate information and definitions.

Parkinson's disease is a progressive neurodegenerative disorder that affects movement. It is characterized by the death of dopamine-producing cells in the brain, specifically in an area called the substantia nigra. The loss of these cells leads to a decrease in dopamine levels, which results in the motor symptoms associated with Parkinson's disease. These symptoms can include tremors at rest, stiffness or rigidity of the limbs and trunk, bradykinesia (slowness of movement), and postural instability (impaired balance and coordination). In addition to these motor symptoms, non-motor symptoms such as cognitive impairment, depression, anxiety, and sleep disturbances are also common in people with Parkinson's disease. The exact cause of Parkinson's disease is unknown, but it is thought to be a combination of genetic and environmental factors. There is currently no cure for Parkinson's disease, but medications and therapies can help manage the symptoms and improve quality of life.

Gas Chromatography-Mass Spectrometry (GC-MS) is a powerful analytical technique that combines the separating power of gas chromatography with the identification capabilities of mass spectrometry. This method is used to separate, identify, and quantify different components in complex mixtures.

In GC-MS, the mixture is first vaporized and carried through a long, narrow column by an inert gas (carrier gas). The various components in the mixture interact differently with the stationary phase inside the column, leading to their separation based on their partition coefficients between the mobile and stationary phases. As each component elutes from the column, it is then introduced into the mass spectrometer for analysis.

The mass spectrometer ionizes the sample, breaks it down into smaller fragments, and measures the mass-to-charge ratio of these fragments. This information is used to generate a mass spectrum, which serves as a unique "fingerprint" for each compound. By comparing the generated mass spectra with reference libraries or known standards, analysts can identify and quantify the components present in the original mixture.

GC-MS has wide applications in various fields such as forensics, environmental analysis, drug testing, and research laboratories due to its high sensitivity, specificity, and ability to analyze volatile and semi-volatile compounds.

The Chernobyl nuclear accident, also known as the Chernobyl disaster, was a catastrophic nuclear meltdown that occurred on April 26, 1986, at the No. 4 reactor in the Chernobyl Nuclear Power Plant, near the city of Pripyat in the north of the Ukrainian SSR in the Soviet Union. It is considered the worst nuclear disaster in history and resulted in a significant release of radioactive material into the environment, which had serious health and environmental consequences both in the immediate vicinity of the reactor and in the wider region.

The accident occurred during a late-night safety test which simulated a station blackout power-failure, in order to test an emergency cooling feature of the reactor. The operators temporarily disabled several safety systems, including the automatic shutdown mechanisms. They also removed too many control rods from the reactor core, which made the reactor extremely unstable. When they performed a surprise test at low power, a sudden power surge occurred, which led to a reactor vessel rupture and a series of explosions. This event exposed the graphite moderator components of the reactor to air, causing them to ignite.

The resulting fire sent a plume of highly radioactive smoke into the atmosphere and over an extensive geographical area, including Pripyat. The plume drifted over large parts of the western Soviet Union and Europe. From 1986 to 2000, 350,000 people were evacuated and resettled from the most severely contaminated areas of Belarus, Russia, and Ukraine.

According to official post-Soviet data, about 60% of the fallout landed in Belarus. The battle to contain the contamination and prevent a subsequent disaster required about 500,000 workers and cost an estimated 18 billion rubles. During the accident itself, 31 people died, and long-term effects such as cancers and deformities are still being accounted for.

The Chernobyl Exclusion Zone was established around the power plant, and it is still in place today, with restricted access. The site of the reactor is now enclosed in a large steel and concrete structure, called the New Safe Confinement, to prevent further leakage of radiation.

"Street drugs" is a colloquial term rather than medical jargon, but it generally refers to illegal substances or medications that are used without a prescription. These can include a wide variety of drugs such as marijuana, cocaine, heroin, methamphetamines, ecstasy, LSD, and many others. They are called "street drugs" because they are often bought and sold on the street or in clandestine settings, rather than through legitimate pharmacies or medical professionals. It's important to note that these substances can be highly dangerous and addictive, with serious short-term and long-term health consequences.

Cerebellar diseases refer to a group of medical conditions that affect the cerebellum, which is the part of the brain located at the back of the head, below the occipital lobe and above the brainstem. The cerebellum plays a crucial role in motor control, coordination, balance, and some cognitive functions.

Cerebellar diseases can be caused by various factors, including genetics, infections, tumors, stroke, trauma, or degenerative processes. These conditions can result in a wide range of symptoms, such as:

1. Ataxia: Loss of coordination and unsteady gait
2. Dysmetria: Inability to judge distance and force while performing movements
3. Intention tremors: Shaking or trembling that worsens during purposeful movements
4. Nystagmus: Rapid, involuntary eye movement
5. Dysarthria: Speech difficulty due to muscle weakness or incoordination
6. Hypotonia: Decreased muscle tone
7. Titubation: Rhythmic, involuntary oscillations of the head and neck
8. Cognitive impairment: Problems with memory, attention, and executive functions

Some examples of cerebellar diseases include:

1. Ataxia-telangiectasia
2. Friedrich's ataxia
3. Multiple system atrophy (MSA)
4. Spinocerebellar ataxias (SCAs)
5. Cerebellar tumors, such as medulloblastomas or astrocytomas
6. Infarctions or hemorrhages in the cerebellum due to stroke or trauma
7. Infections, such as viral encephalitis or bacterial meningitis
8. Autoimmune disorders, like multiple sclerosis (MS) or paraneoplastic syndromes
9. Metabolic disorders, such as Wilson's disease or phenylketonuria (PKU)
10. Chronic alcoholism and withdrawal

Treatment for cerebellar diseases depends on the underlying cause and may involve medications, physical therapy, surgery, or supportive care to manage symptoms and improve quality of life.

Dopamine uptake inhibitors are a class of medications that work by blocking the reuptake of dopamine, a neurotransmitter, into the presynaptic neuron. This results in an increased concentration of dopamine in the synapse, leading to enhanced dopaminergic transmission and activity.

These drugs are used in various medical conditions where dopamine is implicated, such as depression, attention deficit hyperactivity disorder (ADHD), and neurological disorders like Parkinson's disease. They can also be used to treat substance abuse disorders, such as cocaine addiction, by blocking the reuptake of dopamine and reducing the rewarding effects of the drug.

Examples of dopamine uptake inhibitors include:

* Bupropion (Wellbutrin), which is used to treat depression and ADHD
* Methylphenidate (Ritalin, Concerta), which is used to treat ADHD
* Amantadine (Symmetrel), which is used to treat Parkinson's disease and also has antiviral properties.

It's important to note that dopamine uptake inhibitors can have side effects, including increased heart rate, blood pressure, and anxiety. They may also have the potential for abuse and dependence, particularly in individuals with a history of substance abuse. Therefore, these medications should be used under the close supervision of a healthcare provider.

Ectodermal dysplasia (ED) is a group of genetic disorders that affect the development and formation of ectodermal tissues, which include the skin, hair, nails, teeth, and sweat glands. The condition is usually present at birth or appears in early infancy.

The symptoms of ED can vary widely depending on the specific type and severity of the disorder. Common features may include:

* Sparse or absent hair
* Thin, wrinkled, or rough skin
* Abnormal or missing teeth
* Nail abnormalities
* Absent or reduced sweat glands, leading to heat intolerance and problems regulating body temperature
* Ear abnormalities, which can result in hearing loss
* Eye abnormalities

ED is caused by mutations in genes that are involved in the development of ectodermal tissues. Most cases of ED are inherited in an autosomal dominant or autosomal recessive pattern, meaning that a child can inherit the disorder even if only one parent (dominant) or both parents (recessive) carry the mutated gene.

There is no cure for ED, but treatment is focused on managing the symptoms and improving quality of life. This may include measures to maintain body temperature, such as cooling vests or frequent cool baths; dental treatments to replace missing teeth; hearing aids for hearing loss; and skin care regimens to prevent dryness and irritation.

Major Depressive Disorder (MDD), also simply referred to as depression, is a serious mental health condition characterized by the presence of one or more major depressive episodes. A major depressive episode is a period of at least two weeks during which an individual experiences a severely depressed mood and/or loss of interest or pleasure in nearly all activities, accompanied by at least four additional symptoms such as significant changes in appetite or weight, sleep disturbances, psychomotor agitation or retardation, fatigue or loss of energy, feelings of worthlessness or excessive guilt, difficulty thinking, concentrating, or making decisions, and recurrent thoughts of death or suicide.

MDD can significantly impair an individual's ability to function in daily life, and it is associated with increased risks of suicide, substance abuse, and other mental health disorders. The exact cause of MDD is not fully understood, but it is believed to result from a complex interplay of genetic, biological, environmental, and psychological factors. Treatment typically involves a combination of psychotherapy (such as cognitive-behavioral therapy) and medication (such as selective serotonin reuptake inhibitors or tricyclic antidepressants).

Designer drugs are synthetic or chemically altered substances that are designed to mimic the effects of controlled substances. They are often created in clandestine laboratories and marketed as legal alternatives to illegal drugs. These drugs are called "designer" because they are intentionally modified to avoid detection and regulation by law enforcement agencies and regulatory bodies.

Designer drugs can be extremely dangerous, as their chemical composition is often unknown or only partially understood. They may contain potentially harmful impurities or variations that can lead to unpredictable and sometimes severe health consequences. Examples of designer drugs include synthetic cannabinoids (such as "Spice" or "K2"), synthetic cathinones (such as "bath salts"), and novel psychoactive substances (NPS).

It is important to note that while some designer drugs may be legal at the time they are manufactured and sold, their possession and use may still be illegal under federal or state laws. Additionally, many designer drugs have been made illegal through scheduling by the Drug Enforcement Administration (DEA) or through legislation specifically targeting them.

Animal disease models are specialized animals, typically rodents such as mice or rats, that have been genetically engineered or exposed to certain conditions to develop symptoms and physiological changes similar to those seen in human diseases. These models are used in medical research to study the pathophysiology of diseases, identify potential therapeutic targets, test drug efficacy and safety, and understand disease mechanisms.

The genetic modifications can include knockout or knock-in mutations, transgenic expression of specific genes, or RNA interference techniques. The animals may also be exposed to environmental factors such as chemicals, radiation, or infectious agents to induce the disease state.

Examples of animal disease models include:

1. Mouse models of cancer: Genetically engineered mice that develop various types of tumors, allowing researchers to study cancer initiation, progression, and metastasis.
2. Alzheimer's disease models: Transgenic mice expressing mutant human genes associated with Alzheimer's disease, which exhibit amyloid plaque formation and cognitive decline.
3. Diabetes models: Obese and diabetic mouse strains like the NOD (non-obese diabetic) or db/db mice, used to study the development of type 1 and type 2 diabetes, respectively.
4. Cardiovascular disease models: Atherosclerosis-prone mice, such as ApoE-deficient or LDLR-deficient mice, that develop plaque buildup in their arteries when fed a high-fat diet.
5. Inflammatory bowel disease models: Mice with genetic mutations affecting intestinal barrier function and immune response, such as IL-10 knockout or SAMP1/YitFc mice, which develop colitis.

Animal disease models are essential tools in preclinical research, but it is important to recognize their limitations. Differences between species can affect the translatability of results from animal studies to human patients. Therefore, researchers must carefully consider the choice of model and interpret findings cautiously when applying them to human diseases.

Appetite depressants are medications or substances that reduce or suppress feelings of hunger and appetite. They can be prescribed to treat various medical conditions, such as obesity or binge eating disorder, where weight loss is a recommended treatment goal. Some common appetite depressants include:

1. Phentermine: This medication works by stimulating the release of certain neurotransmitters in the brain that help suppress appetite and increase metabolism. It is often prescribed for short-term use (up to 12 weeks) as part of a comprehensive weight loss plan.

2. Diethylpropion: Similar to phentermine, diethylpropion stimulates the release of neurotransmitters that suppress appetite and increase metabolism. It is also prescribed for short-term use in treating obesity.

3. Naltrexone-bupropion (Contrave): This combination medication helps manage weight by reducing appetite and increasing feelings of fullness. Naltrexone is an opioid antagonist that blocks the rewarding effects of food, while bupropion is an antidepressant that can help reduce cravings for high-calorie foods.

4. Lorcaserin (Belviq): This medication works by selectively activating serotonin receptors in the brain, which helps promote satiety and reduce appetite. It was withdrawn from the US market in 2020 due to concerns about its potential link to an increased risk of cancer.

5. Topiramate (Topamax): Although primarily used as an anticonvulsant, topiramate has also been found to have appetite-suppressing effects. It is often combined with phentermine in a single formulation (Qsymia) for the treatment of obesity.

6. Cannabis: Some studies suggest that cannabinoids, the active compounds in marijuana, may help reduce hunger and promote weight loss by interacting with the endocannabinoid system in the body. However, more research is needed to fully understand its potential as an appetite depressant.

It's important to note that appetite suppressants should only be used under the guidance of a healthcare professional and as part of a comprehensive weight management plan. These medications can have side effects and potential risks, so it's crucial to discuss their use with your doctor before starting any new treatment regimen.

Cocaine is a highly addictive stimulant drug derived from the leaves of the coca plant (Erythroxylon coca). It is a powerful central nervous system stimulant that affects the brain and body in many ways. When used recreationally, cocaine can produce feelings of euphoria, increased energy, and mental alertness; however, it can also cause serious negative consequences, including addiction, cardiovascular problems, seizures, and death.

Cocaine works by increasing the levels of dopamine in the brain, a neurotransmitter associated with pleasure and reward. This leads to the pleasurable effects that users seek when they take the drug. However, cocaine also interferes with the normal functioning of the brain's reward system, making it difficult for users to experience pleasure from natural rewards like food or social interactions.

Cocaine can be taken in several forms, including powdered form (which is usually snorted), freebase (a purer form that is often smoked), and crack cocaine (a solid form that is typically heated and smoked). Each form of cocaine has different risks and potential harms associated with its use.

Long-term use of cocaine can lead to a number of negative health consequences, including addiction, heart problems, malnutrition, respiratory issues, and mental health disorders like depression or anxiety. It is important to seek help if you or someone you know is struggling with cocaine use or addiction.

Dopamine plasma membrane transport proteins, also known as dopamine transporters (DAT), are a type of protein found in the cell membrane that play a crucial role in the regulation of dopamine neurotransmission. They are responsible for the reuptake of dopamine from the synaptic cleft back into the presynaptic neuron, thereby terminating the signal transduction of dopamine and regulating the amount of dopamine available for further release.

Dopamine transporters belong to the family of sodium-dependent neurotransmitter transporters and are encoded by the SLC6A3 gene in humans. Abnormalities in dopamine transporter function have been implicated in several neurological and psychiatric disorders, including Parkinson's disease, attention deficit hyperactivity disorder (ADHD), and substance use disorders.

In summary, dopamine plasma membrane transport proteins are essential for the regulation of dopamine neurotransmission by mediating the reuptake of dopamine from the synaptic cleft back into the presynaptic neuron.

Cognitive disorders are a category of mental health disorders that primarily affect cognitive abilities including learning, memory, perception, and problem-solving. These disorders can be caused by various factors such as brain injury, degenerative diseases, infection, substance abuse, or developmental disabilities. Examples of cognitive disorders include dementia, amnesia, delirium, and intellectual disability. It's important to note that the specific definition and diagnostic criteria for cognitive disorders may vary depending on the medical source or classification system being used.

Sprague-Dawley rats are a strain of albino laboratory rats that are widely used in scientific research. They were first developed by researchers H.H. Sprague and R.C. Dawley in the early 20th century, and have since become one of the most commonly used rat strains in biomedical research due to their relatively large size, ease of handling, and consistent genetic background.

Sprague-Dawley rats are outbred, which means that they are genetically diverse and do not suffer from the same limitations as inbred strains, which can have reduced fertility and increased susceptibility to certain diseases. They are also characterized by their docile nature and low levels of aggression, making them easier to handle and study than some other rat strains.

These rats are used in a wide variety of research areas, including toxicology, pharmacology, nutrition, cancer, and behavioral studies. Because they are genetically diverse, Sprague-Dawley rats can be used to model a range of human diseases and conditions, making them an important tool in the development of new drugs and therapies.

A depressive disorder is a mental health condition characterized by persistent feelings of sadness, hopelessness, and loss of interest or pleasure in activities. It can also include changes in sleep, appetite, energy levels, concentration, and self-esteem, as well as thoughts of death or suicide. Depressive disorders can vary in severity and duration, with some people experiencing mild and occasional symptoms, while others may have severe and chronic symptoms that interfere with their ability to function in daily life.

There are several types of depressive disorders, including major depressive disorder (MDD), persistent depressive disorder (PDD), and postpartum depression. MDD is characterized by symptoms that interfere significantly with a person's ability to function and last for at least two weeks, while PDD involves chronic low-grade depression that lasts for two years or more. Postpartum depression occurs in women after childbirth and can range from mild to severe.

Depressive disorders are thought to be caused by a combination of genetic, biological, environmental, and psychological factors. Treatment typically involves a combination of medication, psychotherapy (talk therapy), and lifestyle changes.

Synucleins are a family of small, heat-stable, water-soluble proteins that are primarily expressed in neurons. They are involved in various cellular processes such as modulating synaptic plasticity, vesicle trafficking, and neurotransmitter release. The most well-known members of this family are alpha-synuclein, beta-synuclein, and gamma-synuclein.

Abnormal accumulation and aggregation of alpha-synuclein into insoluble fibrils called Lewy bodies and Lewy neurites are hallmark features of several neurodegenerative disorders, including Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. These conditions are collectively referred to as synucleinopathies. The dysfunction and aggregation of alpha-synuclein are thought to contribute to the progressive loss of dopaminergic neurons in the substantia nigra pars compacta, a region of the brain involved in motor control, leading to the characteristic symptoms observed in these disorders.

The corpus striatum is a part of the brain that plays a crucial role in movement, learning, and cognition. It consists of two structures called the caudate nucleus and the putamen, which are surrounded by the external and internal segments of the globus pallidus. Together, these structures form the basal ganglia, a group of interconnected neurons that help regulate voluntary movement.

The corpus striatum receives input from various parts of the brain, including the cerebral cortex, thalamus, and other brainstem nuclei. It processes this information and sends output to the globus pallidus and substantia nigra, which then project to the thalamus and back to the cerebral cortex. This feedback loop helps coordinate and fine-tune movements, allowing for smooth and coordinated actions.

Damage to the corpus striatum can result in movement disorders such as Parkinson's disease, Huntington's disease, and dystonia. These conditions are characterized by abnormal involuntary movements, muscle stiffness, and difficulty initiating or controlling voluntary movements.

Neurons, also known as nerve cells or neurocytes, are specialized cells that constitute the basic unit of the nervous system. They are responsible for receiving, processing, and transmitting information and signals within the body. Neurons have three main parts: the dendrites, the cell body (soma), and the axon. The dendrites receive signals from other neurons or sensory receptors, while the axon transmits these signals to other neurons, muscles, or glands. The junction between two neurons is called a synapse, where neurotransmitters are released to transmit the signal across the gap (synaptic cleft) to the next neuron. Neurons vary in size, shape, and structure depending on their function and location within the nervous system.

Comorbidity is the presence of one or more additional health conditions or diseases alongside a primary illness or condition. These co-occurring health issues can have an impact on the treatment plan, prognosis, and overall healthcare management of an individual. Comorbidities often interact with each other and the primary condition, leading to more complex clinical situations and increased healthcare needs. It is essential for healthcare professionals to consider and address comorbidities to provide comprehensive care and improve patient outcomes.

Lewy bodies are abnormal aggregates of alpha-synuclein protein that develop in nerve cells (neurons) in the brain. They are named after Frederick Lewy, a German-American neurologist who discovered them while working with Dr. Alois Alzheimer. The presence of Lewy bodies is a hallmark feature of Lewy body dementia, which includes both Parkinson's disease dementia and dementia with Lewy bodies.

Lewy bodies can lead to the dysfunction and death of neurons in areas of the brain that control movement, cognition, and behavior. This can result in a range of symptoms, including motor impairments, cognitive decline, visual hallucinations, and mood changes. The exact role of Lewy bodies in the development and progression of these disorders is not fully understood, but they are believed to contribute to the neurodegenerative process that underlies these conditions.

Analysis of Variance (ANOVA) is a statistical technique used to compare the means of two or more groups and determine whether there are any significant differences between them. It is a way to analyze the variance in a dataset to determine whether the variability between groups is greater than the variability within groups, which can indicate that the groups are significantly different from one another.

ANOVA is based on the concept of partitioning the total variance in a dataset into two components: variance due to differences between group means (also known as "between-group variance") and variance due to differences within each group (also known as "within-group variance"). By comparing these two sources of variance, ANOVA can help researchers determine whether any observed differences between groups are statistically significant, or whether they could have occurred by chance.

ANOVA is a widely used technique in many areas of research, including biology, psychology, engineering, and business. It is often used to compare the means of two or more experimental groups, such as a treatment group and a control group, to determine whether the treatment had a significant effect. ANOVA can also be used to compare the means of different populations or subgroups within a population, to identify any differences that may exist between them.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

Methylphenidate is a central nervous system (CNS) stimulant drug that is primarily used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It works by increasing the levels of neurotransmitters, such as dopamine and norepinephrine, in the brain, which helps to improve focus, concentration, and alertness.

Methylphenidate is available under various brand names, including Ritalin, Concerta, and Methylin, among others. It comes in different forms, such as tablets, capsules, or extended-release formulations, and is typically taken orally. The dosage and duration of treatment are usually individualized based on the patient's response to the medication and any potential side effects.

It is important to note that methylphenidate has a high potential for abuse and addiction, and its use should be closely monitored by a healthcare professional. Additionally, it can interact with other medications and medical conditions, so it is essential to inform your doctor of any health concerns before starting treatment with methylphenidate.

Post-traumatic stress disorder (PTSD) is a psychiatric condition that can occur in people who have experienced or witnessed a traumatic event such as a natural disaster, serious accident, war combat, rape, or violent personal assault. According to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5), PTSD is characterized by the following symptoms, which must last for more than one month:

1. Intrusion symptoms: These include distressing memories, nightmares, flashbacks, or intense psychological distress or reactivity to internal or external cues that symbolize or resemble an aspect of the traumatic event.
2. Avoidance symptoms: Persistent avoidance of stimuli associated with the traumatic event, including thoughts, feelings, conversations, activities, places, or people.
3. Negative alterations in cognitions and mood: This includes negative beliefs about oneself, others, or the world; distorted blame of self or others for causing the trauma; persistent negative emotional state; decreased interest in significant activities; and feelings of detachment or estrangement from others.
4. Alterations in arousal and reactivity: This includes irritable behavior and angry outbursts, reckless or self-destructive behavior, hypervigilance, exaggerated startle response, problems with concentration, and sleep disturbance.
5. Duration of symptoms: The symptoms must last for more than one month.
6. Functional significance: The symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning.

It is essential to note that PTSD can occur at any age and can be accompanied by various physical and mental health problems, such as depression, substance abuse, memory problems, and other difficulties in cognition. Appropriate treatment, which may include psychotherapy, medication, or a combination of both, can significantly improve the symptoms and overall quality of life for individuals with PTSD.

Alcoholism is a chronic and often relapsing brain disorder characterized by the excessive and compulsive consumption of alcohol despite negative consequences to one's health, relationships, and daily life. It is also commonly referred to as alcohol use disorder (AUD) or alcohol dependence.

The diagnostic criteria for AUD include a pattern of alcohol use that includes problems controlling intake, continued use despite problems resulting from drinking, development of a tolerance, drinking that leads to risky behaviors or situations, and withdrawal symptoms when not drinking.

Alcoholism can cause a wide range of physical and psychological health problems, including liver disease, heart disease, neurological damage, mental health disorders, and increased risk of accidents and injuries. Treatment for alcoholism typically involves a combination of behavioral therapies, medications, and support groups to help individuals achieve and maintain sobriety.

I must clarify that the term "pedigree" is not typically used in medical definitions. Instead, it is often employed in genetics and breeding, where it refers to the recorded ancestry of an individual or a family, tracing the inheritance of specific traits or diseases. In human genetics, a pedigree can help illustrate the pattern of genetic inheritance in families over multiple generations. However, it is not a medical term with a specific clinical definition.

Dementia is a broad term that describes a decline in cognitive functioning, including memory, language, problem-solving, and judgment, severe enough to interfere with daily life. It is not a specific disease but rather a group of symptoms that may be caused by various underlying diseases or conditions. Alzheimer's disease is the most common cause of dementia, accounting for 60-80% of cases. Other causes include vascular dementia, Lewy body dementia, frontotemporal dementia, and Huntington's disease.

The symptoms of dementia can vary widely depending on the cause and the specific areas of the brain that are affected. However, common early signs of dementia may include:

* Memory loss that affects daily life
* Difficulty with familiar tasks
* Problems with language or communication
* Difficulty with visual and spatial abilities
* Misplacing things and unable to retrace steps
* Decreased or poor judgment
* Withdrawal from work or social activities
* Changes in mood or behavior

Dementia is a progressive condition, meaning that symptoms will gradually worsen over time. While there is currently no cure for dementia, early diagnosis and treatment can help slow the progression of the disease and improve quality of life for those affected.

Medical Definition:

"Risk factors" are any attribute, characteristic or exposure of an individual that increases the likelihood of developing a disease or injury. They can be divided into modifiable and non-modifiable risk factors. Modifiable risk factors are those that can be changed through lifestyle choices or medical treatment, while non-modifiable risk factors are inherent traits such as age, gender, or genetic predisposition. Examples of modifiable risk factors include smoking, alcohol consumption, physical inactivity, and unhealthy diet, while non-modifiable risk factors include age, sex, and family history. It is important to note that having a risk factor does not guarantee that a person will develop the disease, but rather indicates an increased susceptibility.

A phobic disorder is a type of anxiety disorder characterized by an excessive and irrational fear or avoidance of specific objects, situations, or activities. This fear can cause significant distress and interfere with a person's daily life. Phobic disorders are typically classified into three main categories: specific phobias (such as fear of heights, spiders, or needles), social phobia (or social anxiety disorder), and agoraphobia (fear of open spaces or situations where escape might be difficult).

People with phobic disorders often recognize that their fear is excessive or unreasonable, but they are unable to control it. When exposed to the feared object or situation, they may experience symptoms such as rapid heartbeat, sweating, trembling, and difficulty breathing. These symptoms can be so distressing that individuals with phobic disorders go to great lengths to avoid the feared situation, which can have a significant impact on their quality of life.

Treatment for phobic disorders typically involves cognitive-behavioral therapy (CBT), which helps individuals identify and challenge their irrational thoughts and fears, as well as exposure therapy, which gradually exposes them to the feared object or situation in a safe and controlled environment. In some cases, medication may also be recommended to help manage symptoms of anxiety.

Pervasive developmental disorders (PDD) are a group of conditions that affect the development and functioning of the brain, leading to delays in many areas of development. The American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) has replaced the term "pervasive developmental disorders" with "autism spectrum disorder" and "other neurodevelopmental disorders."

Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by persistent deficits in social communication and interaction across multiple contexts, as well as restricted, repetitive patterns of behavior, interests, or activities. The symptoms of ASD can range from mild to severe, and the condition affects approximately 1 in 54 children in the United States.

Other neurodevelopmental disorders that were previously classified as PDDs include:

1. Intellectual disability (ID): a condition characterized by significant limitations in intellectual functioning and adaptive behavior, which covers many everyday social and practical skills. This disorder used to be referred to as "mental retardation."
2. Communication disorders: these are disorders that affect an individual's ability to communicate, including language disorders, speech sound disorders, and stuttering.
3. Attention-deficit/hyperactivity disorder (ADHD): a neurodevelopmental disorder characterized by symptoms of inattention, hyperactivity, and impulsivity.
4. Specific learning disorder: a neurodevelopmental disorder that affects an individual's ability to learn and use specific academic skills, such as reading, writing, or mathematics.
5. Motor disorders: these are disorders that affect an individual's movement and coordination, including developmental coordination disorder, stereotypic movement disorder, and tic disorders.

The medical definition of 'Child Development Disorders, Pervasive' has been replaced with more specific diagnoses in the DSM-5 to better reflect the diverse nature of these conditions and improve diagnostic accuracy and treatment planning.

Hallucinogens are a class of psychoactive substances that alter perception, mood, and thought, often causing hallucinations, which are profound distortions in a person's perceptions of reality. These substances work by disrupting the normal functioning of the brain, particularly the parts that regulate mood, sensory perception, sleep, hunger, and sexual behavior.

Hallucinogens can be found in various forms, including plants, mushrooms, and synthetic compounds. Some common examples of hallucinogens include LSD (d-lysergic acid diethylamide), psilocybin (found in certain species of mushrooms), DMT (dimethyltryptamine), and ayahuasca (a plant-based brew from South America).

The effects of hallucinogens can vary widely depending on the specific substance, the dose, the individual's personality, mood, and expectations, and the environment in which the drug is taken. These effects can range from pleasant sensory experiences and heightened emotional awareness to terrifying hallucinations and overwhelming feelings of anxiety or despair.

It's important to note that hallucinogens can be dangerous, particularly when taken in high doses or in combination with other substances. They can also cause long-term psychological distress and may trigger underlying mental health conditions. As such, they should only be used under the guidance of a trained medical professional for therapeutic purposes.

Genetic predisposition to disease refers to an increased susceptibility or vulnerability to develop a particular illness or condition due to inheriting specific genetic variations or mutations from one's parents. These genetic factors can make it more likely for an individual to develop a certain disease, but it does not guarantee that the person will definitely get the disease. Environmental factors, lifestyle choices, and interactions between genes also play crucial roles in determining if a genetically predisposed person will actually develop the disease. It is essential to understand that having a genetic predisposition only implies a higher risk, not an inevitable outcome.

Nerve tissue proteins are specialized proteins found in the nervous system that provide structural and functional support to nerve cells, also known as neurons. These proteins include:

1. Neurofilaments: These are type IV intermediate filaments that provide structural support to neurons and help maintain their shape and size. They are composed of three subunits - NFL (light), NFM (medium), and NFH (heavy).

2. Neuronal Cytoskeletal Proteins: These include tubulins, actins, and spectrins that provide structural support to the neuronal cytoskeleton and help maintain its integrity.

3. Neurotransmitter Receptors: These are specialized proteins located on the postsynaptic membrane of neurons that bind neurotransmitters released by presynaptic neurons, triggering a response in the target cell.

4. Ion Channels: These are transmembrane proteins that regulate the flow of ions across the neuronal membrane and play a crucial role in generating and transmitting electrical signals in neurons.

5. Signaling Proteins: These include enzymes, receptors, and adaptor proteins that mediate intracellular signaling pathways involved in neuronal development, differentiation, survival, and death.

6. Adhesion Proteins: These are cell surface proteins that mediate cell-cell and cell-matrix interactions, playing a crucial role in the formation and maintenance of neural circuits.

7. Extracellular Matrix Proteins: These include proteoglycans, laminins, and collagens that provide structural support to nerve tissue and regulate neuronal migration, differentiation, and survival.

A dose-response relationship in the context of drugs refers to the changes in the effects or symptoms that occur as the dose of a drug is increased or decreased. Generally, as the dose of a drug is increased, the severity or intensity of its effects also increases. Conversely, as the dose is decreased, the effects of the drug become less severe or may disappear altogether.

The dose-response relationship is an important concept in pharmacology and toxicology because it helps to establish the safe and effective dosage range for a drug. By understanding how changes in the dose of a drug affect its therapeutic and adverse effects, healthcare providers can optimize treatment plans for their patients while minimizing the risk of harm.

The dose-response relationship is typically depicted as a curve that shows the relationship between the dose of a drug and its effect. The shape of the curve may vary depending on the drug and the specific effect being measured. Some drugs may have a steep dose-response curve, meaning that small changes in the dose can result in large differences in the effect. Other drugs may have a more gradual dose-response curve, where larger changes in the dose are needed to produce significant effects.

In addition to helping establish safe and effective dosages, the dose-response relationship is also used to evaluate the potential therapeutic benefits and risks of new drugs during clinical trials. By systematically testing different doses of a drug in controlled studies, researchers can identify the optimal dosage range for the drug and assess its safety and efficacy.

A case-control study is an observational research design used to identify risk factors or causes of a disease or health outcome. In this type of study, individuals with the disease or condition (cases) are compared with similar individuals who do not have the disease or condition (controls). The exposure history or other characteristics of interest are then compared between the two groups to determine if there is an association between the exposure and the disease.

Case-control studies are often used when it is not feasible or ethical to conduct a randomized controlled trial, as they can provide valuable insights into potential causes of diseases or health outcomes in a relatively short period of time and at a lower cost than other study designs. However, because case-control studies rely on retrospective data collection, they are subject to biases such as recall bias and selection bias, which can affect the validity of the results. Therefore, it is important to carefully design and conduct case-control studies to minimize these potential sources of bias.

Tau proteins are a type of microtubule-associated protein (MAP) found primarily in neurons of the central nervous system. They play a crucial role in maintaining the stability and structure of microtubules, which are essential components of the cell's cytoskeleton. Tau proteins bind to and stabilize microtubules, helping to regulate their assembly and disassembly.

In Alzheimer's disease and other neurodegenerative disorders known as tauopathies, tau proteins can become abnormally hyperphosphorylated, leading to the formation of insoluble aggregates called neurofibrillary tangles (NFTs) within neurons. These aggregates disrupt the normal function of microtubules and contribute to the degeneration and death of nerve cells, ultimately leading to cognitive decline and other symptoms associated with these disorders.

Neuropsychological tests are a type of psychological assessment that measures cognitive functions, such as attention, memory, language, problem-solving, and perception. These tests are used to help diagnose and understand the cognitive impact of neurological conditions, including dementia, traumatic brain injury, stroke, Parkinson's disease, and other disorders that affect the brain.

The tests are typically administered by a trained neuropsychologist and can take several hours to complete. They may involve paper-and-pencil tasks, computerized tasks, or interactive activities. The results of the tests are compared to normative data to help identify any areas of cognitive weakness or strength.

Neuropsychological testing can provide valuable information for treatment planning, rehabilitation, and assessing response to treatment. It can also be used in research to better understand the neural basis of cognition and the impact of neurological conditions on cognitive function.

Adrenergic uptake inhibitors are a class of medications that work by blocking the reuptake of neurotransmitters, such as norepinephrine and dopamine, into the presynaptic neuron. This results in an increase in the amount of neurotransmitter available to bind to postsynaptic receptors, leading to an enhancement of adrenergic transmission.

These medications are used in the treatment of various medical conditions, including depression, attention deficit hyperactivity disorder (ADHD), and narcolepsy. Some examples of adrenergic uptake inhibitors include:

* Tricyclic antidepressants (TCAs): These medications, such as imipramine and amitriptyline, were developed in the 1950s and are used to treat depression, anxiety disorders, and chronic pain.
* Selective serotonin-norepinephrine reuptake inhibitors (SNRIs): These medications, such as venlafaxine and duloxetine, were developed in the 1990s and are used to treat depression, anxiety disorders, and chronic pain.
* Norepinephrine-dopamine reuptake inhibitors (NDRIs): These medications, such as bupropion, are used to treat depression and ADHD.

It's important to note that these medications can have side effects and should be used under the supervision of a healthcare provider.

The Enzyme Multiplied Immunoassay Technique (EMIT) is a type of immunoassay used for the quantitative or qualitative determination of various substances, such as drugs, hormones, or antibodies. The technique utilizes an enzyme-linked antigen or antibody that reacts with the substance being measured (analyte) in the sample to form an immune complex. This complex then interacts with a second enzyme-labeled antigen or antibody, leading to the formation of an enzyme-analyte-enzyme "sandwich." The enzymes present in this sandwich are capable of catalyzing a reaction that produces a colored product, which can be measured spectrophotometrically.

The amount of color produced is proportional to the concentration of the analyte present in the sample. This allows for the determination of the analyte's concentration through comparison with a standard curve generated using samples with known concentrations of the analyte. EMIT is widely used in clinical laboratories for diagnostic and therapeutic drug monitoring purposes, as well as in forensic toxicology to detect drugs of abuse.

In summary, Enzyme Multiplied Immunoassay Technique (EMIT) is a sensitive and specific immunoassay method that utilizes enzyme-labeled antigens or antibodies to quantitatively or qualitatively measure the concentration of various substances in a sample.

Forensic medicine, also known as legal medicine or medical jurisprudence, is a branch of medicine that deals with the application of medical knowledge to legal issues and questions. It involves the examination, interpretation, and analysis of medical evidence for use in courts of law. This may include determining the cause and manner of death, identifying injuries or diseases, assessing the effects of substances or treatments, and evaluating the competency or capacity of individuals. Forensic medicine is often used in criminal investigations and court cases, but it can also be applied to civil matters such as personal injury claims or medical malpractice suits.

Prevalence, in medical terms, refers to the total number of people in a given population who have a particular disease or condition at a specific point in time, or over a specified period. It is typically expressed as a percentage or a ratio of the number of cases to the size of the population. Prevalence differs from incidence, which measures the number of new cases that develop during a certain period.

Psychometrics is a branch of psychology that deals with the theory and technique of psychological measurement, such as the development and standardization of tests used to measure intelligence, aptitude, personality, attitudes, and other mental abilities or traits. It involves the construction and validation of measurement instruments, including the determination of their reliability and validity, and the application of statistical methods to analyze test data and interpret results. The ultimate goal of psychometrics is to provide accurate, objective, and meaningful measurements that can be used to understand individual differences and make informed decisions in educational, clinical, and organizational settings.

Dopamine agonists are a class of medications that mimic the action of dopamine, a neurotransmitter in the brain that regulates movement, emotion, motivation, and reinforcement of rewarding behaviors. These medications bind to dopamine receptors in the brain and activate them, leading to an increase in dopaminergic activity.

Dopamine agonists are used primarily to treat Parkinson's disease, a neurological disorder characterized by motor symptoms such as tremors, rigidity, bradykinesia (slowness of movement), and postural instability. By increasing dopaminergic activity in the brain, dopamine agonists can help alleviate some of these symptoms.

Examples of dopamine agonists include:

1. Pramipexole (Mirapex)
2. Ropinirole (Requip)
3. Rotigotine (Neupro)
4. Apomorphine (Apokyn)

Dopamine agonists may also be used off-label to treat other conditions, such as restless legs syndrome or certain types of dopamine-responsive dystonia. However, these medications can have significant side effects, including nausea, dizziness, orthostatic hypotension, compulsive behaviors (such as gambling, shopping, or sexual addiction), and hallucinations. Therefore, they should be used with caution and under the close supervision of a healthcare provider.

The "age of onset" is a medical term that refers to the age at which an individual first develops or displays symptoms of a particular disease, disorder, or condition. It can be used to describe various medical conditions, including both physical and mental health disorders. The age of onset can have implications for prognosis, treatment approaches, and potential causes of the condition. In some cases, early onset may indicate a more severe or progressive course of the disease, while late-onset symptoms might be associated with different underlying factors or etiologies. It is essential to provide accurate and precise information regarding the age of onset when discussing a patient's medical history and treatment plan.

The neostriatum is a component of the basal ganglia, a group of subcortical nuclei in the brain that are involved in motor control, procedural learning, and other cognitive functions. It is composed primarily of two types of neurons: medium spiny neurons and aspiny interneurons. The neostriatum receives input from various regions of the cerebral cortex and projects to other parts of the basal ganglia, forming an important part of the cortico-basal ganglia-thalamo-cortical loop.

In medical terminology, the neostriatum is often used interchangeably with the term "striatum," although some sources reserve the term "neostriatum" for the caudate nucleus and putamen specifically, while using "striatum" to refer to the entire structure including the ventral striatum (also known as the nucleus accumbens).

Damage to the neostriatum has been implicated in various neurological conditions, such as Huntington's disease and Parkinson's disease.

P-Chloroamphetamine, also known as PCA or 4-chloroamphetamine, is a synthetic stimulant drug that has been used in scientific research but is not commonly used medically. It is a derivative of amphetamine and has similar effects, such as increasing heart rate, blood pressure, and alertness. However, it also has hallucinogenic properties and can cause psychological disturbances.

PCA acts as a releasing agent for the neurotransmitters dopamine, norepinephrine, and serotonin, which are involved in regulating mood, appetite, and other physiological processes. It is classified as a Schedule I controlled substance in the United States due to its high potential for abuse and lack of accepted medical use.

It's important to note that PCA is not approved for any medical use in humans and should only be used in a controlled research setting with appropriate safety measures in place.

Dopamine D2 receptor is a type of metabotropic G protein-coupled receptor that binds to the neurotransmitter dopamine. It is one of five subtypes of dopamine receptors (D1-D5) and is encoded by the gene DRD2. The activation of D2 receptors leads to a decrease in the activity of adenylyl cyclase, which results in reduced levels of cAMP and modulation of ion channels.

D2 receptors are widely distributed throughout the central nervous system (CNS) and play important roles in various physiological functions, including motor control, reward processing, emotion regulation, and cognition. They are also involved in several neurological and psychiatric disorders, such as Parkinson's disease, schizophrenia, drug addiction, and Tourette syndrome.

D2 receptors have two main subtypes: D2 short (D2S) and D2 long (D2L). The D2S subtype is primarily located in the presynaptic terminals and functions as an autoreceptor that regulates dopamine release, while the D2L subtype is mainly found in the postsynaptic neurons and modulates intracellular signaling pathways.

Antipsychotic drugs, which are used to treat schizophrenia and other psychiatric disorders, work by blocking D2 receptors. However, excessive blockade of these receptors can lead to side effects such as extrapyramidal symptoms (EPS), tardive dyskinesia, and hyperprolactinemia. Therefore, the development of drugs that selectively target specific subtypes of dopamine receptors is an active area of research in the field of neuropsychopharmacology.

"Terminology as a topic" in the context of medical education and practice refers to the study and use of specialized language and terms within the field of medicine. This includes understanding the meaning, origins, and appropriate usage of medical terminology in order to effectively communicate among healthcare professionals and with patients. It may also involve studying the evolution and cultural significance of medical terminology. The importance of "terminology as a topic" lies in promoting clear and accurate communication, which is essential for providing safe and effective patient care.

A missense mutation is a type of point mutation in which a single nucleotide change results in the substitution of a different amino acid in the protein that is encoded by the affected gene. This occurs when the altered codon (a sequence of three nucleotides that corresponds to a specific amino acid) specifies a different amino acid than the original one. The function and/or stability of the resulting protein may be affected, depending on the type and location of the missense mutation. Missense mutations can have various effects, ranging from benign to severe, depending on the importance of the changed amino acid for the protein's structure or function.

Dopamine antagonists are a class of drugs that block the action of dopamine, a neurotransmitter in the brain associated with various functions including movement, motivation, and emotion. These drugs work by binding to dopamine receptors and preventing dopamine from attaching to them, which can help to reduce the symptoms of certain medical conditions such as schizophrenia, bipolar disorder, and gastroesophageal reflux disease (GERD).

There are several types of dopamine antagonists, including:

1. Typical antipsychotics: These drugs are primarily used to treat psychosis, including schizophrenia and delusional disorders. Examples include haloperidol, chlorpromazine, and fluphenazine.
2. Atypical antipsychotics: These drugs are also used to treat psychosis but have fewer side effects than typical antipsychotics. They may also be used to treat bipolar disorder and depression. Examples include risperidone, olanzapine, and quetiapine.
3. Antiemetics: These drugs are used to treat nausea and vomiting. Examples include metoclopramide and prochlorperazine.
4. Dopamine agonists: While not technically dopamine antagonists, these drugs work by stimulating dopamine receptors and can be used to treat conditions such as Parkinson's disease. However, they can also have the opposite effect and block dopamine receptors in high doses, making them functionally similar to dopamine antagonists.

Common side effects of dopamine antagonists include sedation, weight gain, and movement disorders such as tardive dyskinesia. It's important to use these drugs under the close supervision of a healthcare provider to monitor for side effects and adjust the dosage as needed.

Pregnancy is a physiological state or condition where a fertilized egg (zygote) successfully implants and grows in the uterus of a woman, leading to the development of an embryo and finally a fetus. This process typically spans approximately 40 weeks, divided into three trimesters, and culminates in childbirth. Throughout this period, numerous hormonal and physical changes occur to support the growing offspring, including uterine enlargement, breast development, and various maternal adaptations to ensure the fetus's optimal growth and well-being.

Substance-induced psychosis is a type of psychosis that is caused by the use of drugs, alcohol, or other substances. The American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) defines substance/medication-induced psychotic disorder as follows:

A. Presence of one (or more) of the following symptoms:

1. Delusions.
2. Hallucinations.
3. Disorganized speech (e.g., frequent derailment or incoherence).

B. There is evidence from the history, physical examination, or laboratory findings that the disturbance is caused by the direct physiological effects of a substance (e.g., a drug of abuse, a medication) or a combination of substances.

C. The disturbance does not occur exclusively during the course of a delirium and is not better explained by a psychotic disorder that is not substance/medication-induced. The symptoms in Criterion A developed during or soon after substance intoxication or withdrawal, or after exposure to a medication.

D. The disturbance causes significant distress or impairment in social, occupational, or other important areas of functioning.

E. The disturbance is not better accounted for by another mental disorder (e.g., major depressive disorder, bipolar disorder).

It's important to note that the diagnosis of substance-induced psychosis requires a thorough medical and psychiatric evaluation to determine if the symptoms are caused by substance use or another underlying mental health condition.

Psychotropic drugs, also known as psychoactive drugs, are a class of medications that affect the function of the central nervous system, leading to changes in consciousness, perception, mood, cognition, or behavior. These drugs work by altering the chemical neurotransmitters in the brain, such as dopamine, serotonin, and norepinephrine, which are involved in regulating mood, thought, and behavior.

Psychotropic drugs can be classified into several categories based on their primary therapeutic effects, including:

1. Antipsychotic drugs: These medications are used to treat psychosis, schizophrenia, and other related disorders. They work by blocking dopamine receptors in the brain, which helps reduce hallucinations, delusions, and disordered thinking.
2. Antidepressant drugs: These medications are used to treat depression, anxiety disorders, and some chronic pain conditions. They work by increasing the availability of neurotransmitters such as serotonin, norepinephrine, or dopamine in the brain, which helps improve mood and reduce anxiety.
3. Mood stabilizers: These medications are used to treat bipolar disorder and other mood disorders. They help regulate the ups and downs of mood swings and can also be used as adjunctive treatment for depression and anxiety.
4. Anxiolytic drugs: Also known as anti-anxiety medications, these drugs are used to treat anxiety disorders, panic attacks, and insomnia. They work by reducing the activity of neurotransmitters such as GABA, which can help reduce anxiety and promote relaxation.
5. Stimulant drugs: These medications are used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. They work by increasing the availability of dopamine and norepinephrine in the brain, which helps improve focus, concentration, and alertness.

It is important to note that psychotropic drugs can have significant side effects and should only be used under the close supervision of a qualified healthcare provider.

Conduct Disorder is a mental health disorder that typically begins in childhood or adolescence and is characterized by a repetitive pattern of behavior that violates the rights of others or major age-appropriate societal norms and rules. The behaviors fall into four main categories: aggression to people and animals, destruction of property, deceitfulness or theft, and serious violation of rules.

The specific symptoms of Conduct Disorder can vary widely among individuals, but they generally include:

1. Aggression to people and animals: This may include physical fights, bullying, threatening others, cruelty to animals, and use of weapons.
2. Destruction of property: This may include deliberate destruction of others' property, arson, and vandalism.
3. Deceitfulness or theft: This may include lying, shoplifting, stealing, and breaking into homes, buildings, or cars.
4. Serious violation of rules: This may include running away from home, truancy, staying out late without permission, and frequent violations of school rules.

Conduct Disorder can have serious consequences for individuals who suffer from it, including academic failure, substance abuse, depression, anxiety, and difficulties in interpersonal relationships. It is important to note that Conduct Disorder should be diagnosed by a qualified mental health professional based on a comprehensive evaluation.

Microdialysis is a minimally invasive technique used in clinical and research settings to continuously monitor the concentration of various chemicals, such as neurotransmitters, drugs, or metabolites, in biological fluids (e.g., extracellular fluid of tissues, blood, or cerebrospinal fluid). This method involves inserting a small, flexible catheter with a semipermeable membrane into the region of interest. A physiological solution is continuously perfused through the catheter, allowing molecules to diffuse across the membrane based on their concentration gradient. The dialysate that exits the catheter is then collected and analyzed for target compounds using various analytical techniques (e.g., high-performance liquid chromatography, mass spectrometry).

In summary, microdialysis is a valuable tool for monitoring real-time changes in chemical concentrations within biological systems, enabling better understanding of physiological processes or pharmacokinetic properties of drugs.

I'm sorry for any confusion, but "Methyltyrosines" is not a widely recognized medical term or concept in the field of medicine or biochemistry. It seems that there might be some misunderstanding or typo in your question.

If you are referring to "3-Methoxytyrosine" or "3-MT," it is a metabolite of dopamine, which is formed in the body by the enzyme catechol-O-methyltransferase (COMT). 3-MT can be measured in various biological samples, such as urine or plasma, to evaluate the activity of COMT and assess the exposure to drugs that inhibit this enzyme.

If you meant something else by "Methyltyrosines," please provide more context or clarify your question so I can give a more accurate answer.

Amyloid beta-peptides (Aβ) are small protein fragments that are crucially involved in the pathogenesis of Alzheimer's disease. They are derived from a larger transmembrane protein called the amyloid precursor protein (APP) through a series of proteolytic cleavage events.

The two primary forms of Aβ peptides are Aβ40 and Aβ42, which differ in length by two amino acids. While both forms can be harmful, Aβ42 is more prone to aggregation and is considered to be the more pathogenic form. These peptides have the tendency to misfold and accumulate into oligomers, fibrils, and eventually insoluble plaques that deposit in various areas of the brain, most notably the cerebral cortex and hippocampus.

The accumulation of Aβ peptides is believed to initiate a cascade of events leading to neuroinflammation, oxidative stress, synaptic dysfunction, and neuronal death, which are all hallmarks of Alzheimer's disease. Although the exact role of Aβ in the onset and progression of Alzheimer's is still under investigation, it is widely accepted that they play a central part in the development of this debilitating neurodegenerative disorder.

DNA Mutational Analysis is a laboratory test used to identify genetic variations or changes (mutations) in the DNA sequence of a gene. This type of analysis can be used to diagnose genetic disorders, predict the risk of developing certain diseases, determine the most effective treatment for cancer, or assess the likelihood of passing on an inherited condition to offspring.

The test involves extracting DNA from a patient's sample (such as blood, saliva, or tissue), amplifying specific regions of interest using polymerase chain reaction (PCR), and then sequencing those regions to determine the precise order of nucleotide bases in the DNA molecule. The resulting sequence is then compared to reference sequences to identify any variations or mutations that may be present.

DNA Mutational Analysis can detect a wide range of genetic changes, including single-nucleotide polymorphisms (SNPs), insertions, deletions, duplications, and rearrangements. The test is often used in conjunction with other diagnostic tests and clinical evaluations to provide a comprehensive assessment of a patient's genetic profile.

It is important to note that not all mutations are pathogenic or associated with disease, and the interpretation of DNA Mutational Analysis results requires careful consideration of the patient's medical history, family history, and other relevant factors.

Phenmetrazine is a stimulant drug that was previously used for the treatment of obesity, but its use has been discontinued in many countries due to its addictive potential and adverse effects. It acts as a central nervous system stimulant, increasing heart rate, blood pressure, and alertness, and decreasing appetite.

The medical definition of Phenmetrazine is:

A psychostimulant drug that has been used in the treatment of obesity but has been discontinued in many countries due to its addictive potential and adverse effects. It is a phenylpropylamine derivative, structurally related to amphetamine and methamphetamine, and acts as a central nervous system stimulant, increasing heart rate, blood pressure, and alertness, and decreasing appetite. Phenmetrazine has sympathomimetic effects, releasing catecholamines from presynaptic nerve endings and blocking their reuptake, resulting in increased concentrations of these neurotransmitters in the synaptic cleft. It also inhibits monoamine oxidase, further increasing the concentration of catecholamines in the brain.

Phenmetrazine is classified as a Schedule II controlled substance in the United States due to its high potential for abuse and dependence. Its use is limited to research purposes only and requires a special license from the Drug Enforcement Administration (DEA).

Medical Definition:

Magnetic Resonance Imaging (MRI) is a non-invasive diagnostic imaging technique that uses a strong magnetic field and radio waves to create detailed cross-sectional or three-dimensional images of the internal structures of the body. The patient lies within a large, cylindrical magnet, and the scanner detects changes in the direction of the magnetic field caused by protons in the body. These changes are then converted into detailed images that help medical professionals to diagnose and monitor various medical conditions, such as tumors, injuries, or diseases affecting the brain, spinal cord, heart, blood vessels, joints, and other internal organs. MRI does not use radiation like computed tomography (CT) scans.

A Severity of Illness Index is a measurement tool used in healthcare to assess the severity of a patient's condition and the risk of mortality or other adverse outcomes. These indices typically take into account various physiological and clinical variables, such as vital signs, laboratory values, and co-morbidities, to generate a score that reflects the patient's overall illness severity.

Examples of Severity of Illness Indices include the Acute Physiology and Chronic Health Evaluation (APACHE) system, the Simplified Acute Physiology Score (SAPS), and the Mortality Probability Model (MPM). These indices are often used in critical care settings to guide clinical decision-making, inform prognosis, and compare outcomes across different patient populations.

It is important to note that while these indices can provide valuable information about a patient's condition, they should not be used as the sole basis for clinical decision-making. Rather, they should be considered in conjunction with other factors, such as the patient's overall clinical presentation, treatment preferences, and goals of care.

Nomifensine is a medication that was previously used in the treatment of depression, but it is no longer available in many countries due to safety concerns. It is a non-tricyclic antidepressant that works by inhibiting the reuptake of dopamine and noradrenaline, which helps to increase the levels of these neurotransmitters in the brain and improve mood.

The medical definition of Nomifensine is:

"Nomifensine is a non-tricyclic antidepressant that is a potent inhibitor of dopamine and noradrenaline reuptake, with minimal effects on serotonin reuptake. It was used in the treatment of depression but has been withdrawn from the market due to safety concerns."

It's important to note that Nomifensine should only be taken under the supervision of a medical professional, and it is not available in many countries due to its potential for causing serious side effects such as liver toxicity and the risk of developing a rare but potentially fatal condition called hemolytic anemia.

Brain diseases, also known as neurological disorders, refer to a wide range of conditions that affect the brain and nervous system. These diseases can be caused by various factors such as genetics, infections, injuries, degeneration, or structural abnormalities. They can affect different parts of the brain, leading to a variety of symptoms and complications.

Some examples of brain diseases include:

1. Alzheimer's disease - a progressive degenerative disorder that affects memory and cognitive function.
2. Parkinson's disease - a movement disorder characterized by tremors, stiffness, and difficulty with coordination and balance.
3. Multiple sclerosis - a chronic autoimmune disease that affects the nervous system and can cause a range of symptoms such as vision loss, muscle weakness, and cognitive impairment.
4. Epilepsy - a neurological disorder characterized by recurrent seizures.
5. Brain tumors - abnormal growths in the brain that can be benign or malignant.
6. Stroke - a sudden interruption of blood flow to the brain, which can cause paralysis, speech difficulties, and other neurological symptoms.
7. Meningitis - an infection of the membranes surrounding the brain and spinal cord.
8. Encephalitis - an inflammation of the brain that can be caused by viruses, bacteria, or autoimmune disorders.
9. Huntington's disease - a genetic disorder that affects muscle coordination, cognitive function, and mental health.
10. Migraine - a neurological condition characterized by severe headaches, often accompanied by nausea, vomiting, and sensitivity to light and sound.

Brain diseases can range from mild to severe and may be treatable or incurable. They can affect people of all ages and backgrounds, and early diagnosis and treatment are essential for improving outcomes and quality of life.

Hyperkinesis is not considered a formal medical diagnosis. However, the term is often used informally to refer to a state of excessive or involuntary muscle movements. It is sometimes used as a synonym for hyperkinetic movement disorders, which are a group of neurological conditions characterized by an excess of involuntary movements. Examples of hyperkinetic movement disorders include chorea, dystonia, tics, myoclonus, and stereotypies.

It is important to note that the term "hyperkinesis" is not used in the current diagnostic classifications such as the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) or the International Classification of Diseases (ICD-10). Instead, specific movement disorders are diagnosed and classified based on their underlying causes and symptoms.

Tic disorders are a group of conditions characterized by the presence of repetitive, involuntary movements or sounds, known as tics. These movements or sounds can vary in complexity and severity, and they may be worsened by stress or strong emotions.

There are several different types of tic disorders, including:

1. Tourette's disorder: This is a neurological condition characterized by the presence of both motor (movement-related) and vocal tics that have been present for at least one year. The tics may wax and wane in severity over time, but they do not disappear for more than three consecutive months.
2. Persistent (chronic) motor or vocal tic disorder: This type of tic disorder is characterized by the presence of either motor or vocal tics (but not both), which have been present for at least one year. The tics may wax and wane in severity over time, but they do not disappear for more than three consecutive months.
3. Provisional tic disorder: This type of tic disorder is characterized by the presence of motor or vocal tics (or both) that have been present for less than one year. The tics may wax and wane in severity over time, but they do not disappear for more than three consecutive months.
4. Tic disorder not otherwise specified: This category is used to describe tic disorders that do not meet the criteria for any of the other types of tic disorders.

Tic disorders are thought to be caused by a combination of genetic and environmental factors, and they often co-occur with other conditions such as attention deficit hyperactivity disorder (ADHD) and obsessive-compulsive disorder (OCD). Treatment for tic disorders may include behavioral therapy, medication, or a combination of both.

Pyrazolones are a group of non-steroidal anti-inflammatory drugs (NSAIDs) that contain a pyrazole ring in their chemical structure. They have analgesic, antipyretic, and anti-inflammatory properties. Pyrazolones include drugs such as phenylbutazone, oxyphenbutazone, and aminopyrine. However, due to their potential for serious side effects, including agranulocytosis (a severe decrease in white blood cells), pyrazolones are rarely used in modern clinical practice.

A newborn infant is a baby who is within the first 28 days of life. This period is also referred to as the neonatal period. Newborns require specialized care and attention due to their immature bodily systems and increased vulnerability to various health issues. They are closely monitored for signs of well-being, growth, and development during this critical time.

Ephedrine is a medication that stimulates the nervous system and is used to treat low blood pressure, asthma, and nasal congestion. It works by narrowing the blood vessels and increasing heart rate, which can help to increase blood pressure and open up the airways in the lungs. Ephedrine may also be used as a bronchodilator to treat COPD (chronic obstructive pulmonary disease).

Ephedrine is available in various forms, including tablets, capsules, and solutions for injection. It is important to follow the instructions of a healthcare provider when taking ephedrine, as it can have side effects such as rapid heart rate, anxiety, headache, and dizziness. Ephedrine should not be used by people with certain medical conditions, such as heart disease, high blood pressure, or narrow-angle glaucoma, and it should not be taken during pregnancy or breastfeeding without consulting a healthcare provider.

In addition to its medical uses, ephedrine has been used as a performance-enhancing drug and is banned by many sports organizations. It can also be found in some over-the-counter cold and allergy medications, although these products are required to carry warnings about the potential for misuse and addiction.

"Age factors" refer to the effects, changes, or differences that age can have on various aspects of health, disease, and medical care. These factors can encompass a wide range of issues, including:

1. Physiological changes: As people age, their bodies undergo numerous physical changes that can affect how they respond to medications, illnesses, and medical procedures. For example, older adults may be more sensitive to certain drugs or have weaker immune systems, making them more susceptible to infections.
2. Chronic conditions: Age is a significant risk factor for many chronic diseases, such as heart disease, diabetes, cancer, and arthritis. As a result, age-related medical issues are common and can impact treatment decisions and outcomes.
3. Cognitive decline: Aging can also lead to cognitive changes, including memory loss and decreased decision-making abilities. These changes can affect a person's ability to understand and comply with medical instructions, leading to potential complications in their care.
4. Functional limitations: Older adults may experience physical limitations that impact their mobility, strength, and balance, increasing the risk of falls and other injuries. These limitations can also make it more challenging for them to perform daily activities, such as bathing, dressing, or cooking.
5. Social determinants: Age-related factors, such as social isolation, poverty, and lack of access to transportation, can impact a person's ability to obtain necessary medical care and affect their overall health outcomes.

Understanding age factors is critical for healthcare providers to deliver high-quality, patient-centered care that addresses the unique needs and challenges of older adults. By taking these factors into account, healthcare providers can develop personalized treatment plans that consider a person's age, physical condition, cognitive abilities, and social circumstances.

Operant conditioning is a type of learning in which behavior is modified by its consequences, either reinforcing or punishing the behavior. It was first described by B.F. Skinner and involves an association between a response (behavior) and a consequence (either reward or punishment). There are two types of operant conditioning: positive reinforcement, in which a desirable consequence follows a desired behavior, increasing the likelihood that the behavior will occur again; and negative reinforcement, in which a undesirable consequence is removed following a desired behavior, also increasing the likelihood that the behavior will occur again.

For example, if a child cleans their room (response) and their parent gives them praise or a treat (positive reinforcement), the child is more likely to clean their room again in the future. If a child is buckling their seatbelt in the car (response) and the annoying buzzer stops (negative reinforcement), the child is more likely to buckle their seatbelt in the future.

It's important to note that operant conditioning is a form of learning, not motivation. The behavior is modified by its consequences, regardless of the individual's internal state or intentions.

Fenfluramine is a drug that was previously used for the short-term treatment of obesity. It works by suppressing appetite and increasing the feeling of fullness. Fenfluramine is an amphetamine derivative and stimulates the release of serotonin, a neurotransmitter in the brain that helps regulate mood, appetite, and sleep.

Fenfluramine was commonly prescribed in combination with phentermine, another appetite suppressant, under the brand name Fen-Phen. However, in 1997, the U.S. Food and Drug Administration (FDA) issued a public health warning about the potential risk of serious heart valve damage associated with the use of fenfluramine and withdrew its approval for the drug's use. Since then, fenfluramine has not been approved for medical use in many countries, including the United States.

Transgenic mice are genetically modified rodents that have incorporated foreign DNA (exogenous DNA) into their own genome. This is typically done through the use of recombinant DNA technology, where a specific gene or genetic sequence of interest is isolated and then introduced into the mouse embryo. The resulting transgenic mice can then express the protein encoded by the foreign gene, allowing researchers to study its function in a living organism.

The process of creating transgenic mice usually involves microinjecting the exogenous DNA into the pronucleus of a fertilized egg, which is then implanted into a surrogate mother. The offspring that result from this procedure are screened for the presence of the foreign DNA, and those that carry the desired genetic modification are used to establish a transgenic mouse line.

Transgenic mice have been widely used in biomedical research to model human diseases, study gene function, and test new therapies. They provide a valuable tool for understanding complex biological processes and developing new treatments for a variety of medical conditions.

Substance Withdrawal Syndrome is a medically recognized condition that occurs when an individual who has been using certain substances, such as alcohol, opioids, or benzodiazepines, suddenly stops or significantly reduces their use. The syndrome is characterized by a specific set of symptoms that can be physical, cognitive, and emotional in nature. These symptoms can vary widely depending on the substance that was being used, the length and intensity of the addiction, and individual factors such as genetics, age, and overall health.

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), published by the American Psychiatric Association, provides the following diagnostic criteria for Substance Withdrawal Syndrome:

A. The development of objective evidence of withdrawal, referring to the specific physiological changes associated with the particular substance, or subjective evidence of withdrawal, characterized by the individual's report of symptoms that correspond to the typical withdrawal syndrome for the substance.

B. The symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning.

C. The symptoms are not better explained by co-occurring mental, medical, or other substance use disorders.

D. The withdrawal syndrome is not attributable to another medical condition and is not better accounted for by another mental disorder.

The DSM-5 also specifies that the diagnosis of Substance Withdrawal Syndrome should be substance-specific, meaning that it should specify the particular class of substances (e.g., alcohol, opioids, benzodiazepines) responsible for the withdrawal symptoms. This is important because different substances have distinct withdrawal syndromes and require different approaches to management and treatment.

In general, Substance Withdrawal Syndrome can be a challenging and potentially dangerous condition that requires professional medical supervision and support during the detoxification process. The specific symptoms and their severity will vary depending on the substance involved, but they may include:

* For alcohol: tremors, seizures, hallucinations, agitation, anxiety, nausea, vomiting, and insomnia.
* For opioids: muscle aches, restlessness, lacrimation (tearing), rhinorrhea (runny nose), yawning, perspiration, chills, mydriasis (dilated pupils), piloerection (goosebumps), nausea or vomiting, diarrhea, and abdominal cramps.
* For benzodiazepines: anxiety, irritability, insomnia, restlessness, confusion, hallucinations, seizures, and increased heart rate and blood pressure.

It is essential to consult with a healthcare professional if you or someone you know is experiencing symptoms of Substance Withdrawal Syndrome. They can provide appropriate medical care, support, and referrals for further treatment as needed.

The caudate nucleus is a part of the brain located within the basal ganglia, a group of structures that are important for movement control and cognition. It has a distinctive C-shaped appearance and plays a role in various functions such as learning, memory, emotion, and motivation. The caudate nucleus receives inputs from several areas of the cerebral cortex and sends outputs to other basal ganglia structures, contributing to the regulation of motor behavior and higher cognitive processes.

Benzphetamine is a sympathomimetic amine, which is a type of drug that stimulates the sympathetic nervous system. It is a central nervous system stimulant and an appetite suppressant. Benzphetamine is used as a short-term supplement to diet and exercise in the treatment of obesity.

The medical definition of benzphetamine is:

A CNS stimulant and anorectic, structurally related to amphetamines, but pharmacologically related to the phenylethylamines. It has a longer duration of action than other amphetamines because it is absorbed more slowly and is excreted more slowly. Benzphetamine is used as an appetite suppressant in the treatment of obesity.

It's important to note that benzphetamine, like other weight-loss medications, should be used in conjunction with a reduced-calorie diet and exercise. It also has a risk for abuse and dependence, so it is usually prescribed for short-term use only.

Obesity is a complex disease characterized by an excess accumulation of body fat to the extent that it negatively impacts health. It's typically defined using Body Mass Index (BMI), a measure calculated from a person's weight and height. A BMI of 30 or higher is indicative of obesity. However, it's important to note that while BMI can be a useful tool for identifying obesity in populations, it does not directly measure body fat and may not accurately reflect health status in individuals. Other factors such as waist circumference, blood pressure, cholesterol levels, and blood sugar levels should also be considered when assessing health risks associated with weight.

A cohort study is a type of observational study in which a group of individuals who share a common characteristic or exposure are followed up over time to determine the incidence of a specific outcome or outcomes. The cohort, or group, is defined based on the exposure status (e.g., exposed vs. unexposed) and then monitored prospectively to assess for the development of new health events or conditions.

Cohort studies can be either prospective or retrospective in design. In a prospective cohort study, participants are enrolled and followed forward in time from the beginning of the study. In contrast, in a retrospective cohort study, researchers identify a cohort that has already been assembled through medical records, insurance claims, or other sources and then look back in time to assess exposure status and health outcomes.

Cohort studies are useful for establishing causality between an exposure and an outcome because they allow researchers to observe the temporal relationship between the two. They can also provide information on the incidence of a disease or condition in different populations, which can be used to inform public health policy and interventions. However, cohort studies can be expensive and time-consuming to conduct, and they may be subject to bias if participants are not representative of the population or if there is loss to follow-up.

Serotonin, also known as 5-hydroxytryptamine (5-HT), is a monoamine neurotransmitter that is found primarily in the gastrointestinal (GI) tract, blood platelets, and the central nervous system (CNS) of humans and other animals. It is produced by the conversion of the amino acid tryptophan to 5-hydroxytryptophan (5-HTP), and then to serotonin.

In the CNS, serotonin plays a role in regulating mood, appetite, sleep, memory, learning, and behavior, among other functions. It also acts as a vasoconstrictor, helping to regulate blood flow and blood pressure. In the GI tract, it is involved in peristalsis, the contraction and relaxation of muscles that moves food through the digestive system.

Serotonin is synthesized and stored in serotonergic neurons, which are nerve cells that use serotonin as their primary neurotransmitter. These neurons are found throughout the brain and spinal cord, and they communicate with other neurons by releasing serotonin into the synapse, the small gap between two neurons.

Abnormal levels of serotonin have been linked to a variety of disorders, including depression, anxiety, schizophrenia, and migraines. Medications that affect serotonin levels, such as selective serotonin reuptake inhibitors (SSRIs), are commonly used to treat these conditions.

I'm sorry for any confusion, but "United States" is a geopolitical entity, specifically the name of the country consisting of 50 states, and it is not a medical term or concept. Therefore, I can't provide a medical definition for it. If you have any questions related to health, medicine, or biology, I would be happy to try to help answer those!

Genotype, in genetics, refers to the complete heritable genetic makeup of an individual organism, including all of its genes. It is the set of instructions contained in an organism's DNA for the development and function of that organism. The genotype is the basis for an individual's inherited traits, and it can be contrasted with an individual's phenotype, which refers to the observable physical or biochemical characteristics of an organism that result from the expression of its genes in combination with environmental influences.

It is important to note that an individual's genotype is not necessarily identical to their genetic sequence. Some genes have multiple forms called alleles, and an individual may inherit different alleles for a given gene from each parent. The combination of alleles that an individual inherits for a particular gene is known as their genotype for that gene.

Understanding an individual's genotype can provide important information about their susceptibility to certain diseases, their response to drugs and other treatments, and their risk of passing on inherited genetic disorders to their offspring.

Borderline Personality Disorder (BPD) is a mental health disorder characterized by a pervasive pattern of instability in interpersonal relationships, self-image, affect, and mood, as well as marked impulsivity that begins by early adulthood and is present in various contexts.

Individuals with BPD often experience intense and fluctuating emotions, ranging from profound sadness, anxiety, and anger to feelings of happiness or calm. They may have difficulty managing these emotions, leading to impulsive behavior, self-harm, or suicidal ideation.

People with BPD also tend to have an unstable sense of self, which can lead to rapid changes in their goals, values, and career choices. They often struggle with feelings of emptiness and boredom, and may engage in risky behaviors such as substance abuse, reckless driving, or binge eating to alleviate these feelings.

Interpersonal relationships are often strained due to the individual's fear of abandonment, intense emotional reactions, and difficulty regulating their emotions. They may experience idealization and devaluation of others, leading to rapid shifts in how they view and treat people close to them.

Diagnosis of BPD is typically made by a mental health professional using criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), which is published by the American Psychiatric Association. Treatment for BPD may include psychotherapy, medication, and support groups to help individuals manage their symptoms and improve their quality of life.

A "knockout" mouse is a genetically engineered mouse in which one or more genes have been deleted or "knocked out" using molecular biology techniques. This allows researchers to study the function of specific genes and their role in various biological processes, as well as potential associations with human diseases. The mice are generated by introducing targeted DNA modifications into embryonic stem cells, which are then used to create a live animal. Knockout mice have been widely used in biomedical research to investigate gene function, disease mechanisms, and potential therapeutic targets.

Serotonin agents are a class of drugs that work on the neurotransmitter serotonin (5-hydroxytryptamine, 5-HT) in the brain and elsewhere in the body. They include several types of medications such as:

1. Selective Serotonin Reuptake Inhibitors (SSRIs): These drugs block the reabsorption (reuptake) of serotonin into the presynaptic neuron, increasing the availability of serotonin in the synapse to interact with postsynaptic receptors. SSRIs are commonly used as antidepressants and include medications such as fluoxetine, sertraline, and citalopram.
2. Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): These drugs block the reabsorption of both serotonin and norepinephrine into the presynaptic neuron, increasing the availability of these neurotransmitters in the synapse. SNRIs are also used as antidepressants and include medications such as venlafaxine and duloxetine.
3. Serotonin Receptor Agonists: These drugs bind to and activate serotonin receptors, mimicking the effects of serotonin. They are used for various indications, including migraine prevention (e.g., sumatriptan) and Parkinson's disease (e.g., pramipexole).
4. Serotonin Receptor Antagonists: These drugs block serotonin receptors, preventing the effects of serotonin. They are used for various indications, including nausea and vomiting (e.g., ondansetron) and as mood stabilizers in bipolar disorder (e.g., olanzapine).
5. Serotonin Synthesis Inhibitors: These drugs block the enzymatic synthesis of serotonin, reducing its availability in the brain. They are used as antidepressants and include medications such as monoamine oxidase inhibitors (MAOIs) like phenelzine and tranylcypromine.

It's important to note that while these drugs all affect serotonin, they have different mechanisms of action and are used for various indications. It's essential to consult a healthcare professional before starting any new medication.

Autoantibodies are defined as antibodies that are produced by the immune system and target the body's own cells, tissues, or organs. These antibodies mistakenly identify certain proteins or molecules in the body as foreign invaders and attack them, leading to an autoimmune response. Autoantibodies can be found in various autoimmune diseases such as rheumatoid arthritis, lupus, and thyroiditis. The presence of autoantibodies can also be used as a diagnostic marker for certain conditions.

C57BL/6 (C57 Black 6) is an inbred strain of laboratory mouse that is widely used in biomedical research. The term "inbred" refers to a strain of animals where matings have been carried out between siblings or other closely related individuals for many generations, resulting in a population that is highly homozygous at most genetic loci.

The C57BL/6 strain was established in 1920 by crossing a female mouse from the dilute brown (DBA) strain with a male mouse from the black strain. The resulting offspring were then interbred for many generations to create the inbred C57BL/6 strain.

C57BL/6 mice are known for their robust health, longevity, and ease of handling, making them a popular choice for researchers. They have been used in a wide range of biomedical research areas, including studies of cancer, immunology, neuroscience, cardiovascular disease, and metabolism.

One of the most notable features of the C57BL/6 strain is its sensitivity to certain genetic modifications, such as the introduction of mutations that lead to obesity or impaired glucose tolerance. This has made it a valuable tool for studying the genetic basis of complex diseases and traits.

Overall, the C57BL/6 inbred mouse strain is an important model organism in biomedical research, providing a valuable resource for understanding the genetic and molecular mechanisms underlying human health and disease.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

In the context of medicine, particularly in behavioral neuroscience and psychology, "reward" is not typically used as a definitive medical term. However, it generally refers to a positive outcome or incentive that reinforces certain behaviors, making them more likely to be repeated in the future. This can involve various stimuli such as food, water, sexual activity, social interaction, or drug use, among others.

In the brain, rewards are associated with the activation of the reward system, primarily the mesolimbic dopamine pathway, which includes the ventral tegmental area (VTA) and the nucleus accumbens (NAcc). The release of dopamine in these areas is thought to reinforce and motivate behavior linked to rewards.

It's important to note that while "reward" has a specific meaning in this context, it is not a formal medical diagnosis or condition. Instead, it is a concept used to understand the neural and psychological mechanisms underlying motivation, learning, and addiction.

A startle reaction is a natural, defensive response to an unexpected stimulus that is characterized by a sudden contraction of muscles, typically in the face, neck, and arms. It's a reflexive action that occurs involuntarily and is mediated by the brainstem. The startle reaction can be observed in many different species, including humans, and is thought to have evolved as a protective mechanism to help organisms respond quickly to potential threats. In addition to the muscle contraction, the startle response may also include other physiological changes such as an increase in heart rate and blood pressure.

Movement disorders are a group of neurological conditions that affect the control and coordination of voluntary movements. These disorders can result from damage to or dysfunction of the cerebellum, basal ganglia, or other parts of the brain that regulate movement. Symptoms may include tremors, rigidity, bradykinesia (slowness of movement), akathisia (restlessness and inability to remain still), dystonia (sustained muscle contractions leading to abnormal postures), chorea (rapid, unpredictable movements), tics, and gait disturbances. Examples of movement disorders include Parkinson's disease, Huntington's disease, Tourette syndrome, and dystonic disorders.

Somatoform disorders are a group of psychological disorders characterized by the presence of physical symptoms that cannot be fully explained by a medical condition or substance abuse. These symptoms cause significant distress and impairment in social, occupational, or other important areas of functioning. The individual's belief about the symptoms is not consistent with the medical evaluation and often leads to excessive or repeated medical evaluations.

Examples of somatoform disorders include:

1. Somatization disorder: characterized by multiple physical symptoms that cannot be explained medically, affecting several parts of the body.
2. Conversion disorder: characterized by the presence of one or more neurological symptoms (such as blindness, paralysis, or difficulty swallowing) that cannot be explained medically and appear to have a psychological origin.
3. Pain disorder: characterized by chronic pain that is not fully explained by a medical condition.
4. Hypochondriasis: characterized by an excessive preoccupation with having a serious illness, despite reassurance from medical professionals.
5. Body dysmorphic disorder: characterized by the obsessive idea that some aspect of one's own body part or appearance is severely flawed and warrants exceptional measures to hide or fix it.

It's important to note that these disorders are not caused by intentional deceit or malingering, but rather reflect a genuine belief in the presence of physical symptoms and distress related to them.

A drug interaction is the effect of combining two or more drugs, or a drug and another substance (such as food or alcohol), which can alter the effectiveness or side effects of one or both of the substances. These interactions can be categorized as follows:

1. Pharmacodynamic interactions: These occur when two or more drugs act on the same target organ or receptor, leading to an additive, synergistic, or antagonistic effect. For example, taking a sedative and an antihistamine together can result in increased drowsiness due to their combined depressant effects on the central nervous system.
2. Pharmacokinetic interactions: These occur when one drug affects the absorption, distribution, metabolism, or excretion of another drug. For example, taking certain antibiotics with grapefruit juice can increase the concentration of the antibiotic in the bloodstream, leading to potential toxicity.
3. Food-drug interactions: Some drugs may interact with specific foods, affecting their absorption, metabolism, or excretion. An example is the interaction between warfarin (a blood thinner) and green leafy vegetables, which can increase the risk of bleeding due to enhanced vitamin K absorption from the vegetables.
4. Drug-herb interactions: Some herbal supplements may interact with medications, leading to altered drug levels or increased side effects. For instance, St. John's Wort can decrease the effectiveness of certain antidepressants and oral contraceptives by inducing their metabolism.
5. Drug-alcohol interactions: Alcohol can interact with various medications, causing additive sedative effects, impaired judgment, or increased risk of liver damage. For example, combining alcohol with benzodiazepines or opioids can lead to dangerous levels of sedation and respiratory depression.

It is essential for healthcare providers and patients to be aware of potential drug interactions to minimize adverse effects and optimize treatment outcomes.

The Ventral Tegmental Area (VTA) is a collection of neurons located in the midbrain that is part of the dopamine system. It is specifically known as the A10 group and is the largest source of dopaminergic neurons in the brain. These neurons project to various regions, including the prefrontal cortex, amygdala, hippocampus, and nucleus accumbens, and are involved in reward, motivation, addiction, and various cognitive functions. The VTA also contains GABAergic and glutamatergic neurons that modulate dopamine release and have various other functions.

'Gene expression regulation' refers to the processes that control whether, when, and where a particular gene is expressed, meaning the production of a specific protein or functional RNA encoded by that gene. This complex mechanism can be influenced by various factors such as transcription factors, chromatin remodeling, DNA methylation, non-coding RNAs, and post-transcriptional modifications, among others. Proper regulation of gene expression is crucial for normal cellular function, development, and maintaining homeostasis in living organisms. Dysregulation of gene expression can lead to various diseases, including cancer and genetic disorders.

Alpha-Methyltyrosine (α-MT) is a synthetic amino acid that acts as an inhibitor of the enzyme tyrosine hydroxylase. This enzyme is a rate-limiting step in the biosynthesis of catecholamines, including neurotransmitters such as dopamine and norepinephrine. By inhibiting tyrosine hydroxylase, α-MT reduces the synthesis of these catecholamines, which can lead to various effects on the nervous system.

In medical contexts, α-MT has been used in research settings to study the functions of catecholamines and their role in various physiological processes. It has also been investigated as a potential treatment for certain conditions, such as hypertension and anxiety disorders, although its clinical use is not widespread due to its side effects and limited efficacy.

It's important to note that α-MT should only be used under the supervision of a medical professional, as it can have significant effects on the nervous system and may interact with other medications or health conditions.

Sleep disorders are a group of conditions that affect the ability to sleep well on a regular basis. They can include problems with falling asleep, staying asleep, or waking up too early in the morning. These disorders can be caused by various factors such as stress, anxiety, depression, medical conditions, or substance abuse.

The American Academy of Sleep Medicine (AASM) recognizes over 80 distinct sleep disorders, which are categorized into the following major groups:

1. Insomnia - difficulty falling asleep or staying asleep.
2. Sleep-related breathing disorders - abnormal breathing during sleep such as obstructive sleep apnea.
3. Central disorders of hypersomnolence - excessive daytime sleepiness, including narcolepsy.
4. Circadian rhythm sleep-wake disorders - disruption of the internal body clock that regulates the sleep-wake cycle.
5. Parasomnias - abnormal behaviors during sleep such as sleepwalking or night terrors.
6. Sleep-related movement disorders - repetitive movements during sleep such as restless legs syndrome.
7. Isolated symptoms and normal variants - brief and occasional symptoms that do not warrant a specific diagnosis.

Sleep disorders can have significant impacts on an individual's quality of life, productivity, and overall health. If you suspect that you may have a sleep disorder, it is recommended to consult with a healthcare professional or a sleep specialist for proper evaluation and treatment.

Apomorphine is a non-selective dopamine receptor agonist, which means that it activates dopamine receptors in the brain. It has a high affinity for D1 and D2 dopamine receptors and is used medically to treat Parkinson's disease, particularly in cases of severe or intractable motor fluctuations.

Apomorphine can be administered subcutaneously (under the skin) as a solution or as a sublingual (under the tongue) film. It works by stimulating dopamine receptors in the brain, which helps to reduce the symptoms of Parkinson's disease such as stiffness, tremors, and difficulty with movement.

In addition to its use in Parkinson's disease, apomorphine has also been investigated for its potential therapeutic benefits in other neurological disorders, including alcohol use disorder and drug addiction. However, more research is needed to establish its safety and efficacy in these conditions.

Phenethylamines are a class of organic compounds that share a common structural feature, which is a phenethyl group (a phenyl ring bonded to an ethylamine chain). In the context of pharmacology and neuroscience, "phenethylamines" often refers to a specific group of psychoactive drugs, including stimulants like amphetamine and mescaline, a classic psychedelic. These compounds exert their effects by modulating the activity of neurotransmitters in the brain, such as dopamine, norepinephrine, and serotonin. It is important to note that many phenethylamines have potential for abuse and are controlled substances.

Multiple myeloma is a type of cancer that forms in a type of white blood cell called a plasma cell. Plasma cells help your body fight infection by producing antibodies. In multiple myeloma, cancerous plasma cells accumulate in the bone marrow and crowd out healthy blood cells. Rather than producing useful antibodies, the cancer cells produce abnormal proteins that can cause complications such as kidney damage, bone pain and fractures.

Multiple myeloma is a type of cancer called a plasma cell neoplasm. Plasma cell neoplasms are diseases in which there is an overproduction of a single clone of plasma cells. In multiple myeloma, this results in the crowding out of normal plasma cells, red and white blood cells and platelets, leading to many of the complications associated with the disease.

The abnormal proteins produced by the cancer cells can also cause damage to organs and tissues in the body. These abnormal proteins can be detected in the blood or urine and are often used to monitor the progression of multiple myeloma.

Multiple myeloma is a relatively uncommon cancer, but it is the second most common blood cancer after non-Hodgkin lymphoma. It typically occurs in people over the age of 65, and men are more likely to develop multiple myeloma than women. While there is no cure for multiple myeloma, treatments such as chemotherapy, radiation therapy, and stem cell transplantation can help manage the disease and its symptoms, and improve quality of life.

Narcolepsy is a chronic neurological disorder that affects the control of sleep and wakefulness. It's characterized by excessive daytime sleepiness (EDS), where people experience sudden, uncontrollable episodes of falling asleep during the day. These "sleep attacks" can occur at any time - while working, talking, eating, or even driving.

In addition to EDS, narcolepsy often includes cataplexy, a condition that causes loss of muscle tone, leading to weakness and sometimes collapse, often triggered by strong emotions like laughter or surprise. Other common symptoms are sleep paralysis (a temporary inability to move or speak while falling asleep or waking up), vivid hallucinations during the transitions between sleep and wakefulness, and fragmented nighttime sleep.

The exact cause of narcolepsy is not fully understood, but it's believed to involve genetic and environmental factors, as well as problems with certain neurotransmitters in the brain, such as hypocretin/orexin, which regulate sleep-wake cycles. Narcolepsy can significantly impact a person's quality of life, making it essential to seek medical attention for proper diagnosis and management.

Follow-up studies are a type of longitudinal research that involve repeated observations or measurements of the same variables over a period of time, in order to understand their long-term effects or outcomes. In medical context, follow-up studies are often used to evaluate the safety and efficacy of medical treatments, interventions, or procedures.

In a typical follow-up study, a group of individuals (called a cohort) who have received a particular treatment or intervention are identified and then followed over time through periodic assessments or data collection. The data collected may include information on clinical outcomes, adverse events, changes in symptoms or functional status, and other relevant measures.

The results of follow-up studies can provide important insights into the long-term benefits and risks of medical interventions, as well as help to identify factors that may influence treatment effectiveness or patient outcomes. However, it is important to note that follow-up studies can be subject to various biases and limitations, such as loss to follow-up, recall bias, and changes in clinical practice over time, which must be carefully considered when interpreting the results.

"Cocaine-Related Disorders" is a term used in the medical and psychiatric fields to refer to a group of conditions related to the use of cocaine, a powerful stimulant drug. These disorders are classified and diagnosed based on the criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), published by the American Psychiatric Association.

The two main categories of Cocaine-Related Disorders are:

1. Cocaine Use Disorder: This disorder is characterized by a problematic pattern of cocaine use leading to clinically significant impairment or distress, as manifested by at least two symptoms within a 12-month period. These symptoms may include using larger amounts of cocaine over a longer period than intended, persistent desire or unsuccessful efforts to cut down or control cocaine use, spending a great deal of time obtaining, using, or recovering from the effects of cocaine, and continued use despite physical or psychological problems caused or exacerbated by cocaine.
2. Cocaine-Induced Disorders: These disorders are directly caused by the acute effects of cocaine intoxication or withdrawal. They include:
* Cocaine Intoxication: Presents with a reversible syndrome due to recent use of cocaine, characterized by euphoria, increased energy, and psychomotor agitation. It may also cause elevated heart rate, blood pressure, and body temperature, as well as pupillary dilation.
* Cocaine Withdrawal: Occurs when an individual who has been using cocaine heavily for a prolonged period abruptly stops or significantly reduces their use. Symptoms include depressed mood, fatigue, increased appetite, vivid and unpleasant dreams, and insomnia.

Cocaine-Related Disorders can have severe negative consequences on an individual's physical health, mental wellbeing, and social functioning. They often require professional treatment to manage and overcome.

Signal transduction is the process by which a cell converts an extracellular signal, such as a hormone or neurotransmitter, into an intracellular response. This involves a series of molecular events that transmit the signal from the cell surface to the interior of the cell, ultimately resulting in changes in gene expression, protein activity, or metabolism.

The process typically begins with the binding of the extracellular signal to a receptor located on the cell membrane. This binding event activates the receptor, which then triggers a cascade of intracellular signaling molecules, such as second messengers, protein kinases, and ion channels. These molecules amplify and propagate the signal, ultimately leading to the activation or inhibition of specific cellular responses.

Signal transduction pathways are highly regulated and can be modulated by various factors, including other signaling molecules, post-translational modifications, and feedback mechanisms. Dysregulation of these pathways has been implicated in a variety of diseases, including cancer, diabetes, and neurological disorders.

Longitudinal studies are a type of research design where data is collected from the same subjects repeatedly over a period of time, often years or even decades. These studies are used to establish patterns of changes and events over time, and can help researchers identify causal relationships between variables. They are particularly useful in fields such as epidemiology, psychology, and sociology, where the focus is on understanding developmental trends and the long-term effects of various factors on health and behavior.

In medical research, longitudinal studies can be used to track the progression of diseases over time, identify risk factors for certain conditions, and evaluate the effectiveness of treatments or interventions. For example, a longitudinal study might follow a group of individuals over several decades to assess their exposure to certain environmental factors and their subsequent development of chronic diseases such as cancer or heart disease. By comparing data collected at multiple time points, researchers can identify trends and correlations that may not be apparent in shorter-term studies.

Longitudinal studies have several advantages over other research designs, including their ability to establish temporal relationships between variables, track changes over time, and reduce the impact of confounding factors. However, they also have some limitations, such as the potential for attrition (loss of participants over time), which can introduce bias and affect the validity of the results. Additionally, longitudinal studies can be expensive and time-consuming to conduct, requiring significant resources and a long-term commitment from both researchers and study participants.

Biogenic amine receptors are a type of cell surface receptor that bind and respond to biogenic amines, which are naturally occurring compounds that function as neurotransmitters or hormones in the human body. These receptors play crucial roles in various physiological processes, including regulation of mood, appetite, sleep, and cognition.

Examples of biogenic amines include:

1. Dopamine (DA): Dopamine receptors are involved in motor control, reward processing, and motivation. They are divided into two main classes: D1-like (D1 and D5) and D2-like (D2, D3, and D4).
2. Serotonin (5-HT): Serotonin receptors regulate mood, appetite, sleep, and pain perception. There are seven distinct families of serotonin receptors (5-HT1 to 5-HT7), with multiple subtypes within each family.
3. Norepinephrine (NE): Also known as noradrenaline, norepinephrine receptors play a role in the "fight or flight" response, attention, and arousal. They are divided into two main classes: α-adrenergic (α1 and α2) and β-adrenergic (β1, β2, and β3).
4. Histamine (HA): Histamine receptors regulate allergic responses, wakefulness, and appetite. There are four types of histamine receptors (H1 to H4), with distinct functions and signaling pathways.
5. Acetylcholine (ACh): While not a biogenic amine, acetylcholine is often included in this category due to its similar role as a neurotransmitter. Acetylcholine receptors are involved in learning, memory, and muscle contraction. They can be further divided into muscarinic (M1-M5) and nicotinic (α and β subunits) receptor classes.

Biogenic amine receptors typically function through G protein-coupled receptor (GPCR) signaling pathways, although some can also activate ion channels directly. Dysregulation of biogenic amine systems has been implicated in various neurological and psychiatric disorders, such as Parkinson's disease, depression, and schizophrenia.

"Long-Evans" is a strain of laboratory rats commonly used in scientific research. They are named after their developers, the scientists Long and Evans. This strain is albino, with a brownish-black hood over their eyes and ears, and they have an agouti (salt-and-pepper) color on their backs. They are often used as a model organism due to their size, ease of handling, and genetic similarity to humans. However, I couldn't find any specific medical definition related to "Long-Evans rats" as they are not a medical condition or disease.

Acquired Immunodeficiency Syndrome (AIDS) is a chronic, life-threatening condition caused by the Human Immunodeficiency Virus (HIV). AIDS is the most advanced stage of HIV infection, characterized by the significant weakening of the immune system, making the person more susceptible to various opportunistic infections and cancers.

The medical definition of AIDS includes specific criteria based on CD4+ T-cell count or the presence of certain opportunistic infections and diseases. According to the Centers for Disease Control and Prevention (CDC), a person with HIV is diagnosed with AIDS when:

1. The CD4+ T-cell count falls below 200 cells per cubic millimeter of blood (mm3) - a normal range is typically between 500 and 1,600 cells/mm3.
2. They develop one or more opportunistic infections or cancers that are indicative of advanced HIV disease, regardless of their CD4+ T-cell count.

Some examples of these opportunistic infections and cancers include:

* Pneumocystis pneumonia (PCP)
* Candidiasis (thrush) affecting the esophagus, trachea, or lungs
* Cryptococcal meningitis
* Toxoplasmosis of the brain
* Cytomegalovirus disease
* Kaposi's sarcoma
* Non-Hodgkin's lymphoma
* Invasive cervical cancer

It is important to note that with appropriate antiretroviral therapy (ART), people living with HIV can maintain their CD4+ T-cell counts, suppress viral replication, and prevent the progression to AIDS. Early diagnosis and consistent treatment are crucial for managing HIV and improving life expectancy and quality of life.

Raclopride is not a medical condition but a drug that belongs to the class of dopamine receptor antagonists. It's primarily used in research and diagnostic settings as a radioligand in positron emission tomography (PET) scans to visualize and measure the distribution and availability of dopamine D2 and D3 receptors in the brain.

In simpler terms, Raclopride is a compound that can be labeled with a radioactive isotope and then introduced into the body to track the interaction between the radioligand and specific receptors (in this case, dopamine D2 and D3 receptors) in the brain. This information can help researchers and clinicians better understand neurochemical processes and disorders related to dopamine dysfunction, such as Parkinson's disease, schizophrenia, and drug addiction.

It is important to note that Raclopride is not used as a therapeutic agent in clinical practice due to its short half-life and the potential for side effects associated with dopamine receptor blockade.

Self-administration, in the context of medicine and healthcare, refers to the act of an individual administering medication or treatment to themselves. This can include various forms of delivery such as oral medications, injections, or topical treatments. It is important that individuals who self-administer are properly trained and understand the correct dosage, timing, and technique to ensure safety and effectiveness. Self-administration promotes independence, allows for timely treatment, and can improve overall health outcomes.

Adrenergic agents are a class of drugs that bind to and activate adrenergic receptors, which are cell surface receptors found in the nervous system and other tissues. These receptors are activated by neurotransmitters such as norepinephrine and epinephrine (also known as adrenaline), which are released by the sympathetic nervous system in response to stress or excitement.

Adrenergic agents can be classified based on their mechanism of action and the specific receptors they bind to. There are two main types of adrenergic receptors: alpha and beta receptors, each with several subtypes. Some adrenergic agents bind to both alpha and beta receptors, while others are selective for one or the other.

Adrenergic agents have a wide range of therapeutic uses, including the treatment of asthma, cardiovascular diseases, glaucoma, and neurological disorders. They can also be used as diagnostic tools to test the function of the sympathetic nervous system. Some examples of adrenergic agents include:

* Alpha-agonists: These drugs bind to alpha receptors and cause vasoconstriction (narrowing of blood vessels), which can be useful in the treatment of hypotension (low blood pressure) or nasal congestion. Examples include phenylephrine and oxymetazoline.
* Alpha-antagonists: These drugs block the action of alpha receptors, leading to vasodilation (widening of blood vessels) and a decrease in blood pressure. Examples include prazosin and doxazosin.
* Beta-agonists: These drugs bind to beta receptors and cause bronchodilation (opening of the airways), increased heart rate, and increased force of heart contractions. They are used in the treatment of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders. Examples include albuterol and salmeterol.
* Beta-antagonists: These drugs block the action of beta receptors, leading to a decrease in heart rate, blood pressure, and bronchodilation. They are used in the treatment of hypertension, angina (chest pain), and heart failure. Examples include metoprolol and atenolol.
* Nonselective alpha- and beta-antagonists: These drugs block both alpha and beta receptors and are used in the treatment of hypertension, angina, and heart failure. Examples include labetalol and carvedilol.

Exploratory behavior refers to the actions taken by an individual to investigate and gather information about their environment. This type of behavior is often driven by curiosity and a desire to understand new or unfamiliar situations, objects, or concepts. In a medical context, exploratory behavior may refer to a patient's willingness to learn more about their health condition, try new treatments, or engage in self-care activities. It can also refer to the behaviors exhibited by young children as they explore their world and develop their cognitive and motor skills. Exploratory behavior is an important aspect of learning and development, and it can have a positive impact on overall health and well-being.

Phenylpropanolamine is a decongestant and appetite suppressant that has been used in over-the-counter and prescription medications. It works by narrowing blood vessels in the nose, which can help to relieve nasal congestion. As an appetite suppressant, it is thought to work by affecting certain chemicals in the brain that control appetite.

However, phenylpropanolamine has been associated with an increased risk of hemorrhagic stroke (bleeding in the brain) and other cardiovascular events, particularly in women who are otherwise healthy but have a history of high blood pressure or smoking. As a result, the U.S. Food and Drug Administration (FDA) advised manufacturers to stop selling over-the-counter products containing phenylpropanolamine in 2005.

It is important to note that this substance should only be used under the supervision of a healthcare professional, and individuals should always follow their doctor's instructions carefully when taking any medication.

Medically, hair is defined as a threadlike structure that grows from the follicles found in the skin of mammals. It is primarily made up of a protein called keratin and consists of three parts: the medulla (the innermost part or core), the cortex (middle layer containing keratin filaments) and the cuticle (outer layer of overlapping scales).

Hair growth occurs in cycles, with each cycle consisting of a growth phase (anagen), a transitional phase (catagen), and a resting phase (telogen). The length of hair is determined by the duration of the anagen phase.

While hair plays a crucial role in protecting the skin from external factors like UV radiation, temperature changes, and physical damage, it also serves as an essential aspect of human aesthetics and identity.

Barbiturates are a class of drugs that act as central nervous system depressants, which means they slow down the activity of the brain and nerves. They were commonly used in the past to treat conditions such as anxiety, insomnia, and seizures, but their use has declined due to the risk of addiction, abuse, and serious side effects. Barbiturates can also be used for surgical anesthesia and as a treatment for barbiturate or pentobarbital overdose.

Barbiturates work by enhancing the activity of the neurotransmitter gamma-aminobutyric acid (GABA) in the brain, which results in sedation, hypnosis, and anticonvulsant effects. However, at higher doses, barbiturates can cause respiratory depression, coma, and even death.

Some examples of barbiturates include pentobarbital, phenobarbital, secobarbital, and amobarbital. These drugs are usually available in the form of tablets, capsules, or injectable solutions. It is important to note that barbiturates should only be used under the supervision of a healthcare professional, as they carry a high risk of dependence and abuse.

A biological marker, often referred to as a biomarker, is a measurable indicator that reflects the presence or severity of a disease state, or a response to a therapeutic intervention. Biomarkers can be found in various materials such as blood, tissues, or bodily fluids, and they can take many forms, including molecular, histologic, radiographic, or physiological measurements.

In the context of medical research and clinical practice, biomarkers are used for a variety of purposes, such as:

1. Diagnosis: Biomarkers can help diagnose a disease by indicating the presence or absence of a particular condition. For example, prostate-specific antigen (PSA) is a biomarker used to detect prostate cancer.
2. Monitoring: Biomarkers can be used to monitor the progression or regression of a disease over time. For instance, hemoglobin A1c (HbA1c) levels are monitored in diabetes patients to assess long-term blood glucose control.
3. Predicting: Biomarkers can help predict the likelihood of developing a particular disease or the risk of a negative outcome. For example, the presence of certain genetic mutations can indicate an increased risk for breast cancer.
4. Response to treatment: Biomarkers can be used to evaluate the effectiveness of a specific treatment by measuring changes in the biomarker levels before and after the intervention. This is particularly useful in personalized medicine, where treatments are tailored to individual patients based on their unique biomarker profiles.

It's important to note that for a biomarker to be considered clinically valid and useful, it must undergo rigorous validation through well-designed studies, including demonstrating sensitivity, specificity, reproducibility, and clinical relevance.

The prefrontal cortex is the anterior (frontal) part of the frontal lobe in the brain, involved in higher-order cognitive processes such as planning complex cognitive behavior, personality expression, decision making, and moderating social behavior. It also plays a significant role in working memory and executive functions. The prefrontal cortex is divided into several subregions, each associated with specific cognitive and emotional functions. Damage to the prefrontal cortex can result in various impairments, including difficulties with planning, decision making, and social behavior regulation.

Immunohistochemistry (IHC) is a technique used in pathology and laboratory medicine to identify specific proteins or antigens in tissue sections. It combines the principles of immunology and histology to detect the presence and location of these target molecules within cells and tissues. This technique utilizes antibodies that are specific to the protein or antigen of interest, which are then tagged with a detection system such as a chromogen or fluorophore. The stained tissue sections can be examined under a microscope, allowing for the visualization and analysis of the distribution and expression patterns of the target molecule in the context of the tissue architecture. Immunohistochemistry is widely used in diagnostic pathology to help identify various diseases, including cancer, infectious diseases, and immune-mediated disorders.

Lymphoproliferative disorders (LPDs) are a group of diseases characterized by the excessive proliferation of lymphoid cells, which are crucial components of the immune system. These disorders can arise from both B-cells and T-cells, leading to various clinical manifestations ranging from benign to malignant conditions.

LPDs can be broadly classified into reactive and neoplastic categories:

1. Reactive Lymphoproliferative Disorders: These are typically triggered by infections, autoimmune diseases, or immunodeficiency states. They involve an exaggerated response of the immune system leading to the excessive proliferation of lymphoid cells. Examples include:
* Infectious mononucleosis (IM) caused by Epstein-Barr virus (EBV)
* Lymph node enlargement due to various infections or autoimmune disorders
* Post-transplant lymphoproliferative disorder (PTLD), which occurs in the context of immunosuppression following organ transplantation
2. Neoplastic Lymphoproliferative Disorders: These are malignant conditions characterized by uncontrolled growth and accumulation of abnormal lymphoid cells, leading to the formation of tumors. They can be further classified into Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). Examples include:
* Hodgkin lymphoma (HL): Classical HL and nodular lymphocyte-predominant HL
* Non-Hodgkin lymphoma (NHL): Various subtypes, such as diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and Burkitt lymphoma

It is important to note that the distinction between reactive and neoplastic LPDs can sometimes be challenging, requiring careful clinical, histopathological, immunophenotypic, and molecular evaluations. Proper diagnosis and classification of LPDs are crucial for determining appropriate treatment strategies and predicting patient outcomes.

Retrospective studies, also known as retrospective research or looking back studies, are a type of observational study that examines data from the past to draw conclusions about possible causal relationships between risk factors and outcomes. In these studies, researchers analyze existing records, medical charts, or previously collected data to test a hypothesis or answer a specific research question.

Retrospective studies can be useful for generating hypotheses and identifying trends, but they have limitations compared to prospective studies, which follow participants forward in time from exposure to outcome. Retrospective studies are subject to biases such as recall bias, selection bias, and information bias, which can affect the validity of the results. Therefore, retrospective studies should be interpreted with caution and used primarily to generate hypotheses for further testing in prospective studies.

Dopamine receptors are a type of G protein-coupled receptor that bind to and respond to the neurotransmitter dopamine. There are five subtypes of dopamine receptors (D1-D5), which are classified into two families based on their structure and function: D1-like (D1 and D5) and D2-like (D2, D3, and D4).

Dopamine receptors play a crucial role in various physiological processes, including movement, motivation, reward, cognition, emotion, and neuroendocrine regulation. They are widely distributed throughout the central nervous system, with high concentrations found in the basal ganglia, limbic system, and cortex.

Dysfunction of dopamine receptors has been implicated in several neurological and psychiatric disorders, such as Parkinson's disease, schizophrenia, attention deficit hyperactivity disorder (ADHD), drug addiction, and depression. Therefore, drugs targeting dopamine receptors have been developed for the treatment of these conditions.

Locomotion, in a medical context, refers to the ability to move independently and change location. It involves the coordinated movement of the muscles, bones, and nervous system that enables an individual to move from one place to another. This can include walking, running, jumping, or using assistive devices such as wheelchairs or crutches. Locomotion is a fundamental aspect of human mobility and is often assessed in medical evaluations to determine overall health and functioning.

Reserpine is an alkaloid derived from the Rauwolfia serpentina plant, which has been used in traditional medicine for its sedative and hypotensive effects. In modern medicine, reserpine is primarily used to treat hypertension (high blood pressure) due to its ability to lower both systolic and diastolic blood pressure.

Reserpine works by depleting catecholamines, including norepinephrine, epinephrine, and dopamine, from nerve terminals in the sympathetic nervous system. This leads to a decrease in peripheral vascular resistance and heart rate, ultimately resulting in reduced blood pressure.

Reserpine is available in various forms, such as tablets or capsules, and is typically administered orally. Common side effects include nasal congestion, dizziness, sedation, and gastrointestinal disturbances like diarrhea and nausea. Long-term use of reserpine may also lead to depression in some individuals. Due to its potential for causing depression, other antihypertensive medications are often preferred over reserpine when possible.

Biological models, also known as physiological models or organismal models, are simplified representations of biological systems, processes, or mechanisms that are used to understand and explain the underlying principles and relationships. These models can be theoretical (conceptual or mathematical) or physical (such as anatomical models, cell cultures, or animal models). They are widely used in biomedical research to study various phenomena, including disease pathophysiology, drug action, and therapeutic interventions.

Examples of biological models include:

1. Mathematical models: These use mathematical equations and formulas to describe complex biological systems or processes, such as population dynamics, metabolic pathways, or gene regulation networks. They can help predict the behavior of these systems under different conditions and test hypotheses about their underlying mechanisms.
2. Cell cultures: These are collections of cells grown in a controlled environment, typically in a laboratory dish or flask. They can be used to study cellular processes, such as signal transduction, gene expression, or metabolism, and to test the effects of drugs or other treatments on these processes.
3. Animal models: These are living organisms, usually vertebrates like mice, rats, or non-human primates, that are used to study various aspects of human biology and disease. They can provide valuable insights into the pathophysiology of diseases, the mechanisms of drug action, and the safety and efficacy of new therapies.
4. Anatomical models: These are physical representations of biological structures or systems, such as plastic models of organs or tissues, that can be used for educational purposes or to plan surgical procedures. They can also serve as a basis for developing more sophisticated models, such as computer simulations or 3D-printed replicas.

Overall, biological models play a crucial role in advancing our understanding of biology and medicine, helping to identify new targets for therapeutic intervention, develop novel drugs and treatments, and improve human health.

Pargyline is an antihypertensive drug and a irreversible monoamine oxidase inhibitor (MAOI) of type B. It works by blocking the breakdown of certain chemicals in the brain, such as neurotransmitters, which can help improve mood and behavior in people with depression.

Pargyline is not commonly used as a first-line treatment for depression due to its potential for serious side effects, including interactions with certain foods and medications that can lead to dangerously high blood pressure. It is also associated with a risk of serotonin syndrome when taken with selective serotonin reuptake inhibitors (SSRIs) or other drugs that increase serotonin levels in the brain.

Pargyline is available only through a prescription and should be used under the close supervision of a healthcare provider.

Chlorfenvinphos is an organophosphate insecticide that has been used to control a wide variety of pests in agriculture, horticulture, and animal husbandry. It functions by inhibiting the enzyme acetylcholinesterase, which leads to an accumulation of the neurotransmitter acetylcholine and results in symptoms such as muscle twitching, tremors, convulsions, and eventually respiratory failure.

Chlorfenvinphos is highly toxic to both mammals and birds, and it can also have harmful effects on aquatic organisms. It has been banned or restricted in many countries due to its environmental persistence and potential health risks to humans. Exposure to chlorfenvinphos can occur through inhalation, skin contact, or ingestion, and symptoms of poisoning may include nausea, vomiting, diarrhea, abdominal cramps, headache, dizziness, and respiratory distress. Chronic exposure has been linked to neurological effects such as memory loss, decreased cognitive function, and peripheral neuropathy.

"Intraperitoneal injection" is a medical term that refers to the administration of a substance or medication directly into the peritoneal cavity, which is the space between the lining of the abdominal wall and the organs contained within it. This type of injection is typically used in clinical settings for various purposes, such as delivering chemotherapy drugs, anesthetics, or other medications directly to the abdominal organs.

The procedure involves inserting a needle through the abdominal wall and into the peritoneal cavity, taking care to avoid any vital structures such as blood vessels or nerves. Once the needle is properly positioned, the medication can be injected slowly and carefully to ensure even distribution throughout the cavity.

It's important to note that intraperitoneal injections are typically reserved for situations where other routes of administration are not feasible or effective, as they carry a higher risk of complications such as infection, bleeding, or injury to surrounding organs. As with any medical procedure, it should only be performed by trained healthcare professionals under appropriate clinical circumstances.

Dopamine D1 receptors are a type of G protein-coupled receptor that bind to the neurotransmitter dopamine. They are classified as D1-like receptors, along with D5 receptors, and are activated by dopamine through a stimulatory G protein (Gs).

D1 receptors are widely expressed in the central nervous system, including the striatum, prefrontal cortex, hippocampus, and amygdala. They play important roles in various physiological functions, such as movement control, motivation, reward processing, working memory, and cognition.

Activation of D1 receptors leads to increased levels of intracellular cyclic adenosine monophosphate (cAMP) and activation of protein kinase A (PKA), which in turn modulate the activity of various downstream signaling pathways. Dysregulation of dopamine D1 receptor function has been implicated in several neurological and psychiatric disorders, including Parkinson's disease, schizophrenia, attention deficit hyperactivity disorder (ADHD), and drug addiction.

An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.

Impulsive behavior can be defined medically as actions performed without proper thought or consideration of the consequences, driven by immediate needs, desires, or urges. It often involves risky or inappropriate behaviors that may lead to negative outcomes. In a clinical context, impulsivity is frequently associated with certain mental health conditions such as ADHD (Attention Deficit Hyperactivity Disorder), bipolar disorder, borderline personality disorder, and some neurological conditions. It's important to note that everyone can exhibit impulsive behavior at times, but when it becomes a persistent pattern causing distress or functional impairment, it may indicate an underlying condition requiring professional assessment and treatment.

Classical conditioning is a type of learning process that occurs when two stimuli are repeatedly paired together, leading to an association between them. This concept was first introduced by Ivan Pavlov, a Russian physiologist, in his studies on classical conditioning in the late 19th and early 20th centuries.

In classical conditioning, there are typically two types of stimuli involved: the unconditioned stimulus (US) and the neutral stimulus (NS). The US is a stimulus that naturally triggers a response, known as the unconditioned response (UR), in an organism. For example, food is an US that triggers salivation, which is the UR, in dogs.

The NS, on the other hand, is a stimulus that does not initially trigger any response in the organism. However, when the NS is repeatedly paired with the US, it becomes a conditioned stimulus (CS) and begins to elicit a conditioned response (CR). The CR is similar to the UR but is triggered by the CS instead of the US.

For example, if Pavlov repeatedly rang a bell (NS) just before presenting food (US) to a dog, the dog would eventually start salivating (CR) in response to the bell (CS) even when food was not presented. This is an example of classical conditioning.

Classical conditioning has been widely studied and is believed to play a role in various physiological processes, such as learning, memory, and emotion regulation. It has also been used in various applications, including behavioral therapy and advertising.

Selegiline is a selective, irreversible MAO-B inhibitor, which is primarily used in the clinical management of Parkinson's disease. It works by blocking the action of monoamine oxidase B (MAO-B), an enzyme responsible for breaking down dopamine, a neurotransmitter involved in movement regulation. By inhibiting MAO-B, selegiline increases the availability of dopamine in the brain, thereby helping to alleviate symptoms of Parkinson's disease such as stiffness, tremors, and spasms.

Selegiline is also available under the brand name Eldepryl, Zelapar, and Emsam. In addition to its use in Parkinson's disease, selegiline has been explored for its potential benefits in treating depression, dementia, and other neurological disorders. However, its use in these conditions is still considered off-label and requires careful consideration of the potential risks and benefits.

It is important to note that MAO inhibitors like selegiline can have serious interactions with certain foods and medications, particularly those containing tyramine, which can lead to a dangerous increase in blood pressure (hypertensive crisis). Therefore, it is crucial to follow strict dietary restrictions and medication guidelines when taking selegiline or any other MAO inhibitor.

A base sequence in the context of molecular biology refers to the specific order of nucleotides in a DNA or RNA molecule. In DNA, these nucleotides are adenine (A), guanine (G), cytosine (C), and thymine (T). In RNA, uracil (U) takes the place of thymine. The base sequence contains genetic information that is transcribed into RNA and ultimately translated into proteins. It is the exact order of these bases that determines the genetic code and thus the function of the DNA or RNA molecule.

Quinpirole is not a medical condition or disease, but rather a synthetic compound used in research and medicine. It's a selective agonist for the D2 and D3 dopamine receptors, which means it binds to and activates these receptors, mimicking the effects of dopamine, a neurotransmitter involved in various physiological processes such as movement, motivation, reward, and cognition.

Quinpirole is used primarily in preclinical research to study the role of dopamine receptors in different neurological conditions, including Parkinson's disease, schizophrenia, drug addiction, and others. It helps researchers understand how dopamine systems work and contributes to the development of new therapeutic strategies for these disorders.

It is important to note that quinpirole is not used as a medication in humans or animals but rather as a research tool in laboratory settings.

A Fluorescence Polarization Immunoassay (FPIA) is a type of biochemical test used for the detection and quantitation of various analytes, such as drugs, hormones, or proteins, in a sample. It is based on the principle of fluorescence polarization, which measures the rotation of molecules in solution.

In an FPIA, the sample is mixed with a fluorescent tracer that binds specifically to the analyte of interest. When the mixture is excited with plane-polarized light, the fluorescent tracer emits light that retains its polarization if it remains bound to the large complex (analyte+tracer). However, if the tracer is not bound to the analyte and is free to rotate in solution, the emitted light becomes depolarized.

The degree of polarization of the emitted light is then measured and used to determine the amount of analyte present in the sample. Higher concentrations of analyte result in a higher degree of polarization, as more tracer molecules are bound and less likely to rotate.

FPIAs offer several advantages over other types of immunoassays, including simplicity, speed, and sensitivity. They are commonly used in clinical laboratories for the detection of drugs of abuse, therapeutic drugs, and hormones.

Specific gravity is a term used in medicine, particularly in the context of urinalysis and other bodily fluid analysis. It refers to the ratio of the density (mass of a substance per unit volume) of a sample to the density of a reference substance, usually water. At body temperature, this is expressed as:

Specific gravity = Density of sample / Density of water at 37 degrees Celsius

In urinalysis, specific gravity is used to help evaluate renal function and hydration status. It can indicate whether the kidneys are adequately concentrating or diluting the urine. A lower specific gravity (closer to 1) may suggest overhydration or dilute urine, while a higher specific gravity (greater than 1) could indicate dehydration or concentrated urine. However, specific gravity should be interpreted in conjunction with other urinalysis findings and clinical context for accurate assessment.

According to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), alcohol-related disorders are a category of mental disorders defined by a problematic pattern of alcohol use that leads to clinically significant impairment or distress. The disorders include:

1. Alcohol Use Disorder (AUD): A chronic relapsing brain disorder characterized by an impaired ability to stop or control alcohol use despite adverse social, occupational, or health consequences. AUD can be mild, moderate, or severe, and recovery is possible regardless of severity. The symptoms include problems controlling intake of alcohol, continued use despite problems resulting from drinking, development of a tolerance, drinking that leads to risky situations, or withdrawal symptoms when not drinking.
2. Alcohol Intoxication: A state of acute impairment in mental and motor function caused by the recent consumption of alcohol. The symptoms include slurred speech, unsteady gait, nystagmus, impaired attention or memory, stupor, or coma. In severe cases, it can lead to respiratory depression, hypothermia, or even death.
3. Alcohol Withdrawal: A syndrome that occurs when alcohol use is heavily reduced or stopped after prolonged and heavy use. The symptoms include autonomic hyperactivity, increased hand tremor, insomnia, nausea or vomiting, transient visual, tactile, or auditory hallucinations or illusions, psychomotor agitation, anxiety, and grand mal seizures.
4. Other Alcohol-Induced Disorders: These include alcohol-induced sleep disorder, alcohol-induced sexual dysfunction, and alcohol-induced major neurocognitive disorder.

It is important to note that alcohol use disorders are complex conditions that can be influenced by a variety of factors, including genetics, environment, and personal behavior. If you or someone you know is struggling with alcohol use, it is recommended to seek professional help.

Sympathomimetic drugs are substances that mimic or stimulate the actions of the sympathetic nervous system. The sympathetic nervous system is one of the two divisions of the autonomic nervous system, which regulates various automatic physiological functions in the body. The sympathetic nervous system's primary function is to prepare the body for the "fight-or-flight" response, which includes increasing heart rate, blood pressure, respiratory rate, and metabolism while decreasing digestive activity.

Sympathomimetic drugs can exert their effects through various mechanisms, including directly stimulating adrenergic receptors (alpha and beta receptors) or indirectly causing the release of norepinephrine and epinephrine from nerve endings. These drugs are used in various clinical settings to treat conditions such as asthma, nasal congestion, low blood pressure, and attention deficit hyperactivity disorder (ADHD). Examples of sympathomimetic drugs include epinephrine, norepinephrine, dopamine, dobutamine, albuterol, pseudoephedrine, and methylphenidate.

It is important to note that sympathomimetic drugs can also have adverse effects, particularly when used in high doses or in individuals with certain medical conditions. These adverse effects may include anxiety, tremors, palpitations, hypertension, arrhythmias, and seizures. Therefore, these medications should be used under the close supervision of a healthcare provider.

Monoamine oxidase inhibitors (MAOIs) are a class of drugs that work by blocking the action of monoamine oxidase, an enzyme found in the brain and other organs of the body. This enzyme is responsible for breaking down certain neurotransmitters, such as serotonin, dopamine, and norepinephrine, which are chemicals that transmit signals in the brain.

By inhibiting the action of monoamine oxidase, MAOIs increase the levels of these neurotransmitters in the brain, which can help to alleviate symptoms of depression and other mood disorders. However, MAOIs also affect other chemicals in the body, including tyramine, a substance found in some foods and beverages, as well as certain medications. As a result, MAOIs can have serious side effects and interactions with other substances, making them a less commonly prescribed class of antidepressants than other types of drugs.

MAOIs are typically used as a last resort when other treatments for depression have failed, due to their potential for dangerous interactions and side effects. They require careful monitoring and dosage adjustment by a healthcare provider, and patients must follow strict dietary restrictions while taking them.

Tyramine is not a medical condition but a naturally occurring compound called a biogenic amine, which is formed from the amino acid tyrosine during the fermentation or decay of certain foods. Medically, tyramine is significant because it can interact with certain medications, particularly monoamine oxidase inhibitors (MAOIs), used to treat depression and other conditions.

The interaction between tyramine and MAOIs can lead to a hypertensive crisis, a rapid and severe increase in blood pressure, which can be life-threatening if not treated promptly. Therefore, individuals taking MAOIs are often advised to follow a low-tyramine diet, avoiding foods high in tyramine, such as aged cheeses, cured meats, fermented foods, and some types of beer and wine.

"Cells, cultured" is a medical term that refers to cells that have been removed from an organism and grown in controlled laboratory conditions outside of the body. This process is called cell culture and it allows scientists to study cells in a more controlled and accessible environment than they would have inside the body. Cultured cells can be derived from a variety of sources, including tissues, organs, or fluids from humans, animals, or cell lines that have been previously established in the laboratory.

Cell culture involves several steps, including isolation of the cells from the tissue, purification and characterization of the cells, and maintenance of the cells in appropriate growth conditions. The cells are typically grown in specialized media that contain nutrients, growth factors, and other components necessary for their survival and proliferation. Cultured cells can be used for a variety of purposes, including basic research, drug development and testing, and production of biological products such as vaccines and gene therapies.

It is important to note that cultured cells may behave differently than they do in the body, and results obtained from cell culture studies may not always translate directly to human physiology or disease. Therefore, it is essential to validate findings from cell culture experiments using additional models and ultimately in clinical trials involving human subjects.

Propylamines are a class of organic compounds characterized by the presence of a propylamine group, which is a functional group consisting of a propyl chain (-C3H7) attached to an amino group (-NH2). Propylamines can be primary, secondary, or tertiary, depending on the number of organic substituents attached to the nitrogen atom.

In a medical context, propylamines may refer to certain drugs that contain this functional group and have pharmacological activity. For example, some local anesthetics, such as procaine (Novocain), are derivatives of propylamine. Procaine is a ester of p-aminobenzoic acid and diethylaminoethanol, where the amino group is part of a propylamine chain.

It's important to note that not all compounds containing propylamines have medical applications or uses, as this functional group can also be found in various chemicals with different properties and applications.

Euphoria is a medical term that refers to an state of intense happiness and well-being, often exaggerated or irrational in context. It is a heightened state of pleasure or excitement, sometimes reaching levels of ecstasy. Euphoria can be a symptom of certain medical conditions, such as manic episodes associated with bipolar disorder, or it can be a side effect of certain drugs, including some prescription medications and illegal substances.

In a clinical setting, euphoria is often assessed using rating scales to help diagnose and monitor the severity of various mental health disorders. It's important to note that while euphoria can be a positive experience for some individuals, it can also have negative consequences, particularly when it leads to impaired judgment or risky behaviors.

The putamen is a round, egg-shaped structure that is a part of the basal ganglia, located in the forebrain. It is situated laterally to the globus pallidus and medially to the internal capsule. The putamen plays a crucial role in regulating movement and is involved in various functions such as learning, motivation, and habit formation.

It receives input from the cerebral cortex via the corticostriatal pathway and sends output to the globus pallidus and substantia nigra pars reticulata, which are also part of the basal ganglia circuitry. The putamen is heavily innervated by dopaminergic neurons from the substantia nigra pars compacta, and degeneration of these neurons in Parkinson's disease leads to a significant reduction in dopamine levels in the putamen, resulting in motor dysfunction.

An immunoassay is a biochemical test that measures the presence or concentration of a specific protein, antibody, or antigen in a sample using the principles of antibody-antigen reactions. It is commonly used in clinical laboratories to diagnose and monitor various medical conditions such as infections, hormonal disorders, allergies, and cancer.

Immunoassays typically involve the use of labeled reagents, such as enzymes, radioisotopes, or fluorescent dyes, that bind specifically to the target molecule. The amount of label detected is proportional to the concentration of the target molecule in the sample, allowing for quantitative analysis.

There are several types of immunoassays, including enzyme-linked immunosorbent assay (ELISA), radioimmunoassay (RIA), fluorescence immunoassay (FIA), and chemiluminescent immunoassay (CLIA). Each type has its own advantages and limitations, depending on the sensitivity, specificity, and throughput required for a particular application.

Antimanic agents are a class of medications primarily used to treat mania, a symptom of bipolar disorder. These agents help to control and reduce the severity of manic episodes, which can include symptoms such as elevated or irritable mood, increased energy, decreased need for sleep, racing thoughts, and impulsive or risky behavior.

The most commonly used antimanic agents are mood stabilizers, such as lithium and valproate (Depakote), and atypical antipsychotics, such as olanzapine (Zyprexa), risperidone (Risperdal), quetiapine (Seroquel), and aripiprazole (Abilify). These medications work by altering the levels or activity of certain neurotransmitters in the brain, such as dopamine, serotonin, and norepinephrine.

Electroconvulsive therapy (ECT) is also considered an effective antimanic treatment for severe mania that has not responded to medication. ECT involves applying electrical currents to the brain while the patient is under anesthesia, which induces a seizure and can help to reduce symptoms of mania.

It's important to note that antimanic agents should only be used under the supervision of a qualified healthcare provider, as they can have significant side effects and interactions with other medications. Additionally, a comprehensive treatment plan for bipolar disorder typically includes psychotherapy, education, and support to help manage the condition and prevent future episodes.

Speech disorders refer to a group of conditions in which a person has difficulty producing or articulating sounds, words, or sentences in a way that is understandable to others. These disorders can be caused by various factors such as developmental delays, neurological conditions, hearing loss, structural abnormalities, or emotional issues.

Speech disorders may include difficulties with:

* Articulation: the ability to produce sounds correctly and clearly.
* Phonology: the sound system of language, including the rules that govern how sounds are combined and used in words.
* Fluency: the smoothness and flow of speech, including issues such as stuttering or cluttering.
* Voice: the quality, pitch, and volume of the spoken voice.
* Resonance: the way sound is produced and carried through the vocal tract, which can affect the clarity and quality of speech.

Speech disorders can impact a person's ability to communicate effectively, leading to difficulties in social situations, academic performance, and even employment opportunities. Speech-language pathologists are trained to evaluate and treat speech disorders using various evidence-based techniques and interventions.

Combat disorders are a category of mental health conditions that can occur in military personnel as a result of their experiences during combat. These disorders can include post-traumatic stress disorder (PTSD), acute stress disorder, and adjustment disorders, among others. Combat disorders may be caused by exposure to traumatic events, such as experiencing or witnessing combat, the threat of death or serious injury, or the loss of fellow soldiers. Symptoms can include flashbacks, nightmares, avoidance of reminders of the trauma, difficulty sleeping, irritability, and feelings of detachment or numbness. Treatment for combat disorders typically involves a combination of medication and therapy.

Haloperidol is an antipsychotic medication, which is primarily used to treat schizophrenia and symptoms of psychosis, such as delusions, hallucinations, paranoia, or disordered thought. It may also be used to manage Tourette's disorder, tics, agitation, aggression, and hyperactivity in children with developmental disorders.

Haloperidol works by blocking the action of dopamine, a neurotransmitter in the brain, which helps to regulate mood and behavior. It is available in various forms, including tablets, liquid, and injectable solutions. The medication can cause side effects such as drowsiness, restlessness, muscle stiffness, and uncontrolled movements. In rare cases, it may also lead to more serious neurological side effects.

As with any medication, haloperidol should be taken under the supervision of a healthcare provider, who will consider the individual's medical history, current medications, and other factors before prescribing it.

Membrane proteins are a type of protein that are embedded in the lipid bilayer of biological membranes, such as the plasma membrane of cells or the inner membrane of mitochondria. These proteins play crucial roles in various cellular processes, including:

1. Cell-cell recognition and signaling
2. Transport of molecules across the membrane (selective permeability)
3. Enzymatic reactions at the membrane surface
4. Energy transduction and conversion
5. Mechanosensation and signal transduction

Membrane proteins can be classified into two main categories: integral membrane proteins, which are permanently associated with the lipid bilayer, and peripheral membrane proteins, which are temporarily or loosely attached to the membrane surface. Integral membrane proteins can further be divided into three subcategories based on their topology:

1. Transmembrane proteins, which span the entire width of the lipid bilayer with one or more alpha-helices or beta-barrels.
2. Lipid-anchored proteins, which are covalently attached to lipids in the membrane via a glycosylphosphatidylinositol (GPI) anchor or other lipid modifications.
3. Monotopic proteins, which are partially embedded in the membrane and have one or more domains exposed to either side of the bilayer.

Membrane proteins are essential for maintaining cellular homeostasis and are targets for various therapeutic interventions, including drug development and gene therapy. However, their structural complexity and hydrophobicity make them challenging to study using traditional biochemical methods, requiring specialized techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and single-particle cryo-electron microscopy (cryo-EM).

Stereoisomerism is a type of isomerism (structural arrangement of atoms) in which molecules have the same molecular formula and sequence of bonded atoms, but differ in the three-dimensional orientation of their atoms in space. This occurs when the molecule contains asymmetric carbon atoms or other rigid structures that prevent free rotation, leading to distinct spatial arrangements of groups of atoms around a central point. Stereoisomers can have different chemical and physical properties, such as optical activity, boiling points, and reactivities, due to differences in their shape and the way they interact with other molecules.

There are two main types of stereoisomerism: enantiomers (mirror-image isomers) and diastereomers (non-mirror-image isomers). Enantiomers are pairs of stereoisomers that are mirror images of each other, but cannot be superimposed on one another. Diastereomers, on the other hand, are non-mirror-image stereoisomers that have different physical and chemical properties.

Stereoisomerism is an important concept in chemistry and biology, as it can affect the biological activity of molecules, such as drugs and natural products. For example, some enantiomers of a drug may be active, while others are inactive or even toxic. Therefore, understanding stereoisomerism is crucial for designing and synthesizing effective and safe drugs.

Biogenic monoamines are a type of neurotransmitter, which are chemical messengers that transmit signals in the brain and other parts of the nervous system. They are called "biogenic" because they are derived from biological substances, and "monoamines" because they contain one amine group (-NH2) and are derived from the aromatic amino acids: tryptophan, tyrosine, and phenylalanine.

Examples of biogenic monoamines include:

1. Serotonin (5-hydroxytryptamine or 5-HT): synthesized from the amino acid tryptophan and plays a crucial role in regulating mood, appetite, sleep, memory, and learning.
2. Dopamine: formed from tyrosine and is involved in reward, motivation, motor control, and reinforcement of behavior.
3. Norepinephrine (noradrenaline): also derived from tyrosine and functions as a neurotransmitter and hormone that modulates attention, arousal, and stress responses.
4. Epinephrine (adrenaline): synthesized from norepinephrine and serves as a crucial hormone and neurotransmitter in the body's fight-or-flight response to stress or danger.
5. Histamine: produced from the amino acid histidine, it acts as a neurotransmitter and mediates allergic reactions, immune responses, and regulates wakefulness and appetite.

Imbalances in biogenic monoamines have been linked to various neurological and psychiatric disorders, such as depression, anxiety, Parkinson's disease, and schizophrenia. Therefore, medications that target these neurotransmitters, like selective serotonin reuptake inhibitors (SSRIs) for depression or levodopa for Parkinson's disease, are often used in the treatment of these conditions.

Phencyclidine (PCP) is a dissociative drug that was originally developed as an intravenous anesthetic in the 1950s. It can lead to distortions of time, space and body image, hallucinations, and a sense of physical invulnerability.

It can also cause numbness, loss of coordination, and aggressive behavior. High doses can lead to seizures, coma, and death. Long-term use can lead to memory loss, difficulties with speech and thinking, and mental health issues such as depression and suicidal thoughts. It is classified as a Schedule II drug in the United States, indicating it has a high potential for abuse but also an accepted medical use.

Attention Deficit and Disruptive Behavior Disorders (ADDBDs) are a group of childhood-onset disorders characterized by persistent patterns of behavior that are difficult for the individual to control. These disorders include Attention Deficit Hyperactivity Disorder (ADHD), Oppositional Defiant Disorder (ODD), and Conduct Disorder (CD).

Attention Deficit Hyperactivity Disorder (ADHD) is characterized by symptoms of inattention, hyperactivity, and impulsivity that interfere with daily functioning. These symptoms must be present for at least six months and occur in multiple settings, such as school, home, and social situations.

Oppositional Defiant Disorder (ODD) is characterized by a pattern of negative, hostile, and defiant behavior towards authority figures, which includes arguing with adults, losing temper, actively defying rules, and deliberately annoying others. These symptoms must be present for at least six months and occur more frequently than in other children of the same age and developmental level.

Conduct Disorder (CD) is characterized by a repetitive and persistent pattern of behavior that violates the rights of others or major age-appropriate societal norms and rules. These behaviors include aggression towards people and animals, destruction of property, deceitfulness or theft, and serious violation of rules.

It's important to note that these disorders can co-occur with other mental health conditions, such as mood disorders, anxiety disorders, and learning disabilities. Proper diagnosis and treatment are essential for managing the symptoms and improving the individual's quality of life.

Impulse Control Disorders (ICDs) are a group of psychiatric conditions characterized by the failure to resist an impulse, drive, or temptation to perform an act that is harmful to oneself or others. This leads to negative consequences such as distress, anxiety, or disruption in social, occupational, or other important areas of functioning.

The Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) recognizes several specific ICDs, including:

1. Kleptomania - the recurrent failure to resist impulses to steal items, even though they are not needed for personal use or financial gain.
2. Pyromania - the deliberate and purposeful fire-setting on more than one occasion.
3. Intermittent Explosive Disorder - recurrent behavioral outbursts representing a failure to control aggressive impulses, resulting in serious assaultive acts or destruction of property.
4. Pathological Gambling - persistent and recurrent maladaptive gambling behavior that disrupts personal, family, or vocational pursuits.
5. Internet Gaming Disorder - the excessive and prolonged use of the internet for gaming, which leads to clinically significant impairment or distress.

These disorders are typically associated with a range of emotional, cognitive, and behavioral symptoms that can vary depending on the specific disorder and individual presentation. Treatment often involves a combination of psychotherapy, medication, and self-help strategies to manage symptoms and improve overall functioning.

Salicylamides are organic compounds that consist of a salicylic acid molecule (a type of phenolic acid) linked to an amide group. They are derivatives of salicylic acid and are known for their analgesic, anti-inflammatory, and antipyretic properties. Salicylamides have been used in various pharmaceutical and therapeutic applications, including the treatment of pain, fever, and inflammation. However, they have largely been replaced by other compounds such as acetylsalicylic acid (aspirin) due to their lower potency and potential side effects.

Narcotics, in a medical context, are substances that induce sleep, relieve pain, and suppress cough. They are often used for anesthesia during surgical procedures. Narcotics are derived from opium or its synthetic substitutes and include drugs such as morphine, codeine, fentanyl, oxycodone, and hydrocodone. These drugs bind to specific receptors in the brain and spinal cord, reducing the perception of pain and producing a sense of well-being. However, narcotics can also produce physical dependence and addiction, and their long-term use can lead to tolerance, meaning that higher doses are required to achieve the same effect. Narcotics are classified as controlled substances due to their potential for abuse and are subject to strict regulations.

A reinforcement schedule is a concept in behavioral psychology that refers to the timing and pattern of rewards or reinforcements provided in response to certain behaviors. It is used to shape, maintain, or strengthen specific behaviors in individuals. There are several types of reinforcement schedules, including:

1. **Fixed Ratio (FR):** A reward is given after a fixed number of responses. For example, a salesperson might receive a bonus for every 10 sales they make.
2. **Variable Ratio (VR):** A reward is given after an unpredictable number of responses. This schedule is commonly used in gambling, as the uncertainty of when a reward (winning) will occur keeps the individual engaged and motivated to continue the behavior.
3. **Fixed Interval (FI):** A reward is given after a fixed amount of time has passed since the last reward, regardless of the number of responses during that time. For example, an employee might receive a paycheck every two weeks, regardless of how many tasks they completed during that period.
4. **Variable Interval (VI):** A reward is given after an unpredictable amount of time has passed since the last reward, regardless of the number of responses during that time. This schedule can be observed in foraging behavior, where animals search for food at irregular intervals.
5. **Combined schedules:** Reinforcement schedules can also be combined to create more complex patterns, such as a fixed ratio followed by a variable interval (FR-VI) or a variable ratio followed by a fixed interval (VR-FI).

Understanding reinforcement schedules is essential for developing effective behavioral interventions in various settings, including healthcare, education, and rehabilitation.

Reproducibility of results in a medical context refers to the ability to obtain consistent and comparable findings when a particular experiment or study is repeated, either by the same researcher or by different researchers, following the same experimental protocol. It is an essential principle in scientific research that helps to ensure the validity and reliability of research findings.

In medical research, reproducibility of results is crucial for establishing the effectiveness and safety of new treatments, interventions, or diagnostic tools. It involves conducting well-designed studies with adequate sample sizes, appropriate statistical analyses, and transparent reporting of methods and findings to allow other researchers to replicate the study and confirm or refute the results.

The lack of reproducibility in medical research has become a significant concern in recent years, as several high-profile studies have failed to produce consistent findings when replicated by other researchers. This has led to increased scrutiny of research practices and a call for greater transparency, rigor, and standardization in the conduct and reporting of medical research.

Catalepsy is a medical condition characterized by a trance-like state, with reduced sensitivity to pain and external stimuli, muscular rigidity, and fixed postures. In this state, the person's body may maintain any position in which it is placed for a long time, and there is often a decreased responsiveness to social cues or communication attempts.

Catalepsy can be a symptom of various medical conditions, including neurological disorders such as epilepsy, Parkinson's disease, or brain injuries. It can also occur in the context of mental health disorders, such as severe depression, catatonic schizophrenia, or dissociative identity disorder.

In some cases, catalepsy may be induced intentionally through hypnosis or other forms of altered consciousness practices. However, when it occurs spontaneously or as a symptom of an underlying medical condition, it can be a serious concern and requires medical evaluation and treatment.

Norepinephrine plasma membrane transport proteins, also known as norepinephrine transporters (NET), are membrane-bound proteins that play a crucial role in the regulation of neurotransmission. They are responsible for the reuptake of norepinephrine from the synaptic cleft back into the presynaptic neuron, thereby terminating the signal transmission and preventing excessive stimulation of postsynaptic receptors.

The norepinephrine transporter is a member of the sodium-dependent neurotransmitter transporter family and functions as an antiporter, exchanging one intracellular sodium ion for two extracellular sodium ions along with the transport of norepinephrine. This sodium gradient provides the energy required for the active transport process.

Dysregulation of norepinephrine plasma membrane transport proteins has been implicated in various neurological and psychiatric disorders, such as attention deficit hyperactivity disorder (ADHD), depression, and post-traumatic stress disorder (PTSD). Therefore, understanding the function and regulation of these transporters is essential for developing novel therapeutic strategies to treat these conditions.

Biogenic amines are organic compounds that are derived from the metabolic pathways of various biological organisms, including humans. They are formed by the decarboxylation of amino acids, which are the building blocks of proteins. Some examples of biogenic amines include histamine, serotonin, dopamine, and tyramine.

Histamine is a biogenic amine that plays an important role in the immune system's response to foreign invaders, such as allergens. It is also involved in regulating stomach acid production and sleep-wake cycles. Serotonin is another biogenic amine that acts as a neurotransmitter, transmitting signals between nerve cells in the brain. It is involved in regulating mood, appetite, and sleep.

Dopamine is a biogenic amine that functions as a neurotransmitter and is involved in reward and pleasure pathways in the brain. Tyramine is a biogenic amine that is found in certain foods, such as aged cheeses and fermented soy products. It can cause an increase in blood pressure when consumed in large quantities.

Biogenic amines can have various effects on the body, depending on their type and concentration. In general, they play important roles in many physiological processes, but high levels of certain biogenic amines can be harmful and may cause symptoms such as headache, nausea, and hypertension.

Phentermine is a defined in the medical field as a psychostimulant medication that is primarily used for short-term weight management. It acts as an appetite suppressant and has sympathomimetic properties, which means it stimulates the sympathetic nervous system, leading to increased heart rate and blood pressure.

Phentermine is available in various forms, including tablets, capsules, and orally disintegrating tablets. It is typically prescribed for individuals with a body mass index (BMI) of 30 or higher, or for those with a BMI of 27 or higher who have weight-related medical conditions such as high blood pressure, diabetes, or high cholesterol.

It's important to note that phentermine is intended for use in conjunction with a reduced-calorie diet and increased physical activity. It should not be used as a sole means of weight loss, and its long-term effectiveness and safety have not been established. Additionally, phentermine can be habit-forming and may cause dependence, so it should only be used under the close supervision of a healthcare provider.

3,4-Dihydroxyphenylacetic Acid (3,4-DOPAC) is a major metabolite of dopamine, which is a neurotransmitter in the brain. Dopamine is metabolized by the enzyme monoamine oxidase to form dihydroxyphenylacetaldehyde, which is then further metabolized to 3,4-DOPAC by the enzyme aldehyde dehydrogenase.

3,4-DOPAC is found in the urine and can be used as a marker for dopamine turnover in the brain. Changes in the levels of 3,4-DOPAC have been associated with various neurological disorders such as Parkinson's disease and schizophrenia. Additionally, 3,4-DOPAC has been shown to have antioxidant properties and may play a role in protecting against oxidative stress in the brain.

Brain chemistry refers to the chemical processes that occur within the brain, particularly those involving neurotransmitters, neuromodulators, and neuropeptides. These chemicals are responsible for transmitting signals between neurons (nerve cells) in the brain, allowing for various cognitive, emotional, and physical functions.

Neurotransmitters are chemical messengers that transmit signals across the synapse (the tiny gap between two neurons). Examples of neurotransmitters include dopamine, serotonin, norepinephrine, GABA (gamma-aminobutyric acid), and glutamate. Each neurotransmitter has a specific role in brain function, such as regulating mood, motivation, attention, memory, and movement.

Neuromodulators are chemicals that modify the effects of neurotransmitters on neurons. They can enhance or inhibit the transmission of signals between neurons, thereby modulating brain activity. Examples of neuromodulators include acetylcholine, histamine, and substance P.

Neuropeptides are small protein-like molecules that act as neurotransmitters or neuromodulators. They play a role in various physiological functions, such as pain perception, stress response, and reward processing. Examples of neuropeptides include endorphins, enkephalins, and oxytocin.

Abnormalities in brain chemistry can lead to various neurological and psychiatric conditions, such as depression, anxiety disorders, schizophrenia, Parkinson's disease, and Alzheimer's disease. Understanding brain chemistry is crucial for developing effective treatments for these conditions.

Yawning is a reflex characterized by the involuntary opening of the mouth and deep inhalation of air, often followed by a long exhalation. While the exact purpose and mechanism of yawning are not fully understood, it's believed to be associated with regulating brain temperature, promoting arousal, or stretching the muscles of the jaw and face. Yawning is contagious in humans and can also be observed in various animal species. It usually occurs when an individual is tired, bored, or during transitions between sleep stages, but its underlying causes remain a subject of ongoing scientific research.

Tranylcypromine is a type of antidepressant known as a non-selective, irreversible monoamine oxidase inhibitor (MAOI). It works by blocking the action of monoamine oxidase, an enzyme that breaks down certain neurotransmitters (chemical messengers) in the brain such as serotonin, dopamine, and noradrenaline. This leads to an increase in the levels of these neurotransmitters in the brain, which can help improve mood and alleviate symptoms of depression.

Tranylcypromine is used primarily for the treatment of major depressive disorder that has not responded to other antidepressants. It is also used off-label for the treatment of anxiety disorders, panic attacks, and obsessive-compulsive disorder.

It's important to note that MAOIs like tranylcypromine have several dietary and medication restrictions due to their potential to cause serious or life-threatening reactions when combined with certain foods or medications. Therefore, careful monitoring by a healthcare professional is necessary while taking this medication.

Dopamine D4 receptor (DRD4) is a type of dopamine receptor that belongs to the family of G protein-coupled receptors. It is activated by the neurotransmitter dopamine and plays a role in various physiological functions, including regulation of movement, motivation, reward processing, cognition, and emotional responses.

The DRD4 gene contains a variable number of tandem repeats (VNTR) polymorphism in its coding region, which results in different isoforms of the receptor with varying lengths of the third intracellular loop. This genetic variation has been associated with several neuropsychiatric disorders, such as attention-deficit/hyperactivity disorder (ADHD), substance use disorders, and personality traits like novelty seeking.

The D4 receptor is widely expressed in the brain, particularly in the limbic system, prefrontal cortex, hippocampus, and amygdala. It has a lower affinity for dopamine than other dopamine receptors (D1-D3) and exhibits a slower rate of dissociation from dopamine, suggesting that it may act as a modulator of dopaminergic signaling rather than a primary mediator.

In summary, the Dopamine D4 receptor is a type of dopamine receptor involved in various physiological functions and has been associated with several neuropsychiatric disorders due to genetic variations in its coding region.

Antisocial Personality Disorder (ASPD) is a mental health condition characterized by a pervasive pattern of disregard for the rights of others, lack of empathy, and manipulative behaviors. It is defined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), as follows:

A. A consistent pattern of behavior that violates the basic rights of others and major age-appropriate societal norms and rules, as indicated by the presence of at least three of the following:

1. Failure to conform to social norms and laws, indicated by repeatedly performing acts that are grounds for arrest.
2. Deceitfulness, as indicated by repeated lying, use of aliases, or conning others for personal profit or pleasure.
3. Impulsivity or failure to plan ahead; indication of this symptom may include promiscuity.
4. Irritability and aggressiveness, as indicated by repeated physical fights or assaults.
5. Reckless disregard for safety of self or others.
6. Consistent irresponsibility, as indicated by repeated failure to sustain consistent work behavior or honor financial obligations.
7. Lack of remorse, as indicated by being indifferent to or rationalizing having hurt, mistreated, or stolen from another.

B. The individual is at least 18 years of age.

C. There is evidence of conduct disorder with onset before the age of 15 years.

D. The occurrence of antisocial behavior is not exclusively during the course of schizophrenia or bipolar disorder.

E. The individual's criminal behavior has not been better explained by a conduct disorder diagnosis or antisocial behavior that began before the age of 15 years.

It's important to note that ASPD can be challenging to diagnose, and it often requires a comprehensive evaluation from a mental health professional with experience in personality disorders.

Serotonin plasma membrane transport proteins, also known as serotonin transporters (SERTs), are membrane-spanning proteins that play a crucial role in the regulation of serotonergic neurotransmission. They are responsible for the reuptake of serotonin (5-hydroxytryptamine or 5-HT) from the synaptic cleft back into the presynaptic neuron, thereby terminating the signal transmission and allowing for its recycling or degradation.

Structurally, SERTs belong to the family of sodium- and chloride-dependent neurotransmitter transporters and contain 12 transmembrane domains with intracellular N- and C-termini. The binding site for serotonin is located within the transmembrane domain, while the substrate-binding site is formed by residues from both the transmembrane and extracellular loops.

Serotonin transporters are important targets for various psychotropic medications, including selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs), and monoamine oxidase inhibitors (MAOIs). These drugs act by blocking the SERT, increasing synaptic concentrations of serotonin, and enhancing serotonergic neurotransmission. Dysregulation of serotonin transporters has been implicated in several neurological and psychiatric disorders, such as major depressive disorder, anxiety disorders, obsessive-compulsive disorder, and substance abuse.

Benzazepines are a class of heterocyclic compounds that contain a benzene fused to a diazepine ring. In the context of pharmaceuticals, benzazepines refer to a group of drugs with various therapeutic uses, such as antipsychotics and antidepressants. Some examples of benzazepine-derived drugs include clozapine, olanzapine, and loxoprofen. These drugs have complex mechanisms of action, often involving multiple receptor systems in the brain.

Mescaline is a naturally occurring psychoactive alkaloid that is found in several species of cacti, including the peyote (Lophophora williamsii), San Pedro (Echinopsis pachanoi), and Peruvian torch (Echinopsis peruviana) cacti. It is known for its ability to produce profound changes in consciousness, mood, and perception when ingested.

In a medical context, mescaline is classified as a hallucinogen or psychedelic drug. It works by binding to serotonin receptors in the brain, which leads to altered states of consciousness, including visual hallucinations, distorted perceptions of time and space, and altered emotional states.

It's important to note that while mescaline has been used for centuries in religious and spiritual practices among indigenous communities, its use is not without risks. High doses can lead to unpleasant or even dangerous psychological effects, such as anxiety, panic, and psychosis. Additionally, the legal status of mescaline varies by country and region, so it's important to be aware of local laws and regulations before using it.

Lisuride is a type of medication called a dopamine agonist, which works by stimulating dopamine receptors in the brain. It is primarily used to treat Parkinson's disease and related disorders, as it can help to alleviate symptoms such as stiffness, tremors, spasms, and poor muscle control.

Lisuride may also be used off-label for other conditions, such as certain types of headaches or cluster headaches. It is available in the form of tablets and is typically taken several times a day, with dosages adjusted based on individual patient needs and responses to treatment.

As with any medication, lisuride can have side effects, including nausea, dizziness, drowsiness, hallucinations, and orthostatic hypotension (low blood pressure upon standing). It is important for patients taking this medication to follow their healthcare provider's instructions carefully and report any unusual symptoms or concerns.

Binge-Eating Disorder (BED) is a type of eating disorder characterized by recurrent episodes of consuming large amounts of food in a short period of time, often to the point of discomfort or pain. These episodes are accompanied by a loss of control over eating and are not followed by compensatory behaviors such as purging or excessive exercise.

To be diagnosed with BED, an individual must experience these binge-eating episodes at least once a week for three months or more, along with feelings of distress, shame, or guilt about their eating habits. Additionally, the binge eating must occur on average at least once a week for three months.

BED is different from overeating and can cause significant emotional and physical problems, including depression, anxiety, obesity, and other health issues related to weight gain. It is important to seek professional help if you suspect that you or someone you know may have BED.

Addictive behavior is a pattern of repeated self-destructive behavior, often identified by the individual's inability to stop despite negative consequences. It can involve a variety of actions such as substance abuse (e.g., alcohol, drugs), gambling, sex, shopping, or using technology (e.g., internet, social media, video games).

These behaviors activate the brain's reward system, leading to feelings of pleasure and satisfaction. Over time, the individual may require more of the behavior to achieve the same level of pleasure, resulting in tolerance. If the behavior is stopped or reduced, withdrawal symptoms may occur.

Addictive behaviors can have serious consequences on an individual's physical, emotional, social, and financial well-being. They are often associated with mental health disorders such as depression, anxiety, and bipolar disorder. Treatment typically involves a combination of behavioral therapy, medication, and support groups to help the individual overcome the addiction and develop healthy coping mechanisms.

A cell line is a culture of cells that are grown in a laboratory for use in research. These cells are usually taken from a single cell or group of cells, and they are able to divide and grow continuously in the lab. Cell lines can come from many different sources, including animals, plants, and humans. They are often used in scientific research to study cellular processes, disease mechanisms, and to test new drugs or treatments. Some common types of human cell lines include HeLa cells (which come from a cancer patient named Henrietta Lacks), HEK293 cells (which come from embryonic kidney cells), and HUVEC cells (which come from umbilical vein endothelial cells). It is important to note that cell lines are not the same as primary cells, which are cells that are taken directly from a living organism and have not been grown in the lab.

'Catha' is a plant species also known as Khat, Kat, or Qat. It contains psychoactive compounds that can cause stimulant-like effects when chewed, brewed into tea, or taken in other forms. The main active compound in Catha is cathinone, which is similar in structure and effects to amphetamines.

The use of Catha can produce feelings of euphoria, increased alertness, and talkativeness, but it can also cause side effects such as increased heart rate, blood pressure, and anxiety. Long-term use of Catha has been associated with a number of health problems, including tooth decay, gastrointestinal issues, and mental health disorders.

It's worth noting that the legal status of Catha varies by country and region. In some places, it is legal and widely used, while in others, it is considered a controlled substance and its use is restricted or prohibited.

"Wistar rats" are a strain of albino rats that are widely used in laboratory research. They were developed at the Wistar Institute in Philadelphia, USA, and were first introduced in 1906. Wistar rats are outbred, which means that they are genetically diverse and do not have a fixed set of genetic characteristics like inbred strains.

Wistar rats are commonly used as animal models in biomedical research because of their size, ease of handling, and relatively low cost. They are used in a wide range of research areas, including toxicology, pharmacology, nutrition, cancer, cardiovascular disease, and behavioral studies. Wistar rats are also used in safety testing of drugs, medical devices, and other products.

Wistar rats are typically larger than many other rat strains, with males weighing between 500-700 grams and females weighing between 250-350 grams. They have a lifespan of approximately 2-3 years. Wistar rats are also known for their docile and friendly nature, making them easy to handle and work with in the laboratory setting.

Dysthymic disorder, also known as persistent depressive disorder, is a chronic type of depression where a person's moods are regularly low. It is characterized by depressed mood that occurs for most of the day, for at least two years, and is accompanied by at least two other symptoms such as appetite or sleep changes, low energy, low self-esteem, difficulty making decisions, or feelings of hopelessness.

To meet the diagnostic criteria, the symptoms cannot be explained by substance abuse or a medical condition, and they must cause significant distress or impairment in social, occupational, or other important areas of functioning. Dysthymic disorder typically has a chronic course, but it may respond to treatment, including psychotherapy and medication.

Prenylamine is not a medical term in and of itself, but it is the chemical name for a medication that is sometimes used in the medical field. The drug is known as Phenelzine sulfate in its brand name form, with trade names including Nardil.

Phenelzine sulfate (Prenylamine) is a type of medication called a monoamine oxidase inhibitor (MAOI). It works by blocking the action of an enzyme called monoamine oxidase, which helps break down certain chemicals in the brain called neurotransmitters. By blocking this enzyme's action, phenelzine sulfate increases the levels of these neurotransmitters in the brain, which can help to improve mood and alleviate symptoms of depression.

Phenelzine sulfate is used primarily to treat depression that has not responded to other treatments. It may also be used off-label for other conditions, such as anxiety disorders or panic attacks. However, it is important to note that phenelzine sulfate can have serious side effects and interactions with certain foods and medications, so it should only be taken under the close supervision of a healthcare provider.

Microinjection is a medical technique that involves the use of a fine, precise needle to inject small amounts of liquid or chemicals into microscopic structures, cells, or tissues. This procedure is often used in research settings to introduce specific substances into individual cells for study purposes, such as introducing DNA or RNA into cell nuclei to manipulate gene expression.

In clinical settings, microinjections may be used in various medical and cosmetic procedures, including:

1. Intracytoplasmic Sperm Injection (ICSI): A type of assisted reproductive technology where a single sperm is injected directly into an egg to increase the chances of fertilization during in vitro fertilization (IVF) treatments.
2. Botulinum Toxin Injections: Microinjections of botulinum toxin (Botox, Dysport, or Xeomin) are used for cosmetic purposes to reduce wrinkles and fine lines by temporarily paralyzing the muscles responsible for their formation. They can also be used medically to treat various neuromuscular disorders, such as migraines, muscle spasticity, and excessive sweating (hyperhidrosis).
3. Drug Delivery: Microinjections may be used to deliver drugs directly into specific tissues or organs, bypassing the systemic circulation and potentially reducing side effects. This technique can be particularly useful in treating localized pain, delivering growth factors for tissue regeneration, or administering chemotherapy agents directly into tumors.
4. Gene Therapy: Microinjections of genetic material (DNA or RNA) can be used to introduce therapeutic genes into cells to treat various genetic disorders or diseases, such as cystic fibrosis, hemophilia, or cancer.

Overall, microinjection is a highly specialized and precise technique that allows for the targeted delivery of substances into small structures, cells, or tissues, with potential applications in research, medical diagnostics, and therapeutic interventions.

Myeloproliferative disorders (MPDs) are a group of rare, chronic blood cancers that originate from the abnormal proliferation or growth of one or more types of blood-forming cells in the bone marrow. These disorders result in an overproduction of mature but dysfunctional blood cells, which can lead to serious complications such as blood clots, bleeding, and organ damage.

There are several subtypes of MPDs, including:

1. Chronic Myeloid Leukemia (CML): A disorder characterized by the overproduction of mature granulocytes (a type of white blood cell) in the bone marrow, leading to an increased number of these cells in the blood. CML is caused by a genetic mutation that results in the formation of the BCR-ABL fusion protein, which drives uncontrolled cell growth and division.
2. Polycythemia Vera (PV): A disorder characterized by the overproduction of all three types of blood cells - red blood cells, white blood cells, and platelets - in the bone marrow. This can lead to an increased risk of blood clots, bleeding, and enlargement of the spleen.
3. Essential Thrombocythemia (ET): A disorder characterized by the overproduction of platelets in the bone marrow, leading to an increased risk of blood clots and bleeding.
4. Primary Myelofibrosis (PMF): A disorder characterized by the replacement of normal bone marrow tissue with scar tissue, leading to impaired blood cell production and anemia, enlargement of the spleen, and increased risk of infections and bleeding.
5. Chronic Neutrophilic Leukemia (CNL): A rare disorder characterized by the overproduction of neutrophils (a type of white blood cell) in the bone marrow, leading to an increased number of these cells in the blood. CNL can lead to an increased risk of infections and organ damage.

MPDs are typically treated with a combination of therapies, including chemotherapy, targeted therapy, immunotherapy, and stem cell transplantation. The choice of treatment depends on several factors, including the subtype of MPD, the patient's age and overall health, and the presence of any comorbidities.

The limbic system is a complex set of structures in the brain that includes the hippocampus, amygdala, fornix, cingulate gyrus, and other nearby areas. It's associated with emotional responses, instinctual behaviors, motivation, long-term memory formation, and olfaction (smell). The limbic system is also involved in the modulation of visceral functions and drives, such as hunger, thirst, and sexual drive.

The structures within the limbic system communicate with each other and with other parts of the brain, particularly the hypothalamus and the cortex, to regulate various physiological and psychological processes. Dysfunctions in the limbic system can lead to a range of neurological and psychiatric conditions, including depression, anxiety disorders, post-traumatic stress disorder (PTSD), and certain types of memory impairment.

A psychological interview is a clinical assessment tool used by mental health professionals to gather information about a person's cognitive, emotional, and behavioral status. It is a structured or unstructured conversation between the clinician and the client aimed at understanding the client's symptoms, concerns, personal history, current life situation, and any other relevant factors that contribute to their psychological state.

The interview may cover various topics such as the individual's mental health history, family background, social relationships, education, occupation, coping mechanisms, and substance use. The clinician will also assess the person's cognitive abilities, emotional expression, thought processes, and behavior during the interview to help form a diagnosis or treatment plan.

The psychological interview is an essential component of a comprehensive mental health evaluation, as it provides valuable insights into the individual's subjective experiences and helps establish a therapeutic relationship between the clinician and the client. It can be conducted in various settings, including hospitals, clinics, private practices, or community centers.

Stereotypic Movement Disorder is a neurological condition characterized by the presence of repetitive, often rhythmic and seemingly driven movements that are apparently purposeless. These movements may include body rocking, head banging, hand wringing, or complex whole-body movements. The movements interfere with normal activities and development, and they are not better explained by a neurological condition or another mental disorder. Stereotypic Movement Disorder can occur in individuals of all ages, but it is most commonly diagnosed in children and adolescents. The exact cause of the disorder is unknown, but it may be associated with genetic factors, brain abnormalities, or environmental influences.

Dopamine D3 receptors are a type of G protein-coupled receptor that bind to the neurotransmitter dopamine. They are classified as part of the D2-like family of dopamine receptors, which also includes the D2 and D4 receptors. The D3 receptor is primarily expressed in the limbic areas of the brain, including the hippocampus and the nucleus accumbens, where it plays a role in regulating motivation, reward, and cognition.

D3 receptors have been found to be involved in several neurological and psychiatric disorders, such as Parkinson's disease, schizophrenia, and drug addiction. In Parkinson's disease, the loss of dopamine-producing neurons in the substantia nigra results in a decrease in dopamine levels and an increase in D3 receptor expression. This increase in D3 receptor expression has been linked to the development of motor symptoms such as bradykinesia and rigidity.

In schizophrenia, antipsychotic medications that block D2-like receptors, including D3 receptors, are used to treat positive symptoms such as hallucinations and delusions. However, selective D3 receptor antagonists have also been shown to have potential therapeutic effects in treating negative symptoms of schizophrenia, such as apathy and anhedonia.

In drug addiction, D3 receptors have been found to play a role in the rewarding effects of drugs of abuse, such as cocaine and amphetamines. Selective D3 receptor antagonists have shown promise in reducing drug-seeking behavior and preventing relapse in animal models of addiction.

Overall, dopamine D3 receptors play an important role in several neurological and psychiatric disorders, and further research is needed to fully understand their functions and potential therapeutic uses.

Lysergic Acid Diethylamide (LSD) is defined in medical terms as a powerful synthetic hallucinogenic drug. It is derived from lysergic acid, which is found in ergot, a fungus that grows on grains such as rye. LSD is typically distributed as a liquid, tablets, or thin squares of gelatin (commonly known as window panes). It is odorless, colorless, and has a slightly bitter taste.

LSD is considered one of the most potent mood-changing chemicals. Its effects, often called a "trip," can be stimulating, pleasurable, and mind-altering or they can lead to an unpleasant, sometimes terrifying experience called a "bad trip." The effects of LSD are unpredictable depending on factors such as the user's personality, mood, expectations, and the environment in which the drug is used.

In the medical field, LSD has been studied for its potential benefits in treating certain mental health conditions, such as anxiety and depression associated with life-threatening illnesses, but further research is needed to establish its safety and efficacy. It's important to note that the use of LSD outside of approved medical settings and supervision is not legal in most countries and can lead to serious legal consequences.

"Substance-Related and Addictive Disorders", Diagnostic and Statistical Manual of Mental Disorders, DSM Library, American ... Nicotine dependence Amphetamine dependence Cocaine dependence Substance use disorder American Psychiatric Association. " ... "Substance-Related and Addictive Disorders". In American Psychiatric Association. Diagnostic and Statistical Manual of Mental ... "Substance-Related and Addictive Disorders". In American Psychiatric Association. Diagnostic and Statistical Manual of Mental ...
... a new approach for the treatment of amphetamine-related conditions such as addiction and/or disorders in which amphetamine is ... In this article, we focus on the relevance of TAs and their receptors to nervous system-related disorders, namely schizophrenia ... effectiveness of amphetamine in this disorder should be explored. Scassellati C, Bonvicini C, Faraone SV, Gennarelli M (October ... attention deficit hyperactivity disorder, substance abuse and eating disorders [7,8,36]. Clinical studies report increased β- ...
This was found to be comparatively higher than hallucinogens (26%) and amphetamines (22%). To screen for cannabis-related ... Cannabis use disorder is recognized in the fifth version of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), ... The combination of nabilone and zolpidem has been shown to decrease sleep-related and mood-related symptoms of cannabis ... physical/psychological problems related to use, activities given up and craving. For a diagnosis of DSM-5 cannabis use disorder ...
International Journal of Obesity and Related Metabolic Disorders. 22 (Suppl 1): S18-28, discussion S29. PMID 9758240. "FDA ... Older anorectic agents such as amphetamine and fenfluramine force the release of these neurotransmitters rather than affecting ... A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine". ... Substituted amphetamines, Withdrawn drugs, World Anti-Doping Agency prohibited substances). ...
Amphetamine, Attention deficit hyperactivity disorder). ... which might be related to differences in inhibitory brain ... 2008). Any of these can cause you to appear to have a disorder of EFs, such as ADHD, when you do not. You can see the ... Wikiquote has quotations related to Inhibitory control. (Articles with short description, Short description is different from ... ADHD can be conceptualized as a disorder of executive function; specifically, ADHD is characterized by reduced ability to exert ...
... amphetamine psychosis) and the psychoses related to schizophreniform disorder and schizophrenia. Delirium is often drug induced ... particularly conduct disorder, narcissistic personality disorder and antisocial personality disorder). A study in Finland ... In a minority of cases, homicides and acts of violence may be related to mental disorder. These homicides and fantasies do not ... They should be brought swiftly to a place where an assessment can be made and any underlying medical or mental disorder should ...
Related disorder NOS 291.81 Withdrawal 291.0 Withdrawal delirium Amphetamine (or amphetamine-like) 305.70 Abuse 304.40 ... Related disorder NOS Cocaine 305.60 Abuse 304.20 Dependence 292.89 -Induced anxiety disorder 292.84 -Induced mood disorder ... Related disorder NOS Inhalant 305.90 Abuse 304.60 Dependence 292.89 -Induced anxiety disorder 292.84 -Induced mood disorder ... Related disorder NOS Nicotine 305.1 Dependence 292.9 -Related disorder NOS 292.0 Withdrawal Opioid 305.50 Abuse 304.00 ...
... an organic mental disorder (F0) or psychoactive substance-related disorder (F1), such as excess consumption of amphetamine-like ... and stressor-related disorders, personality disorders, substance-related and addictive disorders, neurocognitive disorders". ... bipolar disorders, schizophrenia-spectrum disorders, anxiety disorders, obsessive-compulsive disorders, trauma- ... The disorder does not meet the criteria for panic disorder (F41.0), phobic anxiety disorders (F40.-), obsessive-compulsive ...
Amphetamine use disorders ... 3,788 (3,425-4,145) Greene SL, Kerr F, Braitberg G (October 2008). "Review article: amphetamines ... "Amphetamine Aspartate". Mallinckrodt Pharmaceuticals. March 2014. Retrieved 19 August 2015. Wikimedia Commons has media related ... In 2013, overdose on amphetamine, methamphetamine, and other compounds implicated in an "amphetamine use disorder" resulted in ... Among this group, the most closely related compounds are phenethylamine, the parent compound of amphetamine, and N- ...
Amphetamine use disorders ... 3,788 (3,425-4,145) Greene SL, Kerr F, Braitberg G (October 2008). "Review article: amphetamines ... Among this group, the most closely related compounds are phenethylamine, the parent compound of amphetamine, and N- ... In 2013, overdose on amphetamine, methamphetamine, and other compounds implicated in an "amphetamine use disorder" resulted in ... Amphetamine: Comparative review". Journal of Attention Disorders. 3 (4): 200-211. doi:10.1177/108705470000300403. S2CID ...
... amphetamine enantiomers and pemoline in attention-deficit hyperactivity disorder". Human Psychopharmacology: Clinical and ... Pemoline has been studied in and reported to be effective in the treatment of fatigue due to multiple sclerosis and HIV-related ... Takeda T (March 2009). "Psychopharmacology for attention-deficit/hyperactivity disorder in Japan". Current Attention Disorders ... Pemoline is a member of the 4-oxazolidinone class and is structurally related to other members of the class including aminorex ...
... pharmaceutically important substituted amphetamines. Glennon RA (2013). "Phenylisopropylamine stimulants: amphetamine-related ... is used to treat attention deficit hyperactivity disorder (ADHD) [79]. ... [Figure 4](b) Examples of synthetic, ... MA: Triada-X. ISBN 978-5-94497-029-9. Media related to Substituted amphetamines at Wikimedia Commons (CS1 maint: unfit URL, ... Amphetamine was first produced at the end of the 19th century. By the 1930s, amphetamine and some of its derivative compounds ...
... pharmaceutically important substituted amphetamines. Glennon RA (2013). "Phenylisopropylamine stimulants: amphetamine-related ... Stimulants are used in impulse control disorders such as ADHD and off-label in mood disorders such as major depressive disorder ... "amphetamines and prescription stimulants" (with "amphetamines" including amphetamine and methamphetamine) the value was 0.7%, ... Amphetamines-type stimulants are often used for their therapeutic effects. Physicians sometimes prescribe amphetamine to treat ...
... amphetamine-related disorders MeSH F03.900.300 - cocaine-related disorders MeSH F03.900.635 - marijuana abuse MeSH F03.900.650 ... alcohol-related disorders MeSH F03.900.100.050 - alcohol amnestic disorder MeSH F03.900.100.050.500 - korsakoff syndrome MeSH ... panic disorder MeSH F03.080.725 - phobic disorders MeSH F03.080.931 - stress disorders, traumatic MeSH F03.080.931.249 - combat ... conduct disorder MeSH F03.550.300 - child behavior disorders MeSH F03.550.325 - child development disorders, pervasive MeSH ...
Biology of bipolar disorder, Amphetamine, Serotonin). ... The polymorphism has also been related to personality traits ... Furthermore, a 2003 meta-analysis of affective disorders, major depressive disorder and bipolar disorder, found a minor ... It has been examined in connection with obsessive compulsive disorder (OCD). I425V is a rare mutation on the ninth exon. In ... Transporters are important sites for agents that treat psychiatric disorders. Drugs that reduce the binding of serotonin to ...
... is used to treat attention deficit hyperactivity disorder (ADHD), narcolepsy (a sleep disorder), and obesity, and ... As a member of the phenethylamine class, amphetamine is also chemically related to the naturally occurring trace amine ... Amphetamine use disorders ... 3,788 (3,425-4,145) Albertson TE (2011). "Amphetamines". In Olson KR, Anderson IB, Benowitz NL, ... In 2013, overdose on amphetamine, methamphetamine, and other compounds implicated in an "amphetamine use disorder" resulted in ...
Amphetamine psychosis may be purely related to high drug usage, or high drug usage may trigger an underlying vulnerability to ... The disorders are often distinguished by a rapid resolution of symptoms in amphetamine psychosis, while schizophrenia is more ... Drugs in the class of amphetamines, or substituted amphetamines, are known to induce "amphetamine psychosis" typically when ... However, unlike similar disorders, in AWP, substituted amphetamines reduce rather than increase symptoms, and the psychosis or ...
Lists of child and adult mental disorders can be found in the International Statistical Classification of Diseases and Related ... Psycho stimulants such as Ritalin, amphetamine- related stimulant drugs: e.g., Adderall, and antidepressants such as Wellbutrin ... Oppositional defiant disorder, attention-deficit hyperactivity disorder, and autism spectrum disorder are examples of ... There is also reason to believe that there is co-morbidity of disorders, in that if one disorder is present, there is often ...
... and conduct disorders, and gambling disorder may be included in addiction and related disorders. The role of impulsivity in the ... For example, alcohol has been shown to increase impulsivity while amphetamines have had mixed results. Substance use disorder ... conduct disorder, anxiety disorder, major depressive disorder, bipolar disorder, and substance use disorders. The precise ... and skin-picking disorder as obsessive-compulsive and related disorders, moving intermittent explosive disorder under the ...
For the treatment of attention deficit hyperactivity disorder (ADHD) - e.g., amphetamine, methamphetamine, pemoline As ... A closely related type of drug is a norepinephrine reuptake inhibitor (NRI). Another class of drugs that stimulates adrenergic ... ISBN 978-0-7817-6879-5.[permanent dead link] Media related to Norepinephrine releasing agents at Wikimedia Commons (All ... though this is typically reserved only for those that also induce the release of serotonin and/or dopamine like amphetamine, ...
Related Disorder NOS 292.0 Withdrawal 294.9 Cognitive Disorder NOS 307.9 Communication Disorder NOS Conduct Disorder 312.81 ... 294.8 Amnestic Disorder NOS Amphetamine (or Amphetamine-Like) 305.70 Abuse 304.40 Dependence 292.89 -Induced Anxiety Disorder ... Related Disorder NOS 301.50 Histrionic Personality Disorder 307.44 Hypersomnia related to...[Indicate the Axis I or Axis II ... Related Disorder NOS 307.42 Insomnia Related to...[Indicate the Axis I or Axis II Disorder] 312.34 Intermittent Explosive ...
His clinical work and research focuses on Parkinson's disease and other movement disorders. His work centers on amphetamine- ... is to help find ways to prevent or retard the progression of Parkinson's disease and related neurodegenerative disorders. His ... work also has implications for substance use disorders. Ricaurte's retracted article on the neurotoxicity of ecstasy, ...
... of the amphetamine family (specifically, a derivative of phentermine, and closely related to chlorphentermine, a highly ... Crow S, Brown E (March 2003). "Investigational drugs for eating disorders". Expert Opinion on Investigational Drugs. 12 (3): ... anxiety disorders, and anorexia nervosa by Jouveinal but did not complete development and was never marketed. It reached phase ...
Glennon RA (2013). "Phenylisopropylamine stimulants: amphetamine-related agents". In Lemke TL, Williams DA, Roche VF, Zito W ( ... Biology of attention deficit hyperactivity disorder, Amphetamine). ... Amphetamine can also undergo aromatic hydroxylation to p-hydroxyamphetamine. ... Subsequent oxidation at the benzylic position ... It also participates in the metabolism of xenobiotics related to these substances; for example, the human DBH enzyme catalyzes ...
ATS use disorders are related to the GABA system. Research shows that ATS use would affect normal function of the GABAA ... Amphetamine type stimulants can be used in the treatment of narcolepsy, a rare neurological disorder where the brain is unable ... amphetamine psychosis. Amphetamine, the parent compound of amphetamine-type stimulants was first synthesized by Romanian ... Jiao D, Liu Y, Li X, Liu J, Zhao M (2015). "The role of the GABA system in amphetamine-type stimulant use disorders". Frontiers ...
This alteration is suggested to be related to the pathology, since antipsychotics do not regulate the expression of DARPP-32. A ... amphetamine, nicotine, LSD, caffeine, PCP, ethanol and morphine, and in Parkinson's disease or EPS (Extra-pyramidal symptoms). ... DARPP-32 levels are decreased in the dorsolateral prefrontal cortex and lymphocytes of both schizophrenia and bipolar disorder ... "The leukocytes expressing DARPP-32 are reduced in patients with schizophrenia and bipolar disorder". Progress in Neuro- ...
Depressive symptoms and disorders are common in patients with Parkinson's disease and can affect their quality of life. ... This binding affinity is related to D2 and D3 receptor homology, the homology between them has a high degree of sequence and is ... The most commonly prescribed indirect agonists of dopamine receptors include: Amphetamine and/or dextroamphetamine (used to ... Impulse control disorder that is described as gambling, hypersexuality, compulsive shopping and binge eating is one serious ...
... underlying disorder coexist with the jealousy The course of morbid jealousy closely relates to that of the underlying disorder ... amphetamines.), organic brain disorders (i.e. Parkinson's, Huntington's), schizophrenia, neurosis, affective disturbances or ... Unlike other delusional disorders, people who suffer from this disorder have a strong association with stalking, cyberstalking ... It can be found in the context of schizophrenia and delusional disorder, such as bipolar disorder, but is also associated with ...
... opioid use disorders at 122,100 deaths, amphetamine use disorders at 12,200 deaths, and cocaine use disorders at 11,100. Public ... It is a form of substance-related disorder. Differing definitions of drug abuse are used in public health, medical, and ... The terms "dual diagnosis" or "co-occurring disorders", refer to having a mental health and substance use disorder at the same ... For example, the US, devoid of such measures, has seen large increases in drug-related deaths since 2000 (mostly related to ...
Furthermore, nightmares related to PTSD would be more stressful than idiopathic ones. However, further studies have to be ... Amphetamines, antidepressants, and stimulants like cocaine and caffeine can cause nightmares. Blood pressure medication, ... Dissociative disorders are usually paired with Nightmare Disorder 57% of the time. Nightmare disorder is believed to be ... Nightmare disorders can also be associated with sleep disorders such as night terrors, chronic insomnia and sleep-disordered ...
... describes the following 10 amphetamine-related psychiatric disorders: Amphetamine-induced anxiety disorder Amphetamine-induced ... mood disorder Amphetamine-induced psychotic disorder with delusions Amphetamine-induced psychotic disorder with h... ... The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) ... encoded search term (Amphetamine-Related Psychiatric Disorders) and Amphetamine-Related Psychiatric Disorders What to Read Next ...
Categories: Amphetamine-Related Disorders Image Types: Photo, Illustrations, Video, Color, Black&White, PublicDomain, ...
"Substance-Related and Addictive Disorders", Diagnostic and Statistical Manual of Mental Disorders, DSM Library, American ... Nicotine dependence Amphetamine dependence Cocaine dependence Substance use disorder American Psychiatric Association. " ... "Substance-Related and Addictive Disorders". In American Psychiatric Association. Diagnostic and Statistical Manual of Mental ... "Substance-Related and Addictive Disorders". In American Psychiatric Association. Diagnostic and Statistical Manual of Mental ...
Amphetamine-Related Disorders 1 0 Imagination 1 0 Migraine Disorders 1 0 ... Content source: Public Health Genomics Branch in the Division of Blood Disorders and Public Health Genomics, National Center on ...
See also Amphetamines and Overview of Substance-Related Disorders.)... read more *. Over-the-counter (OTC) drugs, such as cough ... Amphetamines Amphetamines Amphetamines are stimulant drugs that are used to treat certain medical conditions but are also ... and substance use disorders Substance Use Disorders Substance use disorders generally involve behavior patterns in which people ... Amphetamines increase alertness, enhance physical performance, and produce euphoria... read more and methamphetamines ...
... discusses the comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine ... Cocaine-Related Psychiatric Disorders * Opioid Abuse * Case Report: Cardiac Arrest in a Man Who Has Overdosed ... What Do We Know About "Gaming Disorder"? 0.5 CME / CE / ABIM MOC Credits Clinical Review ... You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further ...
... assumed that these levels of exposure are low compared with those related to illicit drug use or therapeutic use of amphetamine ... drugs for managing behavioral issues such as attention deficit hyperactivity disorder (2). In 2015, a family that was ... Amphetamine. Methamphetamine. Amphetamine. 7. Male. 460. 20. Not detected. Not detected. Regularly played games that involved ... The washes also were analyzed for the presence of amphetamines. The lower limit of detection for this analysis was 5 pg/mg for ...
"Amphetamine Related Psychiatric Disorders." May 2022.. *Henning, Ashley, et al. "A Case Study of Acute Stimulant-Induced ... behavioral health disorders, treatment program options, and their related topics.. The information we provide is researched, ... "Amphetamine-Induced Psychosis - a Separate Diagnostic Entity or Primary Psychosis Triggered in the Vulnerable?" BMC Psychiatry ... White Oak Recovery Center strives to improve the lives of people suffering from substance use disorders and co-occurring mental ...
Inhalant-related psychiatric disorders are a heterogenous group of illnesses caused by the abuse of solvents, glues, paint, ... and amphetamines. [10] This study also noted higher reported rates of abuse and neglect among adolescents who were diagnosed ... encoded search term (Inhalant-Related Psychiatric Disorders) and Inhalant-Related Psychiatric Disorders What to Read Next on ... Diagnosis of inhalant-related psychiatric disorders is based on Diagnostic and Statistical Manual of Mental Disorders, Fourth ...
... previous studies have found that PES is reduced in children and adolescents with attention-deficit hyperactivity disorder (ADHD ... previous studies have found that PES is reduced in children and adolescents with attention-deficit hyperactivity disorder (ADHD ... Error-Related Dynamics of Reaction Time and Frontal Midline Theta Activity in Attention Deficit Hyperactivity Disorder (ADHD) ... Wardle, M. C., Yang, A., and de Wit, H. (2012). Effect of d-amphetamine on post-error slowing in healthy volunteers. ...
Amphetamine-Related Disorders. *Amygdala. *Amyloid beta-Peptides. *Analysis of Variance. *Anatomy, Artistic ...
D1.625.62.374 Amphetamine-Related Disorders C25.225 C25.775.225 Analgesics, Opioid D27.505.696.663.850.14.520 D27.505.696.277. ... C25.775.100.87 Alcohol-Induced Disorders, Nervous System C25.100.87.193 C25.775.100.87.193 Alcohol-Related Disorders C25.775. ... C25.775.835 Substance-Related Disorders C25.775 Sweating G7.700.100.693 G7.700.345.421.693 G16.100.57.500.535.693 Swiss 3T3 ... D23.946.833.850.325.220.244 Cocaine-Related Disorders C25.300 C25.775.300 Cocarcinogenesis C4.697.160 C4.697.98.875 C23.550. ...
D1.625.62.374 Amphetamine-Related Disorders C25.225 C25.775.225 Analgesics, Opioid D27.505.696.663.850.14.520 D27.505.696.277. ... C25.775.100.87 Alcohol-Induced Disorders, Nervous System C25.100.87.193 C25.775.100.87.193 Alcohol-Related Disorders C25.775. ... C25.775.835 Substance-Related Disorders C25.775 Sweating G7.700.100.693 G7.700.345.421.693 G16.100.57.500.535.693 Swiss 3T3 ... D23.946.833.850.325.220.244 Cocaine-Related Disorders C25.300 C25.775.300 Cocarcinogenesis C4.697.160 C4.697.98.875 C23.550. ...
Does illicit amphetamine seizures quantity associated with amphetamine use disorder related admissions in Saudi Arabia? ... For each one-unit increase in the amphetamine confiscated quantities, the amphetamine use disorder admission rate increased by ... We used a random intercept Negative Binomial model to predict the yearly count of amphetamine use disorder admission rates. ... The amphetamine disorder admission rate has increased from 1.33% in 2005 to 18.27% in 2018. ...
Amphetamine-Related Disorders. Concept. Why? Patient-relevant outcomes associated with generic tamsulosin, levothyroxine and ... False-positive amphetamine toxicology screen results in three pregnant women using labetalol.. Academic Article. Why? ... Amphetamine-elicited striatal Fos expression is attenuated in neurotensin null mutant mice.. Academic Article. Why? ... Amphetamine-induced decreases in dopamine transporter surface expression are protein kinase C-independent.. Academic Article. ...
... amphetamine, hallucinogen, inhalant, other stimulant, and other psychoactive substance-related disorders). ... Defined as ED visits made by patients aged ≥18 years with a primary diagnosis of substance-related disorders or primary ...
Alcohol, amphetamines, ecstasy (MDMA and derivatives), and cocaine. *Angiogenesis inhibitors (including tyrosine kinase ... Secondary hypertension occurs because of another disorder.. *Drug-induced hypertension is a form of secondary hypertension ... Foods eaten, weight, and other body-related variables, including the amount of added sodium in processed foods ...
Substance-Related Disorders Medicine & Life Sciences 29% * Psychological Stress Medicine & Life Sciences 22% ... keywords = "Amphetamine, Dopamine, Human, Impulsivity, Positron emission tomography (PET), Stress",. author = "Oswald, {Lynn M ... Impulsivity and chronic stress are associated with amphetamine-induced striatal dopamine release. NeuroImage. 2007 May 15;36(1 ... Impulsivity and chronic stress are associated with amphetamine-induced striatal dopamine release. In: NeuroImage. 2007 ; Vol. ...
The drug is an amphetamine, which is an addictive substance. Adderall® has been linked to sudden deaths, heart related deaths, ... This disorder causes loose teeth and jaw pain. At present, there is no cure for jaw osteonecrosis. For more details, please see ... Likewise she treats womens related issues including menopause, PMS, breast cancer and hormone related issues. Dr. Robinson is ... Evidence of asthma-related deaths and serious complications led the panel of experts to warn against continued use of Glaxos ...
Are ADHD-like symptoms in youth a separate disorder from OCD?. *Is pregnancy or childbirth related to the onset of OCD symptoms ... These include Riluzole, opiates, caffeine, amphetamine-like medications, among others.. Are ADHD-like symptoms in youth a ... Some disorders do appear to be occur more often among people with OCD. For example, depression and other anxiety disorders ( ... Have there been any recent developments in drug treatments for OCD or related disorders? ...
Addiction Amphetamine-Related Disorders Anger Management Applied-Toxicology Aquatic-Toxicology Autism Autistic Disorder ... And has dedicated their major research contributions in the field of Addiction research, Substance-Related Disorders, ... Reproductive Toxicology Risky Behavior Schizophrenia Disorder Skin Toxicology Societal Influence Substance-Related Disorders ... Opioid-Related Disorders Oral and Maxillofacial Radiology Oral/dental epidemiology Parental Care Pediatric epidemiology ...
Amphetamine or Related Acting Sympathomimetic Abuse * View other providers who treat Amphetamine or Related Acting ... Alzheimers diseaseAnemiaArthritisAsthmaAutismBipolar disorderBreast cancerCancerConstipationCOPDCoronavirusCrohns disease ... Amphetamine and Other Psychostimulant Dependence * View other providers who treat Amphetamine and Other Psychostimulant ... Conduct and Other Emotional Adolescent Disorders * View other providers who treat Conduct and Other Emotional Adolescent ...
2) Personal or family history of chronic inflammatory skin disease or immune or autoimmune related disorders, diseases or ... 3) History or current evidence of use of amphetamines, barbiturates, narcotic or other drugs of abuse/recreational drug use, ...
Adderall-related emergency department visits went up by a whopping 156 percent since 2006, according to a new study. Research ... To find out if the UA had a similar trend in Adderall-related emergency visits, the Daily Wildcat spoke with Dr. F. Mazda ... Adderall, a combination of amphetamine and dextroamphetamine, is a drug commonly prescribed to treat attention deficit ... Xanax, a highly addictive drug from the benzodiazepine family, is commonly prescribed to treat anxiety disorders. ...
... which can be significantly improved with amphetamine-based medications. This shifts the understanding of ADHD beyond ... The study, "Amphetamines Improve the Motivation to Invest Effort in Attention-Deficit/Hyperactivity Disorder", was authored by ... RELATED. Alcohol Alcohol, relationships, and longevity: Couples with similar drinking habits tend to live longer. April 15, ... New study sheds light on ADHDs impact on motivation and the efficacy of amphetamine-based meds. by Eric W. Dolan ...
  • Prescription amphetamines are used frequently in children and adolescents to treat attention deficit hyperactivity disorder (ADHD), and they are the most commonly prescribed medications in children. (medscape.com)
  • Most commonly, stimulants such as Adderall, Ritalin, and Vyvanse are prescribed for both children and adults diagnosed with attention deficit hyperactivity disorder (ADHD). (wikipedia.org)
  • It is commonly assumed that these levels of exposure are low compared with those related to illicit drug use or therapeutic use of amphetamine-based drugs for managing behavioral issues such as attention deficit hyperactivity disorder ( 2 ). (cdc.gov)
  • Adderall is a prescription medication to treat attention-deficit hyperactivity disorder (ADHD). (whiteoakrecovery.com)
  • Several previous studies have found that PES is reduced in children and adolescents with attention-deficit hyperactivity disorder (ADHD). (frontiersin.org)
  • Adderall, a combination of amphetamine and dextroamphetamine, is a drug commonly prescribed to treat attention deficit hyperactivity disorder. (arizona.edu)
  • In a recent study published in the Journal of Neuroscience , researchers found that individuals with Attention-Deficit/Hyperactivity Disorder (ADHD) show reduced motivation to engage in effortful activities, both cognitive and physical, which can be significantly improved with amphetamine-based medications. (psypost.org)
  • One such condition that it is used for, which has not been approved by the FDA, is in the treatment of Attention Deficit Hyperactivity Disorder ( ADHD ). (selfgrowth.com)
  • The prevalence of attention-deficit hyperactivity disorder (ADHD) in the USA is estimated at approximately 4-9% in children and 4% in adults. (nih.gov)
  • Clinical guidelines recommend psychosocial interventions for cocaine and amphetamine addiction as first-line treatment, but which of the many different interventions should be offered first? (medscape.com)
  • A team of investigators from the University of Oxford in England have performed a network meta-analysis to estimate the comparative effectiveness of all available psychosocial interventions (alone or in combination) for the short- and long-term treatment of people with cocaine and/or amphetamine addiction. (medscape.com)
  • The neuropeptide cocaine and amphetamine regulated transcript (CART) was shown to induce anxiety-like behavior in rodents, and mutations in the human CART gene are associated with depression and anxiety. (lu.se)
  • Health effects were most pronounced in the youngest child, who also had the highest methamphetamine levels in hair, possibly related to a combination of repeated contact with surfaces during play activities and less frequent hand washing. (cdc.gov)
  • None of the family members had ever used methamphetamine or had been taking any prescribed amphetamine-based medications. (cdc.gov)
  • Amphetamine-type stimulants (ATS) such as "ecstasy" and methamphetamine now rank as Africa's second most widely abused drug type. (who.int)
  • A challenging question that continues to plague the field of addiction is why some individuals are more vulnerable for substance use disorders than others. (johnshopkins.edu)
  • Alcoholism was simply defined as a "well-established addiction to alcohol without [a] recognizable underlying disorder" (Washington, DC: American Psychiatric Association 1952;39). (thecarlatreport.com)
  • The manual further stated that "drug addiction is usually symptomatic of a personality disorder" but didn't indicate how one would arrive at a diagnosis. (thecarlatreport.com)
  • Addiction was still considered a personality disturbance but no longer fell under the umbrella of antisocial or "sociopathic" personality disorder. (thecarlatreport.com)
  • The category for addiction was retitled "psychoactive substance use disorders" and the criteria sets for abuse and dependence were further developed. (thecarlatreport.com)
  • Long-term Phentermine Pharmacotherapy: An Investigation for Amphetamine-like Phentermine Addiction, Abuse, Cravings, or Withdrawal. (hendricksforhealth.com)
  • According to the American Society of Addiction Medicine "Addiction is a primary, chronic disease of brain reward, motivation, memory and related circuitry. (rehabcenter.net)
  • That said, there's some compelling early data to suggest that perhaps psychedelics, when paired with psychotherapy, may be able to treat substance use disorders and addiction. (psychiatry.org)
  • 4 A substance is a psychoactive compound with the potential to cause health problems, substance-use disorders, and addiction. (openmedicalpublishing.org)
  • The dose of Adderall(XR) (dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine aspartate monohydrate, amphetamine sulfate) needed to produce toxicity and psychiatric symptoms in a child is as low as 2 mg. (medscape.com)
  • Amphetamine, dextroamphetamine, and methylphenidate act as substrates for the cellular monoamine transporter, especially the dopamine transporter (DAT) and less so the norepinephrine (NET) and serotonin transporter. (nih.gov)
  • The management of amphetamine, dextroamphetamine, and methylphenidate overdose is largely supportive, with a focus on interruption of the sympathomimetic syndrome with judicious use of benzodiazepines. (nih.gov)
  • Stimulant use disorder is a type of substance use disorder where the use of stimulants caused clinically significant impairment or distress. (wikipedia.org)
  • ABSTRACT Amphetamine-type stimulants (ATS) are the second most commonly used illicit drugs in the world, after cannabis. (who.int)
  • Les résultats indiquent que la consommation auto-déclarée de methamphétamine et d'ectasie en 2016 était inférieure à 1 % dans la population générale et parmi les étudiants en universités et les élèves du secondaire, mais que la prévalence des stimulants de type amphétamines était plus élevée parmi certains groupes. (who.int)
  • Les résultats de cette analyse révèlent le besoin en études épidémiologiques de haute qualité et la nécessité d'un suivi plus rapproché de la consommation de stimulants dans différentes populations. (who.int)
  • Rather than the stimulants that are currently used in the treatment of these disorders, Modafinil Now offers benefits of providing a feeling of being wide awake without any need for more sleep when the effects of the drug eventually wear off. (selfgrowth.com)
  • The purpose of this study was to examine associations among impulsivity, stress, and striatal dopamine (DA) responses to amphetamine (AMPH) in humans. (johnshopkins.edu)
  • For all of us, dopamine works like a natural amphetamine and controls our energy, excitement for new things, and motivation. (kinesiologyinstitute.com)
  • A long term drop in dopamine can bring on addictive disorders, obesity, severe fatigue and Parkinson's disease. (kinesiologyinstitute.com)
  • The mechanism of toxicity is primarily related to excessive extracellular dopamine, norepinephrine, and serotonin. (nih.gov)
  • Amphetamine and similar street drugs increase dopamine concentration and their use has been associated with bruxism. (medscape.com)
  • Are there higher occurrences of other mental disorders among individuals with OCD? (hopkinsmedicine.org)
  • The release of the fifth edition of the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders (DSM-5) in May 2013 marks yet another shift in how clinicians diagnose substance use disorders (SUDs). (thecarlatreport.com)
  • The manual ballooned to 494 pages, focused on symptoms and behaviors (rather than putative causes of mental disorders), and introduced the now-familiar format involving criteria sets. (thecarlatreport.com)
  • This new study was conducted to explore how individuals with ADHD differ in their motivation for effortful tasks compared to those without the disorder, and to assess the effectiveness of commonly prescribed ADHD medications in addressing these differences. (psypost.org)
  • We therefore designed a task to specifically test whether motivation is indeed lower in ADHD and, if so, whether amphetamine-based medications that are commonly used to treat ADHD can restore it. (psypost.org)
  • Some CNS depressants are related to medications associated with tranquilizers. (drugrehabottawa.com)
  • Certain medications may be used to alleviate cravings, whereas others may be used to treat co-occurring disorders. (rehabcenter.net)
  • The reason these disorders are so popular is because drug companies market medications that slow children down. (skild-edu.org)
  • In adults, narcolepsy, ADHD of the adult type, and some depression can be treated with amphetamines. (medscape.com)
  • Are ADHD-like symptoms in youth a separate disorder from OCD? (hopkinsmedicine.org)
  • In a recent study, researchers concluded that symptoms of ADHD may be considered a separate disorder in adolescents with OCD. (hopkinsmedicine.org)
  • The ADHD group included individuals who were being treated with amphetamine-based drugs like dexamfetamine or its prodrug, lisdexamfetamine. (psypost.org)
  • ADD and ADHD are unique because they are considered disorders primarily in the United States and not the rest of the world. (skild-edu.org)
  • Still others have another condition called bipolar disorder that can look like ADHD. (skild-edu.org)
  • Other drugs such as Ecstasy, amphetamines or speed had been consumed by less than 1 % of the adolescents. (who.int)
  • Dr. Preda works at Practice in Orange, CA. They frequently treat conditions like Anxiety and Major Depressive Disorder along with other conditions at varying frequencies. (healthline.com)
  • Amphetamine-related psychiatric disorders are conditions resulting from intoxication or long-term use of amphetamines or amphetamine derivatives. (medscape.com)
  • Amphetamine use may elicit or be associated with the recurrence of other psychiatric disorders. (medscape.com)
  • The symptoms of amphetamine-induced psychiatric disorders can be differentiated from those of related primary psychiatric disorders by time. (medscape.com)
  • Inhalant-related psychiatric disorders are a heterogenous group of illnesses caused by the abuse of solvents, glues, paint, fuels, or other volatile substances. (medscape.com)
  • In Saudi Arabia, according to the National Commission for Drug Control, in 2018, there is increasing of substance misuse among Saudis and associated with many medical diseases, psychiatric disorders, and educational, occupational, social and legal consequences. (openmedicalpublishing.org)
  • However, some disorders (such as alcoholism, drug abuse, and schizophrenia) do not occur more frequently in those with OCD. (hopkinsmedicine.org)
  • Amphetamine, heroin, alcohol and cannabis were the most commonly abused among Saudi patients and the main risk factors were peer pressure and psychosocial stresses. (openmedicalpublishing.org)
  • Environmental factors such as economic development, culture, availability of alcohol and the level and effectiveness of alcohol policies are relevant factors in explaining differences and historical trends in alcohol consumption and related harm. (who.int)
  • Nicotine, however, is treated separately psychiatrically under tobacco use disorder. (wikipedia.org)
  • Recently, Alem and Shibre considered the differences in the effect of khat and khat as a substance of abuse and noted that amphetamine are quantitative rather than chewing had the potential to complicate qualitative [20,21]. (who.int)
  • [ 10 ] This study also noted higher reported rates of abuse and neglect among adolescents who were diagnosed with inhalant use disorders. (medscape.com)
  • Dr. Robinson is very knowledgeable in diet and exercise related issues including weight gain/loss, detox-cleansing diets, and obsessive compulsive disorders. (denialism.com)
  • If a substance is used over a long period of time and the user becomes dependent upon it, a substance use disorder may develop. (wikipedia.org)
  • thus it can not be diagnosed as a stimulant use disorder or any other substance use disorder. (wikipedia.org)
  • Certain isolated conditions related to caffeine are recognized in the DSM-5's "substance-related" section, however: caffeine intoxication, caffeine withdrawal and other caffeine-induced disorders (e.g. (wikipedia.org)
  • Substance Use Disorders Substance use disorders generally involve behavior patterns in which people continue to use a substance (for example, a recreational drug) despite having problems caused by its use. (msdmanuals.com)
  • See also Amphetamines and Overview of Substance-Related Disorders. (msdmanuals.com)
  • The findings are consistent with notions that blunted DA responses represent an endophenotype for substance use disorders. (johnshopkins.edu)
  • Problematic substance use was removed from the realm of personality disorders and placed in a new category called "substance use disorders. (thecarlatreport.com)
  • And Dr. Sackett's expertise includes exploring novel therapeutics and treatments as well as psychedelic treatments for substance use disorders. (psychiatry.org)
  • The present study aimed at exploring the psychosocial life aspects among substance misuse clients through conducting a review of the literature related to the research topic. (openmedicalpublishing.org)
  • This can, therefore, work to intensify any side effects that may be stimulant related, such as nervousness, anxiety , and trouble with sleeping. (selfgrowth.com)
  • Amphetamine-type seizures from 2012 to 2013 ( 4 ). (who.int)
  • In comparison with amphetamine, khat hyperactivity and logorrhoea [4]. (who.int)
  • Attention Deficits and Hyperactivity: Is it Really a Disorder? (skild-edu.org)
  • The neurobiological bases of mood disorders remain elusive but both monoamines and neuropeptides may play important roles. (lu.se)
  • In cases where agitation, delirium, and movement disorders are unresponsive to benzodiazepines, second-line therapies include antipsychotics such as ziprasidone or haloperidol, central alpha-adrenoreceptor agonists such as dexmedetomidine, or propofol. (nih.gov)
  • Either prescription or illegally manufactured amphetamines can induce these disorders. (medscape.com)
  • Per recent classification of sleep disorders, bruxism is defined as a sleep-related movement disorder. (medscape.com)
  • Early theories suggesting that bruxism was related to general malocclusion have been disproven, although, in some isolated cases, tooth interferences may play a role in its onset. (medscape.com)
  • A systematic review by Kuang et al found that sleep bruxism is more common in adults with sleep-related gastroesophageal reflux disease, restless leg syndrome, periodic limb movement during sleep, obstructive sleep apnea, REM behavior disorder, and sleep-related epilepsy than in the general population. (medscape.com)
  • Furthermore, amphetamines can be psychologically but not physically addictive. (medscape.com)
  • Xanax, a highly addictive drug from the benzodiazepine family, is commonly prescribed to treat anxiety disorders. (arizona.edu)
  • Modafinil was approved by the United States Food and Drug Administration in 1998 for helping those individuals that suffer from sleep apnea, disorders associated with shift work, and narcolepsy feels more awake. (selfgrowth.com)
  • The United States Food and Drug Administration (FDA) approved Modafinil to treat conditions including shift work sleep disorders, obstructive sleep apnea, and narcolepsy. (selfgrowth.com)
  • We measured CART-like immunoreactivity (-LI) in genetic rat models of depression and anxiety, i.e. the Flinders Sensitive Line (FSL) and rats selected for High Anxiety-related Behavior (HAB) using a radioimmunoassay. (lu.se)
  • For example, depression and other anxiety disorders (such as generalized anxiety disorder and agoraphobia) occur more frequently in those with OCD. (hopkinsmedicine.org)
  • Methylenedioxymethamphetamine (MDMA) MDMA (3,4-methylenedioxymethamphetamine) is similar to an amphetamine but has both stimulant and hallucinogenic effects. (msdmanuals.com)
  • In a 2010 article by Howard et al, the authors reported that rates of suicidal ideation are higher among those with inhalant use disorders than nonusers. (medscape.com)
  • The biochemical hypothesis behind depression is related to the effect of a variety of stressors on specific genes that alter the production of proteins that are essential in the mood machinery of the brain. (skild-edu.org)
  • Bipolar disorder (no longer called manic depression) is a real medical illness, a condition that is caused by a biological problem that is almost certainly genetic. (skild-edu.org)
  • In our studies, anorexia nervosa was not associated with OCD, but other studies have shown higher rates of this eating disorder among people with OCD. (hopkinsmedicine.org)
  • Adderall-related emergency department visits went up by a whopping 156 percent since 2006, according to a new study. (arizona.edu)
  • To find out if the UA had a similar trend in Adderall-related emergency visits, the Daily Wildcat spoke with Dr. F. Mazda Shirazi, associate professor at the UA College of Medicine and medical director at the Arizona Poison and Drug Information Center. (arizona.edu)
  • The current diagnostic system is years out of date and many professionals believe there are bipolar disorders, soft bipolar disorders and a broad spectrum of bipolar disorders. (skild-edu.org)
  • Despite its virtually universal acceptance as the gold standard in treating bipolar disorder, prescription rates for lithium have been decreasing recently. (springer.com)
  • Despite its place as the gold standard for maintenance treatment in bipolar disorder, prescription patterns from a number of (but not all) countries demonstrate a decreasing use of lithium (Karanti et al. (springer.com)
  • According to the US Health Department, nearly 1 in5 children between 11 and 17 have diagnosable mental, emotional or behavioral disorders. (skild-edu.org)
  • A relationship may exist between inhalant use and an increased risk of frequent drinking, binge-type drinking, smoking, and the use of other drugs, making inhalant-related disorders a new public health problem deserving of more attention. (medscape.com)
  • In contrast, schizophrenia and other primary psychosis disorders are lifelong mental health conditions requiring lifelong treatment programs. (whiteoakrecovery.com)
  • The disorders are often self-limiting after cessation, though, in some patients, psychiatric symptoms may last several weeks after discontinuation. (medscape.com)
  • If symptoms do not resolve within 2 weeks after the amphetamines are discontinued, a primary psychiatric disorder should be suspected. (medscape.com)
  • The symptoms of stimulant use disorder include failure to control usage and frequency of use, an intense craving for the drug, increased use over time to obtain the same effects, known as a developed tolerance, and continued use despite negative repercussions and interference in one's everyday life and functioning. (wikipedia.org)
  • The leaves of for asthma, it eases symptoms of intestinal the khat plant contain alkaloids structurally tract disorders [9] and maintains social con- related to amphetamine. (who.int)
  • Is pregnancy or childbirth related to the onset of OCD symptoms? (hopkinsmedicine.org)
  • Children with PANDAS experience a worsening of OCD symptoms and/or tic disorders following streptococcal infections. (hopkinsmedicine.org)
  • One evidence-based option for people with opioid use disorder is medication-assisted treatment (MAT) with buprenorphine-naloxone ("Suboxone") to decrease symptoms of withdrawal and cravings. (recoveryanswers.org)
  • The emergency department may be an optimal setting for screening and intervention for opioid use disorder due to high volumes of patients and the potential for staff to leverage patients' motivation to change. (recoveryanswers.org)
  • In a randomized trial of emergency department interventions for patients with opioid use disorder, the group initiating buprenorphine-naloxone treatment experienced higher rates of treatment engagement and fewer self-reported days of illicit opioid use than patients in the referral and brief intervention groups. (recoveryanswers.org)
  • While other psychosis disorders are permanent mental health conditions requiring lifelong treatment and therapy. (whiteoakrecovery.com)
  • Researchers at the National Institute of Mental Health have been studying pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections, which are referred to as PANDAS. (hopkinsmedicine.org)
  • People addicted to amphetamines sometimes decrease their use after experiencing paranoia and auditory and visual hallucinations. (medscape.com)
  • Such disorders can also be experienced during the withdrawal period from amphetamines. (medscape.com)
  • DSM-III also introduced various course specifiers-the extensions to a diagnosis that further clarify the course, severity, or special features of a disorder: continuous, episodic, and remission. (thecarlatreport.com)